
<html lang="en"     class="pb-page"  data-request-id="3135431d-addc-4a72-beb2-ef6163589d86"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm300573d"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Pharmacological Profile of New 1H-Indazole-3-carboxamide and 2H-Pyrrolo[3,4-c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands" /></meta><meta name="dc.Creator" content="Guido  Furlotti" /></meta><meta name="dc.Creator" content="Maria Alessandra  Alisi" /></meta><meta name="dc.Creator" content="Claudia  Apicella" /></meta><meta name="dc.Creator" content="Alessandra  Capezzone de Joannon" /></meta><meta name="dc.Creator" content="Nicola  Cazzolla" /></meta><meta name="dc.Creator" content="Roberta  Costi" /></meta><meta name="dc.Creator" content="Giuliana  Cuzzucoli Crucitti" /></meta><meta name="dc.Creator" content="Beatrice  Garrone" /></meta><meta name="dc.Creator" content="Alberto  Iacovo" /></meta><meta name="dc.Creator" content="Gabriele  Magarò" /></meta><meta name="dc.Creator" content="Giorgina  Mangano" /></meta><meta name="dc.Creator" content="Gaetano  Miele" /></meta><meta name="dc.Creator" content="Rosella  Ombrato" /></meta><meta name="dc.Creator" content="Luca  Pescatori" /></meta><meta name="dc.Creator" content="Lorenzo  Polenzani" /></meta><meta name="dc.Creator" content="Federica  Rosi" /></meta><meta name="dc.Creator" content="Marco  Vitiello" /></meta><meta name="dc.Creator" content="Roberto  Di Santo" /></meta><meta name="dc.Description" content="Since the discovery of the serotonin 4 receptor (5-HT4R), a large number of receptor ligands have been studied. The safety concerns and the lack of market success of these ligands have mainly been ..." /></meta><meta name="Description" content="Since the discovery of the serotonin 4 receptor (5-HT4R), a large number of receptor ligands have been studied. The safety concerns and the lack of market success of these ligands have mainly been ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 24, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300573d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300573d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300573d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300573d" /></link>
        
    
    

<title>Discovery and Pharmacological Profile of New 1H-Indazole-3-carboxamide and 2H-Pyrrolo[3,4-c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300573d" /></meta><meta property="og:title" content="Discovery and Pharmacological Profile of New 1H-Indazole-3-carboxamide and 2H-Pyrrolo[3,4-c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0020.jpeg" /></meta><meta property="og:description" content="Since the discovery of the serotonin 4 receptor (5-HT4R), a large number of receptor ligands have been studied. The safety concerns and the lack of market success of these ligands have mainly been attributed to their lack of selectivity. In this study we describe the discovery of N-[(4-piperidinyl)methyl]-1H-indazole-3-carboxamide and 4-[(4-piperidinyl)methoxy]-2H-pyrrolo[3,4-c]quinoline derivatives as new 5-HT4R ligands endowed with high selectivity over the serotonin 2A receptor and human ether-a-go-go-related gene potassium ion channel. Within these series, two molecules (11ab and 12g) were identified as potent and selective 5-HT4R antagonists with good in vitro pharmacokinetic properties. These compounds were evaluated for their antinociceptive action in two analgesia animal models. 12g showed a significant antinociceptive effect in both models and is proposed as an interesting lead compound as a 5-HT4R antagonist with analgesic action." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300573d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300573d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-8/abseba.2021.7.issue-8/20210809/abseba.2021.7.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-15/accacs.2021.11.issue-15/20210806/accacs.2021.11.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-31/ascecg.2021.9.issue-31/20210809/ascecg.2021.9.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-8/bomaf6.2021.22.issue-8/20210809/bomaf6.2021.22.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-29/cgeabj.2021.99.issue-29/20210809-01/cgeabj.2021.99.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-15/enfuem.2021.35.issue-15/20210805/enfuem.2021.35.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-15/joceah.2021.86.issue-15/20210806/joceah.2021.86.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-30/jpcafh.2021.125.issue-30/20210805/jpcafh.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-30/jpcbfk.2021.125.issue-30/20210805/jpcbfk.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-30/jpccck.2021.125.issue-30/20210805/jpccck.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-30/jpclcd.2021.12.issue-30/20210805/jpclcd.2021.12.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-8/jprobs.2021.20.issue-8/20210806/jprobs.2021.20.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-15/orlef7.2021.23.issue-15/20210806/orlef7.2021.23.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-15/orgnd7.2021.40.issue-15/20210809/orgnd7.2021.40.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300573d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300573d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300573d&amp;href=/doi/10.1021/jm300573d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9446-9466</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3005306" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300618u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Pharmacological Profile of New 1<i>H</i>-Indazole-3-carboxamide and 2<i>H</i>-Pyrrolo[3,4-<i>c</i>]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guido++Furlotti">Guido Furlotti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Alessandra++Alisi">Maria Alessandra Alisi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Apicella">Claudia Apicella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandra++Capezzone+de+Joannon">Alessandra Capezzone de Joannon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola++Cazzolla">Nicola Cazzolla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberta++Costi">Roberta Costi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuliana++Cuzzucoli+Crucitti">Giuliana Cuzzucoli Crucitti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatrice++Garrone">Beatrice Garrone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alberto++Iacovo">Alberto Iacovo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriele++Magar%C3%B2">Gabriele Magarò</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgina++Mangano">Giorgina Mangano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gaetano++Miele">Gaetano Miele</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosella++Ombrato">Rosella Ombrato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Pescatori">Luca Pescatori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorenzo++Polenzani">Lorenzo Polenzani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Rosi">Federica Rosi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Vitiello">Marco Vitiello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Di+Santo">Roberto Di Santo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Chemistry and <sup>§</sup> Department of Pharmacology, Angelini Santa Palomba Research Center, Piazzale della Stazione snc, 00040 Pomezia, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Istituto Pasteur—Fondazione Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div><div class="corresp-info"><strong>*</strong>Phone: +39-0691045265 (G.F.); +39-0649913965 (R.D.S.). Fax: +39-0691984597 (G.F.); +39-0649913133 (R.D.S.). E-mail: <a href="/cdn-cgi/l/email-protection#a5c28bc3d0d7c9cad1d1cce5c4cbc2c0c9cccbcc8bccd1"><span class="__cf_email__" data-cfemail="98ffb6feedeaf4f7ececf1d8f9f6fffdf4f1f6f1b6f1ec">[email protected]</span></a> (G.F.); <a href="/cdn-cgi/l/email-protection#43312c212631372c6d272a30222d372c03362d2a312c2e22726d2a37"><span class="__cf_email__" data-cfemail="71031e131403051e5f151802101f051e31041f18031e1c10405f1805">[email protected]</span></a> (R.D.S.).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300573d&amp;href=/doi/10.1021%2Fjm300573d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9446–9466</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 9, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 April 2012</li><li><span class="item_label"><b>Published</b> online</span>24 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300573d" title="DOI URL">https://doi.org/10.1021/jm300573d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9446%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuido%2BFurlotti%252C%2BMaria%2BAlessandra%2BAlisi%252C%2BClaudia%2BApicella%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm300573d%26title%3DDiscovery%2Band%2BPharmacological%2BProfile%2Bof%2BNew%2B1H-Indazole-3-carboxamide%2Band%2B2H-Pyrrolo%255B3%252C4-c%255Dquinoline%2BDerivatives%2Bas%2BSelective%2BSerotonin%2B4%2BReceptor%2BLigands%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9466%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300573d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1584</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300573d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Pharmacological Profile of New 1H-Indazole-3-carboxamide and 2H-Pyrrolo[3,4-c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guido&quot;,&quot;last_name&quot;:&quot;Furlotti&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Alessandra Alisi&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Apicella&quot;},{&quot;first_name&quot;:&quot;Alessandra&quot;,&quot;last_name&quot;:&quot;Capezzone de Joannon&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;Cazzolla&quot;},{&quot;first_name&quot;:&quot;Roberta&quot;,&quot;last_name&quot;:&quot;Costi&quot;},{&quot;first_name&quot;:&quot;Giuliana&quot;,&quot;last_name&quot;:&quot;Cuzzucoli Crucitti&quot;},{&quot;first_name&quot;:&quot;Beatrice&quot;,&quot;last_name&quot;:&quot;Garrone&quot;},{&quot;first_name&quot;:&quot;Alberto&quot;,&quot;last_name&quot;:&quot;Iacovo&quot;},{&quot;first_name&quot;:&quot;Gabriele&quot;,&quot;last_name&quot;:&quot;Magarò&quot;},{&quot;first_name&quot;:&quot;Giorgina&quot;,&quot;last_name&quot;:&quot;Mangano&quot;},{&quot;first_name&quot;:&quot;Gaetano&quot;,&quot;last_name&quot;:&quot;Miele&quot;},{&quot;first_name&quot;:&quot;Rosella&quot;,&quot;last_name&quot;:&quot;Ombrato&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Pescatori&quot;},{&quot;first_name&quot;:&quot;Lorenzo&quot;,&quot;last_name&quot;:&quot;Polenzani&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Rosi&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Vitiello&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Di Santo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9446-9466&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300573d&quot;},&quot;abstract&quot;:&quot;Since the discovery of the serotonin 4 receptor (5-HT4R), a large number of receptor ligands have been studied. The safety concerns and the lack of market success of these ligands have mainly been attributed to their lack of selectivity. In this study we describe the discovery of N-[(4-piperidinyl)methyl]-1H-indazole-3-carboxamide and 4-[(4-piperidinyl)methoxy]-2H-pyrrolo[3,4-c]quinoline derivatives as new 5-HT4R ligands endowed with high selectivity over the serotonin 2A receptor and human ether-a-go-go-related gene potassium ion channel. Within these series, two molecules (11ab and 12g) were identified as potent and selective 5-HT4R antagonists with good in vitro pharmacokinetic properties. These compounds were evaluated for their antinociceptive action in two analgesia animal models. 12g showed a significant antinociceptive effect in both models and is proposed as an interesting lead compound as a 5-HT4R antagonist with analgesic action.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300573d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300573d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300573d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300573d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300573d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300573d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300573d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300573d&amp;href=/doi/10.1021/jm300573d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300573d" /></input><a href="/doi/pdf/10.1021/jm300573d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300573d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300573d%26sid%3Dliteratum%253Aachs%26pmid%3D23043420%26genre%3Darticle%26aulast%3DFurlotti%26date%3D2012%26atitle%3DDiscovery%2Band%2BPharmacological%2BProfile%2Bof%2BNew%2B1H-Indazole-3-carboxamide%2Band%2B2H-Pyrrolo%255B3%252C4-c%255Dquinoline%2BDerivatives%2Bas%2BSelective%2BSerotonin%2B4%2BReceptor%2BLigands%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9446%26epage%3D9466%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292006" title="Potassium">Potassium</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Since the discovery of the serotonin 4 receptor (5-HT<sub>4</sub>R), a large number of receptor ligands have been studied. The safety concerns and the lack of market success of these ligands have mainly been attributed to their lack of selectivity. In this study we describe the discovery of <i>N</i>-[(4-piperidinyl)methyl]-1<i>H</i>-indazole-3-carboxamide and 4-[(4-piperidinyl)methoxy]-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline derivatives as new 5-HT<sub>4</sub>R ligands endowed with high selectivity over the serotonin 2A receptor and human ether-a-go-go-related gene potassium ion channel. Within these series, two molecules (<b>11ab</b> and <b>12g</b>) were identified as potent and selective 5-HT<sub>4</sub>R antagonists with good in vitro pharmacokinetic properties. These compounds were evaluated for their antinociceptive action in two analgesia animal models. <b>12g</b> showed a significant antinociceptive effect in both models and is proposed as an interesting lead compound as a 5-HT<sub>4</sub>R antagonist with analgesic action.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Serotonin (5-hydroxytryptamine, 5-HT) is a major neurotransmitter involved in a vast number of processes in both the central and peripheral nervous systems. Its pharmacological action is mediated by a set of specific receptors. Seven families of 5-HT receptors (5-HTRs) have been identified so far that have been cloned and coded from 5-HT<sub>1</sub> to 5-HT<sub>7</sub>.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> With the exception of 5-HT<sub>3</sub>, all 5-HTRs belong to the superfamily of G-protein-coupled receptors and have the typical heptahelical structure of a transmembrane protein monomer. 5-HT<sub>4</sub> receptor (5-HT<sub>4</sub>R) is positively coupled to adenylate cyclase by G<sub>s</sub> protein. After its activation, 5-HT<sub>4</sub>R induces an increase in intracellular levels of cyclic adenosine monophosphate (cAMP), activating protein kinase A (PKA), which in turn results in the modulation of a series of ionic cellular currents.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> 5-HT<sub>4</sub>Rs are widely distributed in both the central and peripheral tissues and are involved in several neuronal functions.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Thus, since its discovery, 5-HT<sub>4</sub>R has been considered as a potential therapeutic target, and a large number of 5-HT<sub>4</sub>R ligands have been described and studied for the treatment of a number of disease indications in the past 15 years.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> The most significant results have been obtained for the treatment of irritable bowel syndrome (IBS) (cisapride (<b>1</b>), tegaserod (<b>2</b>), and prucalopride (<b>3</b>)) and in the treatment of heart failure, with piboserod (<b>4</b>) producing significant improvement in left ventricular function during clinical trials on patients with symptomatic heart failure (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> Further studies led to the discovery of 5-HT<sub>4</sub>R antagonists such as compounds <b>5</b>–<b>9</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref9 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref14 ref15">(9, 14, 15)</a> Moreover, the interest in 5-HT<sub>4</sub>R ligands increased when the 5-HT<sub>4</sub>R was proposed to be involved in the mechanism of nociception. The first example of this involvement was demonstrated when three nonselective 5-HT<sub>4</sub>R agonists, <b>1</b>, <i>endo</i>-<i>N</i>-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1<i>H</i>-benzimidazole-1-carboxamide hydrochloride (BIMU 1), and <i>endo</i>-<i>N</i>-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-3-(1-methylethyl)-2-oxo-1<i>H</i>-benzimidazole-1-carboxamide hydrochloride (BIMU 8), showed an antinociceptive effect in animal models.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Afterward, several studies on 5-HT<sub>4</sub>R antagonists such as <b>5</b>, <b>6</b>, and SDZ-205557 (<b>10</b>) or partial agonists such as <b>2</b> have suggested that the inactivation of this receptor may be an effective method to treat some types of pain (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. 5-HT<sub>4</sub>R Ligands Currently Used in Clinical Practice or Trials, <b>1</b>–<b>10</b>, Including Compounds <b>4</b>–<b>9</b> Used To Develop Pharmacophore Models, and Hit Compounds <b>11b</b> and <b>12a</b> Found in the Present Study by a VS Approach</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unfortunately, most drugs active on the serotoninergic system show side effects consistent with low selectivity toward other serotoninergic receptors or interaction with ion channels such as the human ether-a-go-go-related gene (hERG) potassium channel.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26">(22-26)</a></div><div class="NLM_p">The interaction with these channels is associated with an adverse cardiac QT-interval prolongation and caused the withdrawal of <b>1</b> from the market in 2000.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nowadays, hERG inhibition is routinely investigated in the early phase of the drug discovery process to decrease the risk of subsequent cardiac safety concerns.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Because of the lack of structural data on 5-HT<sub>4</sub>R, there is insufficient information to perform a target-based drug design program. Thus, we decided to apply a virtual screening (VS) approach on our in-house chemical library including around 9500 heterocyclic compounds.</div><div class="NLM_p last">Studies on 5-HT<sub>4</sub>R antagonists described in the literature in the past two decades have provided crucial insights into the structural motifs required for a ligand to have a strong interaction with this receptor.<a onclick="showRef(event, 'ref9 ref14 ref15 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref9 ref14 ref15 ref29 ref30">(9, 14, 15, 29, 30)</a> Therefore, we built a 3D pharmacophore model based on the literature antagonists and used it for the VS of our in-house library. A total of 71 virtual hits were identified that were then tested in vitro in a human recombinant 5-HT<sub>4</sub>R binding assay using <b>4</b> as a reference compound. Two hit compounds were identified, <i>N</i>-[(1-butyl-4-piperidinyl)methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11b</b>) and 4-(4-piperidinylmethoxy)-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12a</b>), and derivatives of <b>11b</b> and <b>12a</b> were synthesized to define the structure–activity relationships (SARs) in these series. In this paper we report the activities of the newly synthesized compounds (<b>11a–ab</b> and <b>12a</b>–<b>k</b>) on 5-HT<sub>4</sub>R, as well as on relevant off-target proteins such as 5-HT<sub>2A</sub> receptors, and inhibition of the hERG potassium ion channel. In vitro absorption, distribution, metabolism, and excretion (ADME) properties and antinociceptive efficacy of the most promising compounds <b>11ab</b> and <b>12g</b> in two different animal models are also described.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Ligand Design</h3><div class="NLM_p">A collection of 16 5-HT<sub>4</sub> antagonists characterized by different chemical scaffolds were taken from the literature,<a onclick="showRef(event, 'ref9 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref14 ref15">(9, 14, 15)</a> and among them, six compounds (<b>4</b>–<b>9</b>) were used to define a data set to generate several 3D pharmacophore models (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). Only three models (referred to as APR29, HPR45, and AAP29) were selected for the validation step on the basis of (i) the highest score obtained and (ii) the largest diversity of electronic features to match chemical groups with different properties (e.g., hydrogen bond acceptor, hydrophobic, positive charge, and aromatic ring) in different combinations. Each model was used to perform a hit search on a database of 1000 druglike ligand decoys from Schrödinger and 10 known active compounds, seeded to have a random hit rate of 1%. The enrichment factor (EF) was calculated after each VS process, and these values were compared to determine the best performing model. The EF is the measure of how many active compounds are found within a defined “early recognition” fraction of the ordered list relative to a random distribution and is calculated as follows:<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/jm-2012-00573d_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>N</i><sup><i>x</i>%</sup><sub>exptl</sub> is the number of experimentally found active structures in the top <i>x</i>% of the sorted database and <i>N</i><sub>active</sub> is the total number of active structures in the database.</div><div class="NLM_p">The best outcome for each VS protocol is 100% (10 out of 10) at the top 1%. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> shows that the APR29 pharmacophore gave the best result compared to the other pharmacophores, showing the maximum EFs at the top 5% of the data set.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Enrichment for the top 2%, 5%, and 10% of the data set for the AAP29, APR29, and HPR32 hypotheses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">APR29 contained three structural features: a hydrogen bond acceptor, an aromatic ring, and a positively charged group distributed as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> overlaid with reference compounds <b>7</b> and <b>8</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pharmacophore model APR29 for 5-HT<sub>4</sub> antagonists <b>7</b> and <b>8</b>: aromatic ring (R12, brown), positive ionizable group (P11, blue), and acceptor H-bond group (A4, red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">APR29 was then used to carry out a virtual hit search in a multiconformer version of our proprietary database (Angelini corporate database). The hits retrieved from the pharmacophore search were filtered for non-drug-like groups and properties, giving 71 compounds characterized by several different chemical scaffolds. These molecules were submitted to a single concentration binding assay, using the human recombinant 5-HT<sub>4</sub>R and <b>4</b> as a reference compound (data not shown). From this, compounds <b>11b</b> and <b>12a</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) emerged as promising hits, showing good 5-HT<sub>4</sub>R binding affinity, with binding inhibition values of 98% and 48%, respectively, at a concentration of 1 μM compared to <b>4</b>, which showed 100% inhibition at the same concentration. The two hit compounds matched all three pharmacophoric features of APR29, proving the validity of this pharmacophore approach for identifying novel scaffold hits (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Match of compounds <b>11b</b> (orange) and <b>12a</b> (green) with the three pharmacophore features of the APR29 hypothesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of its ease of chemical manipulation, we first decided to study the chemical space around hit compound <b>11b</b> (<i>N</i>-[(1-butyl-4-piperidinyl)methyl]-1<i>H</i>-indazole-3-carboxamide), focusing our initial attention on the following substitution sites: (i) the piperidine nitrogen, (ii) the indazole nitrogens, and (iii) the 5-position of the indazole ring. We subsequently applied the SAR from this series to design and synthesize a focused library of 2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline derivatives based on <b>12a</b>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">The <i>N</i>-(4-piperidinylmethyl)-1<i>H</i>-indazole-3-carboxamides <b>11a</b>–<b>g</b>,<b>m</b>,<b>q–y</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for the actual structures). The appropriate <i>N</i>-alkyl-1<i>H</i>-indazole-3-carbonyl chlorides (<b>13</b> or <b>14</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>) were reacted with 1-[1-(phenylmethyl)-4-piperidinyl]methylamine to afford compounds <b>11q</b> and <b>15</b>, which were then hydrogenated to give <i>N</i>-unsubstituted derivatives <b>11a</b> and <b>16</b>, respectively. Compounds <b>11b</b>–<b>d</b>,<b>f</b>,<b>g,m,t–y</b> were obtained by nucleophilic substitution of <b>11a</b> and <b>16</b> with the appropriate alkyl halide or by reaction with 2-vinylpyridine for <b>11e</b> and <b>11r</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Finally, <b>11s</b> was obtained by methylation of piperidine <b>11m</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Compounds <b>11a–g,m,q–y</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, room temperature; (b) H<sub>2</sub>, 10% Pd/C, CH<sub>3</sub>CO<sub>2</sub>H; (c) alkyl bromide, K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux (or DMF, 80 °C); (d) 2-vinylpyridine, CH<sub>3</sub>CO<sub>2</sub>H, H<sub>2</sub>O, reflux → room temperature; (e) CH<sub>3</sub>I, CH<sub>3</sub>COCH<sub>3</sub>, room temperature; (f) CH<sub>3</sub>I, acetone, room temperature.</p></p></figure><div class="NLM_p">The 5-substituted <i>N</i>-[(1-butyl-4-piperidinyl)methyl]-1(2)-methylindazole-3-carboxamides <b>11h</b>–<b>k</b> were obtained by transformation of the 5-substituted-1(2)-methylindazole-3-carboxylic acids <b>17</b>–<b>20</b><a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> into the corresponding acyl chlorides followed by amidation with 1-(1-butyl-4-piperidinyl)methylamine (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> for the actual structures).</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Compounds <b>11h</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) SOCl<sub>2</sub>, toluene, reflux; (ii) 1-(1-butyl-4-piperidinyl)methylamine, toluene, room temperature.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Properties of Derivatives <b>11a</b>–<b>k</b> for the Human 5-HT<sub>4</sub>R and Functional Inhibition of the hERG Potassium Ion Channel</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Percent displacement of the [<sup>3</sup>H]<b>5</b> ligand from the recombinant human 5-HT<sub>4</sub>R, mean values of duplicate measurements.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">See ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Tested as maleic salt.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Tested as hydrochloride salt.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Tested as oxalic salt.</p></div></div><div></div></div><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> shows the synthetic pathway to obtain compounds <b>11l,n–p</b> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> for the actual structures). Indazole-3-carbonyl chloride was first reacted with 1-[1-(2-phenylethyl)-4-piperidinyl]methylamine to furnish <b>11l</b>. Subsequent alkylation with the appropriate alkyl bromide or acetylation with acetic anhydride afforded indazole-3-carboxamides <b>11n</b>–<b>p</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to Compounds <b>11l,n–p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-[1-(2-phenylethyl)-4-piperidinyl]methylamine, toluene, reflux; (b) alkyl bromide, DMF, NaH, 0 °C → room temperature; (c) (CH<sub>3</sub>CO)<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Properties of Derivatives <b>11d</b>,<b>l–p</b> for the Human 5-HT<sub>4</sub> and 5-HT<sub>2A</sub> Receptors and Functional Inhibition of the hERG Potassium Ion Channel</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0015.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">inhibition (%) of 5-HT<sub>4</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">10<sup>–8</sup> M</th><th class="colsep0 rowsep0" align="center" char=".">10<sup>–9</sup> M</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%) of 5-HT<sub>2A</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (10<sup>–7</sup> M)</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%) of hERG<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (10<sup>–6</sup> M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11l</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11m</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">108</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11n</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11o</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11p</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">methysergide</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Precentage of displacement of the [<sup>3</sup>H]<b>5</b> ligand from the recombinant human 5-HT<sub>4</sub>R, mean values of duplicate measurements.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Precentage of displacement of [<sup>3</sup>H]ketanserin ligand from the recombinant human 5-HT<sub>4</sub>R, mean values of duplicate measurements.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">See ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Tested as hydrochloride salt.</p></div></div></div><div class="NLM_p">Derivatives <b>11z–ab</b> were obtained as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for the actual structures). Compound <b>16</b> was alkylated under basic conditions with 1-(2-bromoethyl)-4-nitrobenzene or ethyl 4-(2-bromoethyl)benzoate<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> to afford <b>11z</b> and <b>21</b>, respectively. Then <b>11z</b> was reduced with hydrogen in the presence of Pd to afford amine <b>11aa</b>, while basic hydrolysis of <b>21</b> gave the corresponding carboxylic acid <b>11ab</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Compounds <b>11z,aa,ab</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-(2-bromoethyl)-1-nitrobenzene, EtOH, K<sub>2</sub>CO<sub>3</sub>, reflux; (b) ethyl 4-(2-bromoethyl)benzoate,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> KI, triethylamine, 2-butanone, reflux; (c) 10% Pd/C, H<sub>2</sub>, EtOH, room temperature; (d) 1 N NaOH, THF, EtOH, room temperature.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Properties of Derivatives <b>11m,q–ab</b> for the Human 5-HT<sub>4</sub> and 5-HT<sub>2A</sub> Receptors, Functional Inhibition of the hERG Potassium Ion Channel, and Calculated log <i>D</i> at pH 7.4</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Binding affinity for the human recombinant 5-HT<sub>4</sub> receptor, displacement of the [<sup>3</sup>H]<b>5</b> ligand expressed as p<i>K</i><sub>i</sub>, mean values of duplicate measurements. Confidence intervals of 95% for <i>K</i><sub>i</sub> are not greater than 10% of <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Binding affinity for the human recombinant 5-HT<sub>2A</sub> receptor, displacement of the [<sup>3</sup>H]ketanserin ligand expressed as p<i>K</i><sub>i</sub>, mean values of duplicate measurements. Confidence intervals of 95% for <i>K</i><sub>i</sub> are not greater than 10% of <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">See ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">log <i>D</i><sub>(7.4)</sub> values calculated by ACDLabs 12.0.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Tested as hydrochloride salt.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">Extrapolated values from three-concentration assay.</p></div><div class="footnote" id="t3fn7"><sup>Table g</sup><p class="last">Tested as iodide salt.</p></div><div class="footnote" id="t3fn8"><sup>Table h</sup><p class="last">Tested as dihydrochloride salt.</p></div><div class="footnote" id="t3fn9"><sup>Table i</sup><p class="last">Tested as dimaleic salt.</p></div><div class="footnote" id="t3fn10"><sup>Table j</sup><p class="last">Tested as oxalic salt.</p></div></div><div></div></div><div class="NLM_p">4-(4-Piperidinylmethoxy)-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolines <b>12a–e,i–k</b> were prepared starting from nitrocinnamate <b>22</b>, which underwent annulation with (4-tolylsulfonyl)methyl isocyanide (TosMIC) in the presence of sodium hydride to afford pyrrole <b>23</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> for the actual structures).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to Compounds <b>12a–e,i–k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TosMIC, NaH, DMSO, Et<sub>2</sub>O, room temperature; (b) Fe, CH<sub>3</sub>CO<sub>2</sub>H, 85 °C; (c) XR<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C; (d) POCl<sub>3</sub>, Et<sub>3</sub>N, 120 °C; (e) (1-alkyl-4-piperidinyl)methanol, NaH, DMF, 146 °C; (f) H<sub>2</sub>, 10% Pd/C, EtOH; (g) XR<sub>1</sub>, K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux; (h) XR<sub>1</sub>, EtOH, NaHCO<sub>3</sub>, reflux; (i) XR<sub>1</sub>, NaI, Et<sub>3</sub>N, 2-butanone, reflux; (j) 4-(2-bromoethyl)benzyl alcohol (<b>33</b>) or [4-(methoxymethyl)phenyl]ethyl bromide (<b>34</b>), Et<sub>3</sub>N, 2-butanone, reflux.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Properties of Derivatives <b>12a</b>–<b>k</b> for the Human 5-HT<sub>4</sub> and 5-HT<sub>2A</sub> Receptors, Functional Inhibition of the hERG Potassium Ion Channel, and Calculated log <i>D</i> at pH 7.4</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0018.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0019.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Binding affinity for the human recombinant 5-HT<sub>4</sub> receptor, displacement of the [<sup>3</sup>H]<b>5</b> ligand expressed as p<i>K</i><sub>i</sub>, mean values of duplicate measurements. Confidence intervals of 95% for <i>K</i><sub>i</sub> are not greater than 10% of <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Binding affinity for the human recombinant 5-HT<sub>2A</sub> receptor, displacement of the [<sup>3</sup>H]ketanserin ligand expressed as p<i>K</i><sub>i</sub>, mean values of duplicate measurements. Confidence intervals of 95% for <i>K</i><sub>i</sub> are not greater than 10% of <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">See ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">log <i>D</i><sub>(7.4)</sub> values calculated by ACDLabs 12.0.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Percent inhibition at a concentration of 30 μM.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">Tested as hydrochloride salt.</p></div></div><div></div></div><div class="NLM_p">The latter compound was transformed into 2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(5<i>H</i>)-one (<b>24</b>) in a two-step, one-pot reaction carried out with iron powder in glacial acetic acid at 85 °C.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Substitution at the 2-position of the pyrroloquinoline ring was easily achieved by alkylation of intermediate <b>24</b> with the appropriate alkyl halide in the presence of K<sub>2</sub>CO<sub>3</sub> to achieve <b>25</b> and <b>26</b>.</div><div class="NLM_p">Substitution at the 4-position was achieved via a two-step process involving a POCl<sub>3</sub> chlorination and subsequent nucleophilic displacement of the resultant chlorides <b>27</b> and <b>28</b>, with the appropriate (1-alkyl-4-piperidinyl)methanol derivative to afford <b>12b</b>–<b>d</b> and <b>29</b>. Benzyl derivative <b>29</b> was deprotected by catalytic hydrogenation to give intermediate <b>12a</b>, which was alkylated under basic conditions to give <b>12e</b>,<b>i–k</b>.</div><div class="NLM_p">Compounds <b>12f</b>–<b>h</b> were obtained as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> for the actual structures). Alkylation of piperidine derivative <b>12a</b> with 1-(2-bromoethyl)-4-nitrobenzene gave nitro derivative <b>30</b>, which was reduced to amino compound <b>12f</b>. Esters <b>31</b> and <b>32</b> were obtained by alkylation of <b>12a</b> with the appropriate ethyl<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or methyl (<b>35</b>) (haloethyl)benzoate and were subsequently hydrolyzed to generate the final products <b>12g</b> and <b>12h</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to Compounds <b>12f</b>–<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 4-(2-chloroethyl)benzoate<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or methyl 2-(2-bromoethyl)benzoate (<b>35</b>), NaI, Et<sub>3</sub>N, 2-butanone, reflux; (b) 4-(2-bromoethyl)-1-nitrobenzene, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (c) H<sub>2</sub>, 10% Pd/C, EtOAc (d) 1 N NaOH, THF, EtOH.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Biological Activities</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 5-HTR Affinity in Vitro Assays</h4><div class="NLM_p last">The newly synthesized compounds <b>11a–ab</b> and <b>12a</b>–<b>k</b> were tested for their activity on 5-HT<sub>4</sub>R in competition binding assay, at different concentrations, using [<sup>3</sup>H]<b>5</b> as a radioligand and <b>4</b> as a reference compound. Preliminary data on the binding profile of several hits (<b>11b</b>,<b>d,m</b>) suggested low selectivity over all the 5-HT subtype receptors and transporter (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>); therefore, the affinities of the above compounds versus some off-target proteins were also tested. The screening panel demonstrated significant activity on the 5-HT<sub>2A</sub>R, so we also decided to screen the most interesting compounds in a multiconcentration binding assay for the 5-HT<sub>2A</sub>R to determine the activity at this target. These assays were performed in vitro using [<sup>3</sup>H]ketanserin as a radiologand and methysergide as a reference compound (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5-HT<sub>4</sub>R Affinity in Vitro Assays</h4><div id="sec2_3_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> 1<i>H</i>-Indazole-3-carboxamide Series</h5><div class="NLM_p">The effect of substituents at the piperidinyl nitrogen (R<sub>1</sub>) was studied by replacement of the butyl chain (<b>11b</b>) with several alkyl-, aryl-, and heteroarylalkyl groups (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The unsubstituted derivative <b>11a</b> showed reduced affinity compared to <b>11b</b>, and binding was markedly increased by larger groups such as cyclohexylethyl, phenylethyl, 2-pyridinylethyl, (4-chlorophenyl)ethyl, and phenylbutyl (compounds <b>11c</b>–<b>g</b>, 64–84% inhibition at 10<sup>–8</sup> M). Elongation of the alkyl linker between the piperidine nitrogen and the phenyl group from two to four carbon atoms gave a slight reduction of binding inhibition (compare <b>11d</b> and <b>11g</b>).</div><div class="NLM_p">The effect of substitution on the indazole ring was also studied; in particular, we chose to study the 5-position due to its structural similarity with 5-HT. Chloro, methoxy, and methyl groups were selected as substituents as they have different sizes and electronics. The influence of these substituents on the 5-HTR affinity is usually dependent on the 5-HTR subtype, and in particular, 5-methoxytriptamine has been reported as a 5-HT<sub>4</sub>R agonist comparable to 5-HT.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Introduction of a methyl group (<b>11h</b>) or a chlorine atom (<b>11j</b>) was detrimental for binding inhibition, with values of 43% and 40%, respectively, at 0.1 μM compared to 88% for the unsubstituted compound <b>11b</b> at the same concentration. A methoxy group in the same position (<b>11i</b>) totally depleted any activity even at the highest concentration tested (−9% at 0.1 μM). This drop in binding in the indazole series has not previously been shown for the 5-HT<sub>4</sub> receptor.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The same drop of activity was also observed when the methyl group of <b>11b</b> was shifted from the 1- to 2-position of the indazole ring (<b>11b</b> and <b>11k</b>).</div><div class="NLM_p">A small series of derivatives were also designed to study the influence of substitution at the 1-position of the indazole ring on binding. Thus, we synthesized and tested a few derivatives of compound <b>11d</b>, in which the methyl group on N1 was removed or replaced with larger alkyl groups or with an acetyl (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Desmethyl compound <b>11l</b> showed a lower inhibition for 5-HT<sub>4</sub>R, while the larger isopropyl derivative <b>11m</b> was more active than the parent compound <b>11b</b> (88% at 1 nM). A further increase in the size of the alkyl group, such as for 1-methylpropyl (<b>11n</b>) and isopentyl (<b>11o</b>) derivatives, had a detrimental effect on binding inhibition. Interestingly, the 1-acetyl analogue <b>11p</b> showed better activity than methyl derivative <b>11d</b>. Unfortunately, its chemical instability possibly due to hydrolytic degradation prevented further development.</div><div class="NLM_p">Finally, the SAR around the basic site of the molecule was investigated, keeping the isopropyl group on the 1-position and the unsubstituted benzene of the indazole ring constant as these substitution patterns both gave good affinity. Therefore, the <i>N</i>-[(1-substituted-4-piperidinyl)methyl]-1-isopropyl-1<i>H</i>-indazole-3-carboxamides <b>11m,q–ab</b> were prepared and assayed for their ability to bind 5-HT<sub>4</sub>R (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">When 2-pyridinylethyl or cyclohexylethyl groups were linked to the piperidine nitrogen, excellent affinities were obtained, with compounds <b>11r</b> and <b>11t</b> showing p<i>K</i><sub>i</sub> values comparable to that of compound <b>11m</b> (10.0, 9.8, and 10.1, respectively).</div><div class="NLM_p">Shortening of the linker to one carbon atom between the phenyl and the basic site of <b>11m</b> led to benzyl derivative <b>11q</b>, which was about 10 times less potent than the parent compound.</div><div class="NLM_p">Quaternarization of the basic tertiary nitrogen atom (<b>11s</b>) was totally detrimental to activity, showing a p<i>K</i><sub>i</sub> value about 400 times lower than that of the desmethylated counterpart <b>11m</b>. This drop in activity demonstrates the importance of steric and electronic requirements for the basic site of the molecule for its efficient binding with the receptor.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Reasonably potent 5-HT<sub>4</sub> receptor ligands were obtained when polar alkyl chains were introduced as substituents on the piperidine nitrogen. Morpholine <b>11u</b>, amine <b>11v</b>, sulfonamide <b>11w</b>, and amide <b>11x</b> all showed p<i>K</i><sub>i</sub> values ranging from 9.1 to 9.5.</div><div class="NLM_p last">A study of the effect of the substitution on the 4-position of the phenyl ring of <b>11m</b> was also performed. Binding affinity values in the subnanomolar range were found for 4-hydroxy (<b>11y</b>) and 4-amino (<b>11aa</b>) derivatives (p<i>K</i><sub>i</sub> = 9.6 and 9.7, respectively). A slight decrease in affinity was found when the hydroxyl or amino groups were replaced by nitro or carboxylic moieties (<b>11z</b> and <b>11ab</b> have p<i>K</i><sub>i</sub> = 8.9 and 9.1, respectively). All these results support the hypothesis that the 5-HT<sub>4</sub>R has a large pocket around the interaction point with the basic site of the ligand, which can accommodate both large hydrophobic moieties and polar terminal chains.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec2_3_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> 2<i>H</i>-Pyrrolo[3,4-<i>c</i>]quinoline Series</h5><div class="NLM_p">A focused series of 2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline derivatives related to hit <b>12a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were also synthesized, taking into account the SAR around the indazole-3-carboxamide series. Due to their cumbersome syntheses, substitution on the benzene of the pyrroloquinoline ring was not considered in this study. Contrary to that observed in the previous series, the methyl derivative <b>12c</b> showed 5-HT<sub>4</sub>R binding affinity 2 orders of magnitude higher than that of the isopropyl counterpart <b>12d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, p<i>K</i><sub>i</sub> = 8.7 and 6.9, respectively). This could be due to the steric clash caused by the isopropyl group, on the rigid tricyclic pyrroloquinoline ring, with the receptor. This negative interaction may not occur for the more conformationally free indazolecarboxamide moiety. Thus, the methyl group was selected for the remainder of the SAR studies.</div><div class="NLM_p">Finally, a few derivatives of <b>12a</b> were designed, in which the butyl group on the piperidine ring was removed or substituted with the groups that gave the most potent and selective ligands within the indazolecarboxamide series (see the sections “<a class="ref internalNav" href="#sec2_3_4" aria-label="Selectivity for 5-HT4R vs 5-HT2AR">Selectivity for 5-HT4R vs 5-HT2AR</a>” and “<a class="ref internalNav" href="#sec2_4" aria-label="Effect on the hERG Ion Channel">Effect on the hERG Ion Channel</a>”). These included the morpholinylethyl or (un)substituted phenylethyl moieties.</div><div class="NLM_p">Four substituted phenylethyl derivatives (<b>12h</b>–<b>k</b>) were synthesized to further explore the chemical space around the phenyl ring that seemed to be relevant for both affinity and selectivity in the previous series.</div><div class="NLM_p last">Substitution on the nitrogen of the piperidine ring gave similar results in both series. The phenylethyl derivative <b>12c</b> showed the highest affinity (p<i>K</i><sub>i</sub> = 8.7), and an increase in affinity was also observed for the 4-carboxylic derivative <b>12g</b> and the amide <b>12k</b>. Removal of the acetyl group of <b>12k</b> gave amine <b>12f</b>, which showed a slight decrease in affinity (p<i>K</i><sub>i</sub> = 8.3) compared to the parent compound. Replacement of the carboxylic group of <b>12g</b> with a hydroxymethyl or a methoxymethyl moiety gave compounds that showed a moderate decrease in activity (<b>12i</b> and <b>12j</b>, p<i>K</i><sub>i</sub> = 8.0 and 7.7, respectively), while moving the carboxylic group from the 4- to the 2-position of the phenyl ring gave compound <b>12h</b>, which showed a 2 orders of magnitude drop in binding affinity. Unsubstituted piperidine derivative <b>12a</b> was 200 times less active than phenylethyl derivative <b>12c</b>, while the butyl analogue <b>12b</b> had p<i>K</i><sub>i</sub> = 8.1. Finally, the morpholine derivative <b>12e</b> and the phenyl derivative <b>12c</b> showed comparable binding activities (p<i>K</i><sub>i</sub> = 8.6 and 8.7, respectively).</div></div></div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Selectivity over 5-HT<sub>4</sub>R vs 5-HT<sub>2A</sub>R</h3><div class="NLM_p">Throughout the SAR study directed toward obtaining potent 5-HT<sub>4</sub>R ligands, attention was paid to the selectivity of our compounds versus some off-target proteins. Our concern for a potential lack of selectivity arose from (i) literature data showing that 5-HT<sub>4</sub>R has structural features partially overlapping those of 5-HT<sub>2A</sub>R<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and (ii) preliminary binding data of a few initial hits (<b>11b</b>, <b>11d</b>, and <b>11m</b>) for all the 5-HT subtype receptors and transporter (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), which confirmed the presence of significant activity for the off-target 5-HT<sub>2A</sub>R. We therefore decided to screen the most interesting compounds against 5-HT<sub>2A</sub>R (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_p">Low selectivity between 5-HT<sub>4</sub> and 5-HT<sub>2A</sub> receptors was confirmed for a number of compounds within the indazolecarboxamide series, which show p<i>K</i><sub>i</sub> values for 5-HT<sub>2A</sub>R between 7 and 8 (<b>11m,r,y,aa</b>). However, small chemical modifications led to significant changes in activity. Among the most potent 5-HT<sub>4</sub> ligands, low or very low 5-HT<sub>2A</sub>R binding affinity (p<i>K</i><sub>i</sub> < 6) was obtained with derivatives having polar terminal moieties (<b>11u</b>–<b>w</b>) or electron-withdrawing substituents on the phenyl moiety (<b>11z</b> and <b>11ab</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). These results gave us useful information about the electronic and structural requirements needed to obtain selectivity toward the 5-HT<sub>2A</sub>R, particularly in the region “beyond” the basic site of the molecules, where the 5-HT<sub>4</sub>R shows more tolerance.</div><div class="NLM_p last">Interestingly, the 4-(4-piperidinylmethoxy)-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolines display lower affinity for the 5-HT<sub>4</sub> and 5-HT<sub>2A</sub> receptors compared to their indazolecarboxamide counterparts. Fortunately, the positive effect on 5-HT<sub>4</sub> selectivity shown by the morpholinylethyl and (4-carboxyphenyl)ethyl moieties in the indazolecarboxamide series was retained in the pyrroloquinolines, with compounds <b>12e</b> and <b>12g</b> having p<i>K</i><sub>i</sub> < 5 on 5-HT<sub>2A</sub>R. The 4-acetamido derivative <b>12k</b> also showed high selectivity (5-HT<sub>2A</sub>, p<i>K</i><sub>i</sub> = 5.5).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Effect on the hERG Ion Channel</h3><div class="NLM_p">Our ligands are lipophilic molecules with a basic site, and these structural features are often associated with hERG inhibition.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> We therefore carried out a functional hERG/Kv11.1 cellular assay on selected compounds using <b>1</b> as a reference compound (100% at 10 μM).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The hERG inhibitions shown as percent inhibition at 1 μM or IC<sub>50</sub> values are reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, together with the calculated values of log <i>D</i> (pH 7.4) (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). log <i>D</i><sub>(7.4)</sub> (octanol/water) was selected as a measure of hydrophobicity since it considers the predominance of protonated species or zwitterions at pH 7.4. The results show that in general there is a correlation between the lipophilicity and the hERG activity.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Within the indazole series, neither the Me<sub>2</sub>N– or MeSO<sub>2</sub>NH– groups on the alkyl chain terminal moiety nor the −OH and −NO<sub>2</sub> groups on the 4-position of the phenyl ring led to a significant reduction of hERG inhibition activity (see compounds <b>11v</b>,<b>w,y,z</b>). On the other hand, the morpholine and aniline derivatives <b>11u</b> and <b>11aa</b> (IC<sub>50</sub> = 32.5 and 22.6 μM) showed a reduction in inhibition. The best result was obtained with carboxylic acid derivative <b>11ab</b>, which was inactive in the hERG assay at the highest concentration tested (100 μM). The use of carboxylic acid groups to mitigate hERG has been previously reported.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a></div><div class="NLM_p">Unfortunately, the newly synthesized 2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline derivatives generally exhibited high affinity for the hERG channel. All tested compounds showed IC<sub>50</sub> values ranging from 0.01 to 1.22 μM, including morpholine and aniline derivatives <b>12e</b>,<b>f</b>. One notable exception was carboxylic acid derivative <b>12g</b> (IC<sub>50</sub> = 9.96 μM). The high hERG affinity found in this chemical series could be attributed to the higher lipophilicity of these compounds, which have log <i>D</i><sub>(7.4)</sub> values almost 1 unit higher than those of their <i>N</i>-(4-piperidinylmethyl)-1-isopropyl-1<i>H</i>-indazole-3-carboxamide counterparts (compare log <i>D</i><sub>(7.4)</sub> values of <b>12c</b>,<b>e–g</b> with those of <b>11m</b>,<b>u</b>,<b>aa</b>,<b>ab</b>, respectively). Only the introduction of the carboxylic acid group (<b>12g</b>) significantly decreased the affinity for the hERG ion channel.</div><div class="NLM_p last">Taking into account the interesting in vitro properties of the carboxylates <b>11ab</b> and <b>12g</b> (high affinity for 5-HT<sub>4</sub>R and good selectivity toward the 5-HT<sub>2A</sub>R and hERG channel), we decided to further investigate their pharmacological profile with several biologically relevant receptors and enzymes.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Compound <b>11ab</b> did not show any significant interaction (<50% inhibition at 100 μM) for all the biological targets assayed, whereas compound <b>12g</b> shows only very weak binding affinity for σ1 and σ2 receptors, with 58% and 68% inhibition at 10 μM, respectively (Table 2 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-HT<sub>4</sub>R Antagonism</h3><div class="NLM_p last">The 5-HT<sub>4</sub>R antagonism was tested for a few of the most interesting derivatives. Compounds <b>11b</b>,<b>v</b>,<b>x</b>,<b>y</b>,<b>aa</b> lacked any intrinsic activity on intracellular basal Ca<sup>2+</sup> levels in the HEK293 cellular functional assay, whereas they antagonized (1 μM) 5-HT-induced intracellular ion levels (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The same result was also obtained for <b>11y</b> and <b>11aa</b> in an intracellular cAMP level functional assay for human 5-HT<sub>4</sub>R (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The most interesting compounds <b>11ab</b> and <b>12g</b> showed full receptor antagonism in the cAMP-related functional assay on human recombinant 5-HT<sub>4(e)</sub> receptor (Chinese hamster ovarian, CHO; <b>5</b> as reference antagonist compound), with IC<sub>50</sub> values of 9.8 and 2.8 nM and <i>K</i><sub>b</sub> values of 1.4 and 0.41 nM, respectively (<b>5</b>, IC<sub>50</sub> = 0.21 nM, <i>K</i><sub>b</sub> = 0.03 nM) (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Pharmacokinetic Studies</h3><div class="NLM_p"><b>11ab</b> and <b>12g</b> were tested in an in vitro liver microsome assay from five different species (rat, dog, miniature pig, monkey, and human) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Intrinsic clearance was also calculated for rat and human microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Both compounds showed high metabolic stability in all the tested species, with the exception of <b>12g</b> in cynomolgus monkey liver microsomes, where it showed low and moderate stability at 1 and 10 μM, respectively. This metabolic behavior could possibly be attributed to the presence of a specific cytochrome P450 in monkey (CYP2C76), where compound <b>12g</b> could be metabolized, as observed for other compounds such as tolbutamide and testoterone.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The low values of intrinsic clearance for <b>11ab</b> (3.9 and 2.5 mL/min/kg, respectively) and <b>12g</b> (8.32 and 0.65 mL/min/kg, respectively) supported the selection of these compounds for further in vivo evaluation.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Metabolic Stability of <b>11ab</b> and <b>12g</b> in Pooled Liver Microsomes from Different Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">percentage of compd remaining</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>11ab</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>12g</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">conc (μM)</th><th class="colsep0 rowsep0" align="center" char=".">30 min</th><th class="colsep0 rowsep0" align="center" char=".">60 min</th><th class="colsep0 rowsep0" align="center" char=".">30 min</th><th class="colsep0 rowsep0" align="center" char=".">60 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char=".">Human</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char=".">Mini-Pig</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">109</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">102</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char=".">Cynomolgus Monkey</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char=".">Beagle Dog</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">115</td><td class="colsep0 rowsep0" align="char" char=".">107</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char=".">Rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char=".">Mouse</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">97</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Mean values from three experiments. Warfarin, propranolol, and testosterone incubated as a cocktail were used as a positive control.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Evaluation of the in Vitro Cross-Species Intrinsic Clearance with Rat and Human Liver Microsomes for <b>11ab</b> and <b>12g</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CL<sub>int</sub>(μL/min/mg)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CL<sub>int</sub>(μL/min/kg)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ab</b></td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Mean values from three experiments. Midazolam and propranolol were used as a positive control.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Scale-up factors for microsomes used are 45 mg of liver/g of body mass and 44 and 24 g of liver/kg of body mass for rat and human, respectively.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Antinociceptive Effect</h3><div class="NLM_p">The results reported in the literature for 5-HT<sub>4</sub>R antagonists in animal models of analgesia<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21">(16-21)</a> prompted us to assay <b>11ab</b> and <b>12g</b> in two standard antinociceptive assays in rats: the hot plate test and the formalin test.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> The maximal dose for <i><i>in viv</i>o</i> studies (10 mg/kg) was selected according to preliminary behavioral and toxicological results obtained in the Irwin test on male rats after a single oral dose administration of compound (data not shown).<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></div><div class="NLM_p">Oral administration of <b>11ab</b> in the hot plate test produced a weak, but significant nociceptive response at the highest dose tested (20% increase of latency at 10 mg/kg, <i>p</i> < 0.05 vs vehicle group). Rats treated with <b>12g</b> in the same experiment showed a significant latency increase of antinociceptive response at 5 and 10 mg/kg (<i>p</i> < 0.05 vs vehicle group) with an improvement of 39% and 26%, respectively. Morphine, which was used as a reference drug, produced a significant antinociceptive response (<i>p</i> < 0.05 vs vehicle group) at 6 mg/kg with a 67% latency increase (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Antinociceptive Activity of <b>11ab</b>, <b>12g</b>, and Morphine in the Hot Plate Test after Oral Administration in Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg, po)</th><th class="colsep0 rowsep0" align="center" char="±">latency<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (s)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ab</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.21<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 0.22<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 0.22<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">morphine</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.34<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Latency was measured 1 h postdosing.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last"><i>p</i> < 0.05 vs vehicle group by analysis of variance (ANOVA) followed by Dunnet’s test for multiple comparisons.</p></div></div></div><div class="NLM_p">The results obtained in the formalin test are reported in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Compounds <b>11ab</b> and <b>12g</b> orally administered at 10 mg/kg did not inhibit the paw licking in mice during the first phase of the model (0–10 min), when there is a direct effect on nociceptors, whereas a significant analgesic effect was observed in the second phase of the experiment (panel A, 10–40 min, <i>p</i> < 0.05 vs vehicle group), when an inflammatory response is present. Analysis of the area under the curve (AUC<sub>0–40′</sub>) confirmed a statistically significant analgesic activity following administration of <b>12g</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, <i>p</i> < 0.05 vs vehicle group). As expected, morphine at 3 mg/kg significantly inhibited the licking time in both the early and late phases (data not shown).</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>11ab</b> and <b>12g</b> oral administration in the formalin test in mice: (A) time-course curve, (B) area under time-course curve (0–40 min). The asterisk indicates <i>p</i> < 0.05 vs vehicle group by ANOVA followed by Dunnet’s test for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A VS computational approach performed on our in-house library led us to identify hit compounds <b>11b</b> and <b>12a</b> as new 5-HT<sub>4</sub>R ligands. The activity of these hits was confirmed in in vitro assays on human 5-HT<sub>4</sub>R. A number of derivatives of both <b>11b</b> and <b>12a</b> were designed, synthesized, and tested to define the SAR in these new classes of ligands. Potent ligands were found in both series. Selectivity over undesirable biological targets such as 5-HT<sub>2A</sub>R and hERG was required, so screening on these off-target proteins was performed to find compounds with the highest 5-HT<sub>4</sub>R binding affinity and the lowest interaction with the 5-HT<sub>2A</sub>R and hERG potassium ion channel. Introduction of large lipophilic or weak polar terminal groups on the basic site of the hit compounds of both series led to ligands with high 5-HT<sub>4</sub>R affinities. However, among these, only derivatives with a carboxylate function on the phenethyl moiety (compounds <b>11ab</b> and <b>12g</b>) showed good selectivity over 5-HT<sub>2A</sub> and the hERG potassium ion channel. Therefore, <b>11ab</b> and <b>12g</b> were further studied in vitro (i) in a functional test of 5-HT<sub>4</sub> antagonism, (ii) for their selectivity toward a large panel of biological targets, and (iii) to assess their metabolic stability in several species. Both compounds were potent antagonists with a good selectivity profile and metabolic stability. Finally, <b>12g</b> showed promising pharmacological properties in in vivo models of analgesia (hot plate and formalin tests), demonstrating significant antinociceptive activity after oral administration. Therefore, we considered <b>12g</b> as a candidate for preclinical studies as a potent and selective 5-HT<sub>4</sub> antagonist with excellent analgesic properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Computational Studies</h3><div class="NLM_p">The computational study was performed using the Schrödinger suite (<a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a>). Active compounds were extracted from the literature<a onclick="showRef(event, 'ref9 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref14 ref15">(9, 14, 15)</a> and used as a basic set for pharmacophore modeling. 3D structures of the ligands were first generated by means of Macromodel (version 9.1, 2006, Schrödinger LLC) and then minimized using the OPLS-2005 force field (version 2.0, 2006, Schrödinger LLC) in a continuum dielectric model with a dielectric constant of 1.0. Molecules were kept in their neutral form throughout the process. LigPrep (version 2.0, 2006, Schrödinger LLC) was then used to generate stereoisomers and the most probable ionization states at pH 7 ± 2. Conformers were generated using a maximum of 1000 steps of rapid ConfGen sampling, followed by up to 5000 iterations of truncated Newton conjugate gradient minimization. The OPLS-2005 force field with distance-dependent dielectric solvation treatment was employed. Each minimized conformer was filtered through a relative energy window of 10 kcal/mol and a redundancy check of 1 Å in the heavy atom positions. Pharmacophore development was carried out using PHASE,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> where each ligand structure is represented by a series of chemical features (points) in the 3D space, which set the noncovalent binding properties between the ligand and its target receptor. After applying default feature definitions to each ligand, we performed the common pharmacophore search using a terminal box size of 1 Å, and we required that all the actives should be matched. These pharmacophore sites are characterized by type, location, and, if applicable, directionality. PHASE provides six built-in types of pharmacophore features: hydrogen bond acceptor (A), hydrogen bond donor (D), hydrophobic (H), negative ionizable (N), positive ionizable (P), and aromatic ring (R).</div><div class="NLM_p last">Pharmacophores with features common to all training set active compounds were identified and scored according to superposition of pharmacophore site points, alignment of vector characteristics, overlap of molecular volumes, and penalization of matches to the set of inactive compounds. Different 3D queries were generated and then used to discriminate true positives. The model was validated by means of the search of 5-HT<sub>4</sub> active compounds in a database composed of known actives (not used in the development of the model) and decoy ligands from Schrödinger.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The validated pharmacophoric model was then used to identify hits from the proprietary database. The proprietary database was first prepared using LigPrep to generate 3D structures, stereoisomers, tautomers, and ionization states. Then the structures were used to create a PHASE database, which entails the following steps: expanding structures into conformational ensembles and mapping pharmacophore features to each molecule. The phase database was the starting point for the ligand-based VS. When the pharmacophore hypothesis was used to filter the phase database, all features of the pharmacophore hypothesis were required to match. The distance tolerance was set to its default value of 2.0 Å in all pharmacophore searches. The pharmacophore matching score of PHASE was used in the VS procedure. The identified virtual hits were then submitted to the in vitro assay.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedures</h4><div class="NLM_p">Reagents were purchased from Sigma-Aldrich and were used as received. Reaction progress was monitored by TLC using Merck silica gel 60 F<sub>254</sub> (0.04–0.063 mm) with detection by UV (214 or 254 nm). Merck silica gel 60 or aluminum oxide 90 (active neutral) was used for column chromatography. Melting points (uncorrected) were determined in open Pyrex capillary tubes using a Buchi 510 melting point apparatus. The compounds' purities were always ≥95% determined by high-pressure liquid chromatography (HPLC). HPLC analysis was carried out with a pump/autosampler from Waters (2695-Alliance model), a UV photodiode array detector from Waters (2996 model), and a data management system from Waters (Empower 2). The column used was generally Suplex pkb-100 (250 × 4.6 mm, 5 μm). Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were obtained using a Bruker Avance system, operating at 300 or 400 MHz. All resonance bands were referenced to tetramethylsilane (internal standard). UV–vis spectra were recorded using a Perkin-Elmer (UV/vis) Lambda 25 spectrophotometer. The UV measurement was carried out using matched 1 cm quartz cells and substance dissolved in 95° ethanol. Vibration infrared (IR) spectroscopy was performed using a Perkin-Elmer model FT-2000 infrared spectrophotometer equipped with a universal attenuated total reflectance (UATR) accessory. Elemental analysis was conducted by means of a CHNS-O EA1108 elemental analyzer, Carlo Erba Instruments, and the results were within ±0.4% of the theoretical values, unless otherwise noted. Ultraperformance liquid chromatography/quadrupole time-of-flight (UPLC/QToF) exact mass data were obtained by means of a SYNAPT MS–ACQUITY UPLC system, Waters. The system was operated in positive ion mode in the “V-Optics” configuration. Leucine enkephalin (200 pg/μL) was employed as the lock mass to provide authenticated exact mass measurement in MS and MS/MS modes within 5 ppm rms mass accuracy. The column was an Acquity BEH C18 (2.1 × 50 mm, 1.7 μm). Differential scanning calorimetry data were obtained on a Perkin-Elmer DSC7 differential scanning calorimeter.</div><div class="NLM_p last">1-[1-(Phenylmethyl)-4-piperidinyl]methylamine, 1-methyl-1<i>H</i>-indazole-3-carbonyl chloride (<b>13</b>), 1,5-dimethyl-1<i>H</i>-indazole-3-carboxylic acid (<b>17</b>), 2-methyl-2<i>H</i>-indazole-3-carboxylic acid (<b>20</b>), methyl 5-chloro-1<i>H</i>-indazole-3-carboxylate, 1-(1-butyl-4-piperidinyl)methylamine, 1-[(2-phenylethyl)-4-piperidinyl]methylamine, 1<i>H</i>-indazole-3-carbonyl chloride, (2-bromoethyl)cyclohexane, <i>N</i>-(2-bromoethyl)methansulfonamide, 2-(4-hydroxyphenyl)ethyl bromide, ethyl 3-(2-nitrophenyl)propenoate, 1-butyl-4-piperidinemethanol, 1-(2-phenylethyl)-4-piperidinemethanol, 4-piperidinemethanol, 1-(phenylmethyl)-4-piperidinemethanol, 1-(2-bromoethyl)-4-nitrobenzene, <i>N</i>-[4-(2-bromoethyl)phenyl]acetamide, and 2-(4-chlorophenyl)ethyl bromide are commercially available. 1-Isopropyl-1<i>H</i>-indazole-3-carbonyl chloride (<b>14</b>),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> ethyl 4-(2-bromoethyl)benzoate,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> ethyl 4-(2-chloroethyl)benzoate,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> 5-methoxy-1-methyl-1<i>H</i>-indazole-3-carboxylic acid (<b>18</b>),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and ethyl 3-(2-nitrophenyl)propanoate (<b>22</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> were prepared as previously described.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Syntheses</h4><div class="NLM_p">Specific examples presented below illustrate general synthetic procedures.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 1-Isopropyl-<i>N</i>-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11q</b>)</h5><div class="NLM_p last">1-Isopropyl-1<i>H</i>-indazole-3-carbonyl chloride (<b>14</b>;<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 9.3 g, 42 mmol) was added in portions into a well-stirred suspension of 1-[1-(phenylmethyl)-4-piperidinyl]methylamine (8.6 g, 42 mmol) in toluene (100 mL) at room temperature. After being stirred for 12 h, the mixture was filtered, and the crude product obtained was recrystallized from isopropyl alcohol/water (50:1) to achieve <b>11q</b>. This compound was treated with 2.5 N HCl in ethanol to furnish the corresponding hydrochloride, which was recrystallized from <i>n</i>-hexane/ethyl acetate (7:3; 31%, 109–111 °C). IR (KBr): ν 3498.24, 2931.81, 2538.38, 1630.07, 1543.92, 1455.10, 1203.76, 947.24, 763.94 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.10–2.25 (m, 5H), 2.80–3.80 (m, 10H), 4.0–4.6 (m, 2H), 5.08 (sept, <i>J</i> = 7 Hz, 1H), 7.0–8.0 (m, 8H), 8.05–8.70 (m, 2H), 11.04 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.84, 26.61, 33.98, 43.21, 50.20, 51.13, 58.88, 110.23, 121.77, 122.18, 126.22, 128.58, 129.22, 129.89, 131.37, 136.67, 139.49, 162.21. Anal. (C<sub>24</sub>H<sub>30</sub>N<sub>4</sub>O·HCl·2H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N</i>-[[1-(2-Phenylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11l</b>)</h5><div class="NLM_p last"><b>11l</b> was prepared according to the procedure used for compound <b>11q</b> starting from commercially available 1<i>H</i>-indazole-3-carbonyl chloride using 1-[(2-phenylethyl)-4-piperidinyl]methylamine as reactant. <b>11l</b>·HCl was recrystallized from ethyl acetate/ethanol (33%, 192–194 °C). IR (KBr): ν 2927.12, 2552.32, 1650.83, 1549.71, 1469.81, 1232.18, 1154.07, 954.45, 763.04 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.83 (s, 1H), 10.93 (br s, 1H), 8.60 (t, <i>J</i> = 5.72 Hz, 1H), 8.21 (d, <i>J</i> = 7.63 Hz, 1H), 7.65 (d, <i>J</i> = 8.00 Hz, 1H), 7.02–7.54 (m, 7H), 2.64–4.04 (m, 11H), 1.26–2.29 (m, 5H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 26.87, 29.31, 33.94, 43.13, 51.42, 56.58, 110.64, 121.50, 121.88, 126.36, 126.66, 128.56, 137.25, 141.05, 162.50. Anal. (C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O·HCl·<sup>1</sup>/<sub>3</sub>H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>N</i>-[[1-(Phenylmethyl)-4-piperidinyl]methyl]-1-methyl-1<i>H</i>-indazole-3-carboxamide (<b>15</b>)</h5><div class="NLM_p last"><b>15</b> was prepared according to the procedure used for compound <b>11q</b> starting from commercially available 1-methyl-1<i>H</i>-indazole-3-carbonyl chloride (<b>13</b>) using 1-[1-(phenylmethyl)-4-piperidinyl]methylamine as reactant. <b>15</b>·HCl was obtained (71%, 247–248 °C). IR (KBr): ν 3398.6, 2918.29, 2488.17, 1658.98, 1540.34, 1495.21, 1432.32, 1227.29, 1168.33, 747.70, 700.79 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.20–2.20 (m, 5H), 2.63–3.68 (m, 6H), 4.13 (s, 3H), 4.12–4.36 (m, 2H), 7.26–7.81 (m, 8H), 8.15–8.25 (m, 1H), 8.40–8.75 (m, 1H), 11.10 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 23.01, 26.56, 33.89, 35.79, 43.13, 47.37, 51.13, 58.90, 110.24, 121.68, 122.17, 126.46, 128.60, 129.23, 129.87, 131.35, 136.77, 140.84, 162.00. Anal. (C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-1,5-dimethyl<i>-</i>1<i>H</i>-indazole-3-carboxamide (<b>11h</b>)</h5><div class="NLM_p last">Thionyl chloride (4 mL, 54 mmol) was added to a stirred solution of the commercially available <b>17</b> (5.1 g, 29.6 mmol) in toluene, and the mixture was stirred under reflux for 2 h. After removal of the solvent under vacuum, the residue was recrystallized from <i>n</i>-hexane to give 3.5 g of 1,5-dimethyl-1<i>H</i>-indazol-3-carbonyl chloride. 1-(1-Butyl-4-piperidinyl)methylamine (2.4 g, 14 mmol) in toluene (30 mL) was added dropwise to a suspension in toluene (30 mL) of 2.9 g of the intermediate (14 mmol). The mixture was stirred for 3 h at room temperature. The solid was filtered and dissolved in H<sub>2</sub>O. The solution was treated with 6 N NaOH solution until pH 8 and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 200 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under vacuum. The residue was purified by column chromatography on silica gel (CHCl<sub>3</sub>/MeOH (95:5) as eluent) and then treated with 2.5 N HCl in ethanol to give the corresponding hydrochloride. <b>11h</b>·HCl was recrystallized from isopropyl ether/isopropyl alcohol (4 g, 75%, 212–213 °C). IR (KBr): ν 3421.06, 2957.55, 2496.59, 1659.87, 1538.80, 1500.34, 1459.45, 1181.06, 1163.97, 804.76 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.54 (br s, 1H), 8.43 (t, <i>J</i> = 6.11 Hz, 1H), 7.89–7.99 (m, 1H), 7.62 (d, <i>J</i> = 8.59 Hz, 1H), 7.30 (dd, <i>J</i> = 1.49, 8.75 Hz, 1H), 4.10 (s, 3H), 3.29–3.52 (m, 2H), 3.21 (t, <i>J</i> = 6.28 Hz, 2H), 2.70–3.11 (m, 4H), 2.44 (s, 3H), 1.83 (d, <i>J</i> = 12.88 Hz, 3H), 1.48–1.76 (m, 4H), 1.30 (m, <i>J</i> = 7.40 Hz, 2H), 0.90 (t, <i>J</i> = 7.20 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.42, 19.48, 20.97, 23.17, 25.01, 26.78, 31.18, 33.97, 35.82, 43.10, 47.72, 51.33, 55.58, 109.94, 120.58, 122.49, 128.46, 131.26, 136.13, 139.64, 162.10. Anal. (C<sub>20</sub>H<sub>30</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-5-methoxy<i>-</i>1-methyl<i>-</i>1<i>H</i>-indazole-3-carboxamide (<b>11i</b>)</h5><div class="NLM_p last"><b>11i</b> was prepared according to the procedure described for <b>11h</b> starting from <b>18</b>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Crude <b>11i</b> was then converted to the corresponding oxalic salt by treatment with oxalic acid in ethanol (29%, 191–192 °C). IR (KBr): ν 3410.07, 2944.72, 2677.99, 1720.71, 1655.28, 1541.25, 1497.68, 1271.15, 1206.59, 814.91, 707.69 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.21 (br s, 2H), 8.41 (t, <i>J</i> = 6.14 Hz, 1H), 7.65 (d, <i>J</i> = 9.35 Hz, 1H), 7.56 (d, <i>J</i> = 2.05 Hz, 1H), 7.11 (dd, <i>J</i> = 2.48, 9.21 Hz, 1H), 4.10 (s, 3H), 3.81 (s, 3H), 3.41 (d, <i>J</i> = 11.98 Hz, 2H), 3.23 (t, <i>J</i> = 6.28 Hz, 2H), 2.91–3.03 (m, 2H), 2.84 (t, <i>J</i> = 11.55 Hz, 2H), 1.84 (d, <i>J</i> = 12.57 Hz, 3H), 1.38–1.70 (m, 4H), 1.30 (m, <i>J</i> = 7.50 Hz, 2H), 0.90 (t, <i>J</i> = 7.20 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.43, 19.45, 25.31, 26.64, 33.63, 35.99, 42.77, 51.09, 55.27, 100.42, 111.46, 118.68, 122.82, 135.85, 136.82, 155.34, 162.26, 164.51. Anal. (C<sub>20</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-5-chloro-1-methyl-1<i>H</i>-indazole-3-carboxamide (<b>11j</b>)</h5><div class="NLM_p last"><b>11j</b> was prepared according to the procedure described for <b>11h</b> starting from <b>19</b>. Crude <b>11j</b> was then treated with 2.5 N HCl in ethanol to obtain the corresponding hydrochloride (22%, 250–251 °C). IR (KBr): ν 3418.18, 2933.70, 2496.57, 1656.26, 1536.17, 1480.92, 1213.02, 806.84 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.35 (br s, 1H), 8.58 (t, <i>J</i> = 5.94 Hz, 1H), 8.15 (d, <i>J</i> = 1.98 Hz, 1H), 7.82 (d, <i>J</i> = 8.92 Hz, 1H), 7.50 (dd, <i>J</i> = 1.98, 8.92 Hz, 1H), 4.15 (s, 3H), 3.44 (d, <i>J</i> = 11.56 Hz, 2H), 3.21 (t, <i>J</i> = 6.28 Hz, 2H), 2.71–3.12 (m, 4H), 1.76–2.05 (m, 3H), 1.47–1.75 (m, 4H), 1.31 (m, <i>J</i> = 7.30 Hz, 2H), 0.90 (t, <i>J</i> = 7.30 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.42, 19.48, 23.14, 25.01, 26.76, 31.15, 33.87, 36.14, 43.18, 47.72, 51.31, 55.58, 112.36, 120.48, 122.88, 126.84, 136.30, 139.47, 161.59. Anal. (C<sub>19</sub>H<sub>27</sub>N<sub>4</sub>OCl·HCl) C, H, N, Cl.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-2-methyl-2<i>H</i>-indazole-3-carboxamide (<b>11k</b>)</h5><div class="NLM_p last"><b>11k</b> was prepared according to the procedure described for <b>11h</b> starting from <b>20</b>. <b>11k</b> (5.8 g, 17.6 mmol) was converted to the maleate salt by treatment with maleic acid (2.1 g, 17.6 mmol) in ethanol (15 mL), which was recrystallized from ethyl acetate (40%, 136–137 °C). IR (KBr): ν 3318.37, 2958.21, 2687.75, 1654.57, 1533.95, 1362.15, 1227.22, 1047.89, 872.64, 760.12 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 19.99 (br s, 1H), 9.17 (br s, 1H), 8.67 (t, <i>J</i> = 5.44 Hz, 1H), 7.77 (dd, <i>J</i> = 7.42, 13.69 Hz, 2H), 7.00–7.49 (m, 2H), 6.06 (s, 2H), 4.31 (s, 3H), 2.67–3.72 (m, 8H), 1.06–2.22 (m, 9H), 0.91 (t, <i>J</i> = 7.00 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.42, 19.37, 25.36, 27.13, 33.62, 39.92, 43.74, 51.62, 55.70, 117.22, 119.97, 120.32, 122.73, 125.76, 128.79, 136.00, 146.40, 159.86, 167.19. Anal. (C<sub>19</sub>H<sub>28</sub>N<sub>4</sub>O·C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N, Cl.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 1-Methyl<i>-N</i>-(4-piperidinylmethyl)-1<i>H</i>-indazole-3-carboxamide (<b>11a</b>)</h5><div class="NLM_p last">Compound <b>15</b> (6 g, 16.6 mmol) was dissolved in 312 mL of ethanol/acetic acid (30:1.2), and the resulting solution was hydrogenated by a Parr apparatus (28 psi) in the presence of 10% Pd/C (2.4 g) for 24 h at room temperature. The catalyst was filtered off, the solvent was evaporated, and the residue was portioned between 2 N NaOH (100 mL) and CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuum to obtain the crude product <b>11a</b>, which was directly converted to maleic salt by treatment with 0.66 g of maleic acid (5.7 mmol) dissolved in 25 mL of absolute ethanol, which was recrystallized from ethyl acetate/ethanol (1:1) to provide 1.0 g of salt (16%, 153–154 °C). IR (KBr): ν 3389.42, 2929.19, 1659.66, 1538.79, 1362.74, 1214.19, 1164.27, 867.19, 752.18 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.1–1.65 (m, 5H), 1.65–2.15 (m, 6H), 4.14 (s, 3H) 6.08 (s, 2H), 7.1–8.7 (m, 7H), 20.12 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 26.30, 33.66, 35.81, 42.98, 110.27, 121.68, 122.20, 126.49, 136.09, 136.77, 140.86, 162.06, 167.19. Anal. (C<sub>15</sub>H<sub>20</sub>N<sub>4</sub>O·C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N, Cl.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 1-Isopropyl-<i>N</i>-(4-piperidinylmethyl)-1<i>H</i>-indazole-3-carboxamide (<b>16</b>)</h5><div class="NLM_p last"><b>16</b> was prepared according to the procedure described for <b>11a</b>, starting from <b>11q</b>·HCl salt, 35 psi. Compound <b>16</b> was treated with 2.5 N HCl in ethanol solution to afford the corresponding hydrochloride, which was recrystallized from ethanol/ethyl acetate (42%, 211–214 °C). IR (KBr): ν 3315.32, 2912.86, 2784.55, 1658.70, 1541.40, 1279.82, 1203.35, 750.09, 691.72, 619.88 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.31–2.18 (m, 5H), 2.58–3.64 (m, 6H), 5.09 (m, <i>J</i> = 7 Hz, 1H), 7.12–7.60 (m, 2H), 7.80 (d, <i>J</i> = 8 Hz, 1H), 8.20 (d, <i>J</i> = 8 Hz, 1H), 8.41 (t, <i>J</i> = 6 Hz, 1H), 8.82–9.60 (2 br s, 2H). Anal. (C<sub>17</sub>H<sub>24</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 2-Methyl-4-(4-piperidinylmethoxy)-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12a</b>)</h5><div class="NLM_p last">Pd/C (10%, 200 mg) was added into a solution of <b>29</b> (3.5 mmol, 1.34 g) in methanol (150 mL). The mixture was stirred for 4 days under a H<sub>2</sub> atmosphere at room temperature and pressure. A H<sub>2</sub> stream was passed through every 3 h, and Pd/C (10%, 200 mg) was added every 24 h. After the palladium was filtered off, the solvent was removed under reduced pressure to obtain a residue, which was purified by column chromatography on aluminum oxide (chloroform/methanol (2:1) as eluent) to obtain 410 mg of pure <b>12a</b> as an oil (40%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.47–1.57 (m, 2H), 1.91–2.29 (m, 5H), 2.76 (m, 1H), 3.12 (m, 1H), 3.26 (m, 1H), 4.03 (s, 3H), 4.49 (d, 2H), 7.30–7.47 (m, 4H), 7.78 (m, 1H), 7.94 (m, 1H). Anal. (C<sub>18</sub>H<sub>21</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-1-methyl-1<i>H</i>-indazole-3-carboxamide (<b>11b</b>)</h5><div class="NLM_p last">1-Bromobutane (3.75 g, 27 mmol) and K<sub>2</sub>CO<sub>3</sub> (3.76 g, 27 mmol) were added to a solution of <b>11a</b> (3.6 g, 13 mmol) in 15 mL of ethanol. The reaction mixture was stirred under reflux for 2 h. The solid was filtered off, and the solution was concentrated under vacuum. The residue was diluted with ethyl acetate and treated with 1 N HCl solution. The aqueous layer was neutralized with 1 N NaOH solution until pH 8 was reached and then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was filtered through a silica gel pad that was washed with CHCl<sub>3</sub>. The crude product was converted to the corresponding hydrochloride in the presence of 2.5 N HCl in ethanol. The salt that was obtained was recrystallized from isopropyl alcohol (4.3 g, 91%, 194–195 °C). IR (KBr): ν 3343.52, 2931.41, 2486.99, 1650.42, 1546.64, 1433.36, 1227.18, 1173.28, 953.87, 754.06 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.94 (t, <i>J</i> = 7 Hz, 3H), 1.2–2.2 (m, 9H), 2.7–3.6 (m, 8H), 4.08 (s, 3H), 7.2–7.5 (m, 4H), 8.3 (d, <i>J</i> = 7 Hz, 1H), 10.5 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.42, 19.48, 25.00, 26.78, 33.92, 35.81, 43.17, 51.31, 55.58, 110.26, 121.68, 122.17, 126.46, 136.79, 140.84, 162.01. Anal. (C<sub>19</sub>H<sub>28</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>N</i>-[[1-(2-Cyclohexylethyl)-4-piperidinyl]methyl]-1-methyl-1<i>H</i>-indazole-3-carboxamide (<b>11c</b>)</h5><div class="NLM_p last"><b>11c</b> was prepared according to the procedure described for <b>11b</b> using (2-bromoethyl)cyclohexane as reactant. The crude product was treated with 2.5 N HCl in ethanol to furnish the corresponding hydrochloride, which was recrystallized from ethyl acetate/ethanol (8:2; 78%, 227–230 °C). IR (KBr): ν 3370.73, 2927.48, 2850.47, 2497.79, 1650.41, 1536.21, 1493.85, 1217.49, 1164.54, 945.18, 753.33 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 10.66 (br s, 1H), 8.57 (t, <i>J</i> = 5.50 Hz, 1H), 8.19 (d, <i>J</i> = 7.57 Hz, 1H), 7.75 (d, <i>J</i> = 8.00 Hz, 1H), 7.37–7.59 (m, 1H), 7.16–7.36 (m, 1H), 4.15 (s, 3H), 2.67–3.66 (m, 8H), 0.59–2.16 (m, 18H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 23.15, 25.44, 25.83, 26.81, 30.14, 32.34, 33.92, 35.02, 35.81, 43.15, 47.72, 51.33, 54.15, 110.26, 121.68, 122.17, 126.46, 136.79, 140.84, 162.00. Anal. (C<sub>23</sub>H<sub>34</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 1-Methyl<i>-N</i>-[[1-(2-phenylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11d</b>)</h5><div class="NLM_p last"><b>11d</b> was prepared according to the procedure used for compound <b>11b</b> using (2-bromoethyl)benzene as reactant. The crude product was treated with 2.5 N HCl in ethanol to obtain the corresponding hydrochloride, which was recrystallized from ethyl acetate/ethanol (8:2; 82%, 219–220 °C). IR (KBr): ν 3412.96, 2938.59, 2511.29, 1676.74, 1540.82, 1496.40, 1545.13, 1219.78, 1170.78, 949.11, 746.37, 698.47 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.5–2.1 (m, 5H), 2.8–3.7 (m, 10H), 4.1 (s, 3H), 7.2–7.9 (m, 9H), 8.2 (d, <i>J</i> = 7 Hz, 1H), 8.6 (t, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 23.21, 26.85, 29.27, 33.91, 35.81, 43.15, 51.41, 56.55, 110.26, 121.70, 122.18, 126.48, 126.68, 128.56, 136.79, 137.23, 140.84, 162.03. Anal. (C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>-[[1-[2-(4-Chlorophenyl)ethyl]-4-piperidinyl]methyl]-1-methyl-1<i>H</i>-indazole-3-carboxamide (<b>11f</b>)</h5><div class="NLM_p last"><b>11f</b> was prepared according to the procedure used for compound <b>11b</b> using 2-(4-chlorophenyl)ethyl bromide as reactant. The crude product was treated with 2.5 N HCl in ethanol to furnish the corresponding hydrochloride, which was recrystallized from ethanol/water (58%, 245–246 °C). IR (KBr): ν 3402.56, 2945.21, 2332.05, 1661.10, 1534.41, 1493.17, 1215.08, 858.67, 771.02 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.08 (br s, 1H), 8.59 (t, <i>J</i> = 5.69 Hz, 1H), 8.20 (d, <i>J</i> = 7.66 Hz, 1H), 7.75 (d, <i>J</i> = 8.00 Hz, 1H), 7.14–7.59 (m, <i>J</i> = 3.00 Hz, 6H), 4.15 (s, 3H), 2.63–3.74 (m, 10H), 1.33–2.23 (m, 5H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 26.94, 28.68, 33.98, 35.91, 38.79, 39.06, 39.34, 39.61, 39.89, 40.18, 40.45, 43.24, 51.54, 56.34, 110.36, 121.78, 122.29, 126.58, 128.61, 130.60, 131.45, 136.37, 136.89, 140.94, 162.13. Anal. (C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>ClO·HCl) C, H, N, Cl.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 1-Methyl<i>-N</i>-[[1-(4-phenylbutyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11g</b>)</h5><div class="NLM_p last"><b>11g</b> was prepared according to the procedure used for compound <b>11b</b> using 4-phenylbutyl bromide as reactant. The obtained crude product was reacted with oxalic acid in ethanol to give the corresponding oxalic salt, which was recrystallized from ethyl acetate/ethanol (18%, 170–171 °C). IR (KBr): ν 3407.39, 2926.15, 1653.92, 1542.02, 1494.36, 1404.81, 1222.82, 1166.49, 753.52, 720.00 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.36 (br s, 2H), 8.54 (t, <i>J</i> = 5.62 Hz, 1H), 8.19 (d, <i>J</i> = 7.81 Hz, 1H), 7.74 (d, <i>J</i> = 8.00 Hz, 1H), 7.47 (dt, <i>J</i> = 1.22, <i>J</i> = 7.57 Hz, 1H), 7.04–7.35 (m, 6H), 4.13 (s, 3H), 2.33–3.63 (m, 10H), 1.07–2.07 (m, 9H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 22.98, 26.59, 28.01, 33.55, 34.45, 35.79, 42.77, 51.09, 55.40, 110.26, 121.68, 122.17, 125.73, 126.46, 128.21, 136.79, 140.84, 141.54, 162.01, 164.46. Anal. (C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N, Cl.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 1-Isopropyl<i>-N</i>-[[1-(2-phenylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11m</b>)</h5><div class="NLM_p last"><b>11m</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> using 1-[1-(2-phenylethyl)-4-piperidinyl]methylamine as reactant. <b>11m</b> was purified by flash chromatography on silica gel (CHCl<sub>3</sub>/MeOH (95:5) as eluent) and then treated with 2.5 N HCl in EtOH solution to afford the corresponding hydrochloride (72%, 211–212 °C). IR (KBr): ν 3331.53, 2945.48, 2558.39, 1652.94, 1546.02, 1206.58, 942.45, 743.17 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.56 (d, <i>J</i> = 7 Hz, 6H), 1.50–2.30 (m, 5H), 2.70–3.90 (m, 10H), 5.10 (m, <i>J</i> = 7 Hz, 1H), 7.05–7.63 (m, 7H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 8.21 (d, <i>J</i> = 8 Hz, 1 H), 8.47 (t, <i>J</i> = 6 Hz, 1H), 11.05 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 26.90, 29.27, 33.98, 43.24, 50.22, 51.41, 56.57, 110.26, 121.79, 122.20, 126.23, 126.68, 128.56, 136.67, 137.26, 139.52, 162.22. Anal. (C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> <i>N</i>-[[1-(2-Cyclohexylethyl)-4-piperidinyl]methyl]-1-isopropyl<i>-</i>1<i>H</i>-indazole-3-carboxamide (<b>11t</b>)</h5><div class="NLM_p last"><b>11t</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> using (2-bromoethyl)cyclohexane as reactant. The crude <b>11t</b> was treated with 2.5 N HCl in ethanol to afford the corresponding hydrochloride, which was recrystallized from ethyl acetate/ethanol (36%, 244–246 °C dec). IR (KBr): ν 3329.19, 2922.70, 2552.33, 1655.91, 1544.81, 1441.61, 1207.91, 942.82, 738.08 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 0.68–2.18 (m, 17H), 2.63–3.70 (m, 10H), 5.09 (m, <i>J</i> = 7 Hz, 1H), 7.12–7.60 (m, 2H), 7.80 (d, <i>J</i> = 8 Hz, 1H), 8.20 (d, <i>J</i> = 8 Hz, 1H), 8.41 (t, <i>J</i> = 6 Hz, 1H), 10.70 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.83, 25.42, 25.82, 26.82, 30.11, 32.32, 33.98, 35.00, 43.23, 50.19, 51.31, 54.13, 110.23, 121.76, 122.15, 126.20, 136.65, 139.49, 162.18. Anal. (C<sub>25</sub>H<sub>38</sub>N<sub>4</sub>O·HCl·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 1-Isopropyl<i>-N</i>-[[1-(2-morpholin-4-ylethyl]-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11u</b>)</h5><div class="NLM_p last"><b>11u</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> using 4-(2-chloroethyl)morpholine as reactant. The crude <b>11u</b> was treated with 2.5 N HCl in ethanol to give the corresponding dihydrochloride, which was recrystallized from ethanol (63%, 266–267 °C dec). IR (KBr): ν 3375.90, 2934.70, 2448.48, 1652.35, 1539.86, 1455.66, 1203.01, 1133.42, 1100.85, 754.59 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.30–2.25 (m, 5H), 2.75–4.30 (m, 19H), 5.09 (m, <i>J</i> = 7 Hz, 1H), 7.12–7.60 (m, 2H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 8.20 (d, <i>J</i> = 8 Hz, 1H), 8.45 (t, <i>J</i> = 6 Hz, 1H), 10.80 (br s, 1H), 10.60 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 26.84, 33.68, 43.17, 49.17, 49.65, 50.20, 51.33, 51.95, 63.13, 110.26, 121.77, 122.20, 126.23, 136.64, 139.50, 162.22. Anal. (C<sub>23</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub>·2HCl·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>N</i>-[[1-[3-(Dimethylamino)propyl]-4-piperidinyl]methyl]-1-isopropyl-1<i>H</i>-indazole-3-carboxamide (<b>11v</b>)</h5><div class="NLM_p last"><b>11v</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> (480 mg, 1.6 mmol) using <i>N</i>-(3-chloropropyl)-<i>N</i>,<i>N</i>-dimethylamine hydrochloride (580 mg, 3.7 mmol) as reactant. Compound <b>11v</b> was treated with maleic acid in ethanol to afford the corresponding dimaleate, which was recrystallized from ethanol (840 mg, 84%, 155–156 °C). IR (KBr): ν 3433.88, 2934.55, 2697.84, 1572.28, 1385.77, 1200.30, 1005.05, 875.99, 864.97, 751.10 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.20–1.60 (m, 2H), 1.68–2.28 (m, 5H), 2.81 (s, 6H), 2.75–3.75 (m, 13H), 5.09 (sept, <i>J</i> = 7 Hz, 1H), 6.09 (s, 4H), 7.12–7.60 (m, 2H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 8.20 (d, <i>J</i> = 8 Hz, 1H), 8.45 (t, <i>J</i> = 6 Hz, 1H), 19 (br s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 19.13, 21.86, 26.82, 33.54, 42.36, 42.71, 50.20, 51.45, 52.67, 53.92, 110.26, 121.74, 122.21, 126.26, 135.75, 136.64, 139.52, 162.27, 167.17. Anal. (C<sub>22</sub>H<sub>35</sub>N<sub>5</sub>O·C<sub>8</sub>H<sub>8</sub>O<sub>8</sub>·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 1-Isopropyl-<i>N</i>-[[1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11w</b>)</h5><div class="NLM_p last"><b>11w</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> (4.8 g, 16 mmol) using <i>N</i>-(2-bromoethyl)methanesulfonamide (3.4 g, 16.8 mmol) as reactant. The compound was treated with 2.5 N HCl in ethanol solution to furnish the corresponding hydrochloride, which was recrystallized with ethyl acetate/ethanol (1.5 g, 20%, 186–187 °C dec). IR (KBr): ν 3341.98, 2938.43, 2543.75, 1651.59, 1542.67, 1325.86, 1208.22, 1157.42, 967.42, 750.30 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.40–2.30 (m, 5H), 3.00 (s, 3H), 2.75–3.80 (m, 10H), 5.09 (m, <i>J</i> = 7 Hz, 1H), 7.12–7.70 (m, 3H), 7.80 (d, <i>J</i> = 8 Hz, 1H), 8.20 (d, <i>J</i> = 8 Hz, 1H), 8.45 (t, <i>J</i> = 6 Hz, 1H), 10.73 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 26.78, 33.75, 36.98, 39.30, 43.20, 50.20, 51.79, 55.53, 110.24, 121.77, 122.18, 122.24, 126.23, 136.65, 139.50, 162.21. Anal. (C<sub>20</sub>H<sub>31</sub>N<sub>5</sub>0<sub>3</sub>S·HCI) C, H, N, Cl, S.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 1-Isopropyl-<i>N</i>-[[1-[2-(4-hydroxyphenyl)ethyl]-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11y</b>)</h5><div class="NLM_p last"><b>11y</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> using 2-(4-hydroxyphenyl)ethyl bromide as reactant. Crude <b>11y</b> was treated with 2.5 N HCl in ethanol to give the corresponding hydrochloride, which was crystallized from absolute ethanol (29%, 218–220 °C). IR (KBr): ν 3167.62, 2511.31, 1632.00, 1557.96, 1515.87, 1457.54, 1206.14, 833.57, 746.65 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1. 55 (d, <i>J</i> = 7 Hz, 6H), 1. 63–2.15 (m, 5H), 2.70–3.75 (m, 10H), 5.09 (m, <i>J</i> = 7 Hz, 1H), 6.75 (d, <i>J</i> = 8 Hz, 2H), 7.06 (d, <i>J</i> = 8 Hz, 2H), 7.21–7. Thirty (m, 1 H), 7.40–7.50 (m, 1 H), 7.8 (d, <i>J</i> = 8 Hz, 1H), 8.21 (d, <i>J</i> = 8 Hz, 1H), 8.46 (m, 1H), 9.40 (s, 1H), 10.80 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 26.91, 28.50, 33.97, 43.21, 50.22, 51.44, 57.00, 110.24, 115.36, 121.77, 122.20, 126.23, 126.98, 129.48, 136.67, 139.50, 156.15, 162.22. Anal. (C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub>·HCl) C, H, N, Cl.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 1-Isopropyl-<i>N</i>-[[1-[2-(4-nitrophenyl)ethyl]-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11z</b>)</h5><div class="NLM_p last"><b>11z</b> was prepared according to the procedure described for <b>11b</b> starting from <b>16</b> using 1-(2-bromoethyl)-4-nitrobenzene as reactant. The product was purified by flash chromatography on silica gel (ethyl acetate as eluent). Pure <b>11z</b> was treated with a stoichiometric amount of oxalic acid in ethyl acetate to generate the corresponding oxalate, which was recrystallized twice from ethyl acetate/ethanol (9:1; 39%, 98 °C dec). IR (diffuse reflectance with KBr): ν 3325.5, 2981.0, 2937.6, 1654.7, 1520.1, 1347.6, 1203.8, 855.8, 751.0, 707. 0 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.44–1.66 (m, 2H), 1.83–2.02 (m, 3H), 2.98 (t, <i>J</i> = 12 Hz, 2H), 3.10–3. 40 (m, 6H), 3.55 (d, <i>J</i> = 12 Hz, 2H), 5.07 (m, <i>J</i> = 7 Hz, 1H), 7.28 (t, <i>J</i> = 8 Hz, 1H), 7.46 (t, <i>J</i> = 7 Hz, 1H), 7.59 (d, <i>J</i> = 9 Hz, 2H), 7.79 (d, <i>J</i> = 8 Hz, 1H), 8.11–8.26 (m, 3H), 8.42 (t, <i>J</i> = 6 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 26.81, 29.58, 33.78, 42.92, 50.22, 51.25, 55.73, 110.24, 121.80, 122.20, 122.26, 123.58, 126.25, 130.06, 136.68, 139.52, 145.84, 146.38, 162.22, 164.60. Anal. (C<sub>25</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub>·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 1-Isopropyl-<i>N</i>-[[1-[3-(methylamino)-3-oxo-1-propyl]-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11x</b>)</h5><div class="NLM_p last">A mixture of <b>16</b> (6.9 g, 23 mmol), 3-chloro<i>-N</i>-methylpropanamide (4.8 g, 35.4 mmol), and K<sub>2</sub>CO<sub>3</sub> (10 g, 72 mmol) in DMF (100 mL) was stirred at 80 °C overnight. The cooled solution was poured into water and extracted with ethyl acetate. The organic layer was washed with 0.5 N NaOH, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. Crude <b>11x</b> was treated with Et<sub>2</sub>O/HCl to afford the corresponding hydrochloride, which was recrystallized from isopropyl alcohol/diisopropyl ether (5.2 g, 52%, 190–191.5 °C). IR (diffuse reflectance with KBr): ν 3474, 3352, 3203, 1638, 1541, 1383, 1263, 1207, 948, 832, 760, 642 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.31 (br s, 1H), 8.36 (t, <i>J</i> = 6.19 Hz, 1H), 8.17 (m, <i>J</i> = 0.93, 8.22 Hz, 1H), 8.10 (q, <i>J</i> = 4.30 Hz, 1H), 7.79 (d, <i>J</i> = 8.59 Hz, 1H), 7.43 (m, <i>J</i> = 1.16 Hz, <i>J</i> = 6.98 Hz, <i>J</i> = 8.38 Hz, 1H), 7.25 (m, <i>J</i> = 0.66 Hz, <i>J</i> = 6.98 Hz, <i>J</i> = 8.05 Hz, 1H), 5.08 (m, <i>J</i> = 6.61 Hz, 1H), 3.12–3.58 (m, 8H), 2.77–2.98 (m, 2H), 2.65 (t, <i>J</i> = 8.17 Hz, 2H), 2.59 (d, <i>J</i> = 4.46 Hz, 3H), 1.78–2.12 (m, 3H), 1.46–1.74 (m, 2H), 1.55 (d, <i>J</i> = 6.61 Hz, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.84, 25.47, 26.88, 29.29, 33.84, 43.17, 50.20, 51.50, 52.08, 110.24, 121.77, 122.18, 126.23, 136.65, 139.50, 162.21, 169.05. Anal. (C<sub>21</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>·HCl·<sup>3</sup>/<sub>4</sub>H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 2-Methyl-4-[[1-[2-(4-nitrophenyl)ethyl]-4-piperidinyl]methoxy]-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>30</b>)</h5><div class="NLM_p last">2-(4-Nitrophenyl)ethyl bromide (2.6 mmol, 0.61 g) and K<sub>2</sub>CO<sub>3</sub> (6.6 mmol, 0.91 g) were added into a solution of <b>12a</b> (2.2 mmol, 0.65 g) in DMF (5 mL). The mixture was stirred at 70 °C for 2 h and 45 min. After cooling, the mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 × 30 mL). The combined organic layers were washed with brine (3 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to give a crude product, which was purified by column chromatography on silica gel (chloroform/methanol (10:1) as eluent) to give 0.62 g of pure product (62%, 157–159 °C, recrystallized from toluene/cyclohexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.65 (m, 2H), 2.00 (m, 3H), 2.19 (m, 2H), 2.72 (t, <i>J</i> = 8.2 Hz, 2H), 3.02 (t, <i>J</i> = 8.2 Hz, 2H), 3.12 (m, 2H), 4.03 (s, 3H), 4.53 (d, 2H), 7.32–7.47 (m, 5H), 7.78 (m, 1H), 7.93 (m, <i>J</i> = 8.1 Hz, <i>J</i> = 1.1 Hz, 2H), 8.20 (d, <i>J</i> = 8.7 Hz, 2H). Anal. (C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 1-Methyl<i>-N</i>-[[1-(2-pyridin-2-ylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11e</b>)</h5><div class="NLM_p last">2-Vinylpyridine (14.8 mmol, 1.6 mL) was added to a solution of <b>11a</b> (4 g, 14.7 mmol) in 1.8 mL of water/glacial acetic acid (4:5). The mixture was stirred under reflux for 5 h and then at room temperature overnight. The solution was treated with water and then with solid NaOH until pH 8 was reached. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was filtered through a silica gel pad that was washed with CHCl<sub>3</sub>/MeOH (95:5). The crude <b>11e</b> was recrystallized from <i>n-</i>hexane/ethyl acetate to give 3.8 g of the title product. The dihydrochloride salt was prepared by treating <b>11e</b> with 0.1 N HCl in diethyl ether (3.3 mL) and was recrystallized from ethyl acetate/ethanol (95:5; 2.5 g, 35.5%, 214–215 °C). IR (KBr): ν 3386.36, 2598.25, 1655.28, 1619.82, 1538.55, 1232.88, 939.72, 777.15, 751.34 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.36 (br s, 1H), 8.82 (d, <i>J</i> = 4.64 Hz, 1H), 8.32–8.70 (m, 2H), 7.67–8.26 (m, 4H), 7.48 (dt, <i>J</i> = 1.22, 7.57 Hz, 1H), 7.17–7.36 (m, 1H), 4.15 (s, 3H), 2.70–3.95 (m, 11H), 1.30–2.45 (m, 5H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 26.83, 28.19, 33.67, 35.91, 38.77, 39.05, 39.34, 39.61, 39.89, 40.16, 40.43, 43.15, 51.58, 54.16, 110.36, 121.78, 122.29, 124.72, 126.57, 136.88, 140.94, 143.55, 143.85, 153.48, 162.13. Anal. (C<sub>22</sub>H<sub>27</sub>N<sub>5</sub>O·2HCl) C, H, N, Cl.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 1-Isopropyl-<i>N</i>-[[1-(2-pyridin-2-ylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11r</b>)</h5><div class="NLM_p last"><b>11r</b> was prepared according to the procedure described for <b>11e</b> starting from <b>16</b>. The residue was purified by flash chromatography on silica gel (CHCl<sub>3</sub>/MeOH (97:3) as eluent) to yield <b>11r</b>, which was treated with 2.5 N HCl in ethanol solution to give the hydrochloride, which was recrystallized from ethyl acetate/ethanol (33%, 122–123 °C). IR (KBr): ν 3322.07, 2934.88, 2635.47, 1643.93, 1548.14, 1439.24, 1206.50, 941.32, 753.85 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.68–2.30 (m, 5H), 2.80–3.78 (m, 12H), 5.10 (m, <i>J</i> = 7 Hz, 1H), 7.12–7.60 (m, 4H), 7.68–8.00 (m, 2H), 8.21 (d, <i>J</i> = 7 Hz, 1H), 8.33–8.70 (m, 2H), 11.05 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 31.16, 50.20, 110.24, 121.77, 122.00, 122.18, 123.34, 126.23, 136.87, 139.50, 149.02, 157.00, 162.22. Anal. (C<sub>24</sub>H<sub>31</sub>N<sub>5</sub>O·HCl·H<sub>2</sub>O) C, H, N Cl.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 4-[[[(1-Isopropyl-1<i>H</i>-indazol-3-yl)carbonyl]amino]methyl]-1-methyl-1-(2-phenylethyl)piperidinium Iodide (<b>11s</b>)</h5><div class="NLM_p last">Methyl iodide (0.6 mL, 10 mmol) was slowly added into a solution of <b>11m</b> (4 g, 9.9 mmol) in acetone (40 mL). The mixture was stirred at room temperature for 3 h and then filtered, and the solid that was obtained was recrystallized from ethyl acetate/ethanol (1:1; 1.4 g, 26%, 209–210 °C). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.48 (t, <i>J</i> = 5.67 Hz, 1H), 8.20 (d, <i>J</i> = 7.43 Hz, 1H), 7.82 (d, <i>J</i> = 8.20 Hz, 1H), 7.12–7.58 (m, 7H), 5.11 (m, <i>J</i> = 6.68 Hz, 1H), 2.87–3.93 (m, 13H), 1.36–2.23 (m, 5H), 1.56 (d, <i>J</i> = 6.65 Hz, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 23.56,27.51, 33.46, 42.63, 43.93, 50.23, 59.51, 66.91, 110.26, 121.73, 122.20, 126.25, 126.87, 128.61, 128.96, 136.39, 136.67, 139.50, 162.29. IR (KBr): ν 3314.16, 2976.00, 1646.96, 1550.21, 1487.41, 1204.03, 1130.61, 930.35, 753.43, 710.40, 640.40 cm<sup>–1</sup>. Anal. (C<sub>26</sub>H<sub>35</sub>IN<sub>4</sub>O) C, H, N, I.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 2-Methyl-4-[[1-(2-morpholin-4-ylethyl)-4-piperidinyl]methoxy]-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12e</b>)</h5><div class="NLM_p last">4-(2-Chloroethyl)morpholine hydrochloride (1.3 mmol, 240 mg) and sodium hydrogen carbonate (3.7 mmol, 310 mg) were added into a solution of <b>12a</b> (1.3 mmol, 380 mg) in absolute ethanol (12 mL). The mixture was stirred at reflux for 3 h and 15 min. After cooling, the solvent was removed under reduced pressure and the residue was taken up in water (50 mL) and extracted with ethyl acetate (3 × 50 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to give 480 mg of pure <b>12e</b> (90%, oil). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.61 (m, 2H), 1.89–1.97 (m, 3H), 2.13 (m, 2H), 2.56 (m, 4H), 2.63 (m, 4H), 3.09 (m, 2H), 3.78 (m, 4H), 4.03 (s, 3H), 4.49 (d, 2H), 7.32–7.46 (m, 4H), 7.78 (m, 1H), 7.93 (m, 1H). Anal. (C<sub>24</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N. The product was converted to the hydrochloride as described for the compound <b>12d</b> (41%, 190–192 °C, from isopropyl ether/isopropyl alcohol). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.71–2.01 (m, 2H), 2.16–2.48 (m, 3H), 2.94–3.14 (m, 4H), 3.19–3.39 (m, 4H), 3.57 (t, <i>J</i> = 7.31 Hz, 2H), 3.81 (d, <i>J</i> = 12.57 Hz, 2H), 3.97 (t, <i>J</i> = 4.38 Hz, 3H), 4.01 (s, 3H), 4.42 (d, <i>J</i> = 5.70 Hz, 2H), 7.42 (d, <i>J</i> = 1.75 Hz, 1H), 7.45–7.58 (m, 4H), 7.61 (s, 1H), 7.78 (d, <i>J</i> = 7.75 Hz, 1H).</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 4-[2-[4-[[(2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]-4-quinolinyl)oxy]methyl]-1-piperidinyl]ethyl]benzenemethanol (<b>12i</b>)</h5><div class="NLM_p last">Compound <b>33</b> (800 mg, 3.7 mmol) was added into a solution of <b>12a</b> (3.3 mmol, 990 mg) in 2-butanone (33.5 mL). The mixture was stirred at reflux for 30 min, and then triethylamine (130 mg, 1.29 mmol, 0.2 mL) was added. After the mixture was stirred for 2 h at the same temperature, a further portion of triethylamine (3.3 mmol, 0.33 g) was added. After 2 h the mixture was cooled at room temperature, diluted with water, and extracted with 2-butanone. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to give crude <b>12i</b>, which was purified by column chromatography on aluminum oxide (ethyl acetate as eluent) to obtain 0.67 g of pure <b>12i</b> (48.5%, 145–146 °C, from benzene/cyclohexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.31 (s, 1H), 1.64 (m, 2H), 1.84 (s, 1H), 1.99 (m, 3H), 2.11 (m, 1H), 2.64–2.68 (m, 2H), 2.87–2.92 (m, 2H), 3.14 (d, 2H), 4.03 (s, 3H), 4.53 (d, 2H), 4.72 (d, 2H), 7.26–7.28 (m, 2H), 7.32–7.38 (m, 5H), 7.44 (m, 1H), 7.78–7.80 (dd, 1H), 7.93 (dd, 1H). Anal. (C<sub>27</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 4-[[1-[2-[4-(Methoxymethyl)phenyl]ethyl]-4-piperidinyl]methoxy]-2-methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12j</b>)</h5><div class="NLM_p last"><b>12j</b> was prepared according to the procedure described for <b>12i</b> using <b>34</b> as alkylating agent (48.5%, 102–105 °C, from 2-propanol/<i>n</i>-hexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>: δ 1.61–1.68 (m, 2H), 1.96–1.99 (m, 3H), 2.11 (m, 2H), 2.66 (m, 2H), 2.89 (m, 2H), 3.13 (m, 2H), 3.44 (s, 3H), 4.03 (s, 3H), 4.48 (s, 2H), 4.51–4.54 (d, 2H), 7.25 (m, 2H), 7.32–7.34 (m, 3H), 7.36–7.39 (m, 2H), 7.42–7.45 (dd, 1H), 7.78–7.80 (dd, 1H), 7.92–7.94 (dd, 1H). Anal. (C<sub>28</sub>H<sub>33</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 4-[2-[4-[[(2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]-4-quinolinyl)oxy]methyl]-1-piperidinyl]ethyl]phenylacetamide (<b>12k</b>)</h5><div class="NLM_p last">A mixture of <b>12a</b> (0.5 g, 1.7 mmol), 4-(2-bromoethyl)phenylacetamide (2.2 g, 9.0 mmol), NaI (9.0 mmol, 1.34 g), and triethylamine (0.9 g, 9.0 mmol) in 2-butanone (22 mL) was stirred at reflux for 12 h. After cooling, the mixture was poured into water (200 mL) and extracted with ethyl acetate (2 × 50 mL). The combined organic layers were extracted with 1 N HCl (3 × 50 mL) to extract the final amine as a hydrochloride. The solid that formed and the acidic phases were combined and treated with sodium carbonate until pH 8 and then extracted again with ethyl acetate (3 × 50 mL). The organic layers were collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The crude product was purified by column chromatography on aluminum oxide (ethyl acetate as eluent) to give 330 mg of pure <b>12k</b> (42.5%, 145–146 °C, from ethanol/hexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.64–1.76 (m, 6H), 1.99–2.02 (m, 2H), 2.23–2.24 (s, 3H), 2.93–2.95 (m, 2H), 2.97 (m, 2H), 3.26 (m, 2H), 4.04 (s, 3H), 4.53–4.54 (d, 2H), 7.18 (m, 1H), 7.22–7.24 (m, 2H), 7.35 (m, 1H), 7.39 (m, 4H), 7.77–7.79 (m, 1H), 7.93 (dd, 1H). Anal. (C<sub>28</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Ethyl 4-[2-[4-[[(2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]-4-quinolinyl)oxy]methyl]-1-piperidinyl]ethyl]benzoate (<b>31</b>)</h5><div class="NLM_p last"><b>31</b> was obtained according to the procedure described for <b>12k</b> using ethyl 4-(2-chloroethyl)benzoate<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> as reactant. The crude product was purified by column chromatography on aluminum oxide (chloroform as eluent) to give pure <b>31</b> (51%, brown oil). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.44 (t, 3H), 1.65 (m, 2H), 1.98 (m, 3H), 2.18 (m, 2H), 2.70 (t, 2H), 2.97 (t, 2H), 3.14 (m, 2H), 4.01 (s, 3H), 4.42 (q, 2H), 4.52 (d, 2H), 7.32–7.46 (m, 6H), 7.78 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 1.1 Hz, 1H), 7.92 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 1.1 Hz, 1H), 8.02 (d, <i>J</i> = 8.4 Hz, 2H). Anal. (C<sub>29</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Methyl 2-[2-[4-[[(2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]-4-quinolinyl)oxy]methyl]-1-piperidinyl]ethyl]benzoate (<b>32</b>)</h5><div class="NLM_p last"><b>32</b> was obtained according to the procedure described for <b>12k</b> using <b>35</b> as alkylating agent. Crude <b>32</b> thus obtained was purified by column chromatography on silica gel (ethyl acetate as eluent) to give pure <b>32</b> (30%, yellow oil). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.28 (m, 1H), 1.65–1.68 (m, 1H), 1.96–1.98 (m, 3H), 2.26 (m, 2H), 2.70–2.74 (m, 2H), 3.17–3.29 (m, 4H), 3.92 (s, 3H), 3.99 (s, 3H), 4.50 (dd, 2H), 7.27–7.36 (m, 5H), 7.39–7.48 (m, 2H), 7.75 (dd, 1H), 7.88–7.92 (m, 2H). Anal. (C<sub>28</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> Ethyl 4-[2-[4-[[[(1-Isopropyl-1<i>H</i>-indazol-3-yl)carbonyl]amino]methyl]-1-piperidinyl]ethyl]benzoate (<b>21</b>)</h5><div class="NLM_p last">A solution of <b>16</b> (5.3 g, 17.6 mmol), ethyl 4-(2-bromoethyl)benzoate<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (19 g, 74 mmol), potassium iodide (15.6 g, 94 mmol), and triethylamine (13.1 mL, 94 mmol) in 2-butanone (200 mL) was stirred under reflux for 48 h. The mixture was cooled to room temperature, poured into water (1.7 L), and extracted with ethyl acetate (3 × 350 mL). The organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The crude product was purified by column chromatography on aluminum oxide (Et<sub>2</sub>O/<i>n-</i>hexane (1:1 → 7:3) as eluent) to obtain 3.5 g (42%) of the title compound, which was used for the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.32–1.51 (m, 2H), 1.38 (t, <i>J</i> = 7.16 Hz, 3H), 1.61 (d, <i>J</i> = 6.72 Hz, 6H), 1.64–1.91 (m 3H), 2.05 (m, <i>J</i> = 11.55 Hz, <i>J</i> = 2.34 Hz, 2H), 2.54–2.66 (m, 2H), 2.81–2.91 (m, 2H), 3.02 (d, <i>J</i> = 11.69 Hz, 2H), 3.42 (t, <i>J</i> = 6.43 Hz, 2H), 4.36 (q, <i>J</i> = 7.16 Hz, 2H), 4.87 (m, <i>J</i> = 6.72 Hz, 1H), 7.15 (br t, <i>J</i> = 6.28 Hz, 1H), 7.22–7.31 (m, 3H), 7.35–7.49 (m, 2H), 7.96 (d, <i>J</i> = 7.92 Hz, 2H), 8.39 (m, <i>J</i> = 8.18 Hz, <i>J</i> = 1.02 Hz, 1H). Anal. (C<sub>28</sub>H<sub>36</sub>N<sub>4</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 1-<i>sec-</i>Butyl<i>-N</i>-[[1-(2-phenylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11n</b>)</h5><div class="NLM_p last"><b>11l</b> (15.8 g, 44 mmol) was added into a stirred suspension of NaH (1.76 g, 60% suspension in mineral oil) in DMF (100 mL) cooled at 0 °C. The mixture was stirred at room temperature for 1 h, and then 2-bromobutane (6 mL, 44 mmol) was added. After 24 h at the same temperature, water (200 mL) was added, the solution was filtered, and the solid was dissolved in ethyl acetate. The residual inorganic material was filtered off, and the solution was concentrated under vacuum and treated with Et<sub>2</sub>O/HCl. The hydrochloride that formed was recrystallized from ethanol/ethyl acetate (11.6 g, 65%, 235–237 °C). IR (KBr): ν 3327.21, 2930.72, 2545.81, 1650.95, 1545.41, 1489.88, 1200.85, 941.16, 748.85, 702.42 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 12.27 (br s, 1H), 8.33 (m, <i>J</i> = 0.98 Hz, <i>J</i> = 1.10 Hz, <i>J</i> = 7.93 Hz, 1H), 6.98–7.61 (m, 9H), 4.37–4.82 (m, 1H), 1.69–3.94 (m, 18H), 1.58 (d, <i>J</i> = 6.84 Hz, 3H), 0.79 (t, <i>J</i> = 7.30 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.68, 20.18, 26.90, 29.03, 29.27, 33.98, 43.27, 51.39, 55.91, 56.57, 110.23, 121.77, 122.00, 122.14, 126.25, 126.66, 128.56, 137.26, 140.43, 162.26. Anal. (C<sub>26</sub>H<sub>34</sub>N<sub>4</sub>O·HCl·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 1-Isopentyl-<i>N</i>-[[1-(2-phenylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11o</b>)</h5><div class="NLM_p last"><b>11o</b> was prepared according to the procedure described for <b>11n</b> using isopentyl bromide as reactant. Crude <b>11o</b> was treated with 2.5 N HCl in ethanol solution to give the corresponding hydrochloride, which was recrystallized from isopropyl alcohol (25%, 217–218 °C). IR (KBr): ν 3369.1, 2924.6, 2553.2, 1655.4, 1542.4, 1440.0, 1183.1, 943.3, 754.9, 708.8 cm<sup>–1</sup>. <sup>1</sup>H NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.03 (br s, 1H), 8.51 (t, <i>J</i> = 5.66 Hz, 1H), 8.21 (d, <i>J</i> = 7.68 Hz, 1H), 7.77 (d, <i>J</i> = 8.20 Hz, 1H), 7.08–7.60 (m, 7H), 4.50 (t, <i>J</i> = 7.31 Hz, 2H), 2.63–4.04 (m, 10H), 1.26–2.27 (m, 8H), 0.94 (d, <i>J</i> = 6.21 Hz, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 22.19, 25.24, 26.85, 29.26, 33.91, 38.02, 43.21, 47.09, 51.36, 56.55, 110.17, 121.80, 122.15, 126.43, 126.65, 128.55, 136.88, 137.25, 140.25, 162.09. Anal. (C<sub>27</sub>H<sub>36</sub>N<sub>4</sub>O·HCl) C, H, N, Cl.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(5<i>H</i>)-one (<b>25</b>)</h5><div class="NLM_p last">Methyl iodide (1.5 g, 11 mmol) and anhydrous potassium carbonate (1.5 g, 11 mmol) were added into a solution of <b>24</b> (2.0 g, 11 mmol) in anhydrous DMF (10 mL). The mixture was stirred at 90 °C for 15 h. After cooling, the reaction mixture was treated with water (30 mL) and filtered. The solid obtained was purified by column chromatography on silica gel (chloroform/methanol mixture (10:1) as eluent) to give 1.0 g of <b>25</b> (46%, sublimes at 225 °C, from toluene). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 3.91 (s, 3H), 7.09–7.25 (m, 3H), 7.58–7.81 (m, 3H), 10.73 (s, 1H). Anal. (C<sub>12</sub>H<sub>10</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 2-Isopropyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(5<i>H</i>)-one (<b>26</b>)</h5><div class="NLM_p last">To a solution of <b>24</b> (3.0 g, 16 mmol) in dioxane (150 mL) brought to reflux was added potassium metal (580 mg, 15 mmol), and the mixture was stirred at reflux until total disappearance of the metal was observed (2 h). After cooling, 2-iodopropane (2.8 g, 16 mmol) and 18-crown-6 ether (3.9 g, 15 mmol) were added, and the mixture was refluxed for 5.5 h. A further portion of 2-iodopropane (1.4 g, 8.1 mmol) was then added, and the reaction mixture was stirred at reflux for a further 15 h. After cooling, the dioxane was removed under reduced pressure, and the residue was taken up in ethyl acetate (100 mL) and washed with brine (3 × 50 mL). The organic solution was dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure to obtain a crude product, which was purified by column chromatography of aluminum oxide (ethyl acetate as eluent, 0.9 g, 25%, 189–190 °C, from toluene). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.48 (d, 6H), 4.52 (m, 1H), 7.02–7.20 (m, 3H), 7.63–7.70 (m, 2H), 7.77 (m, 1H), 10.62 (s, 1H). Anal. (C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 1-Acetyl-<i>N</i>-[[1-(2-phenylethyl)-4-piperidinyl]methyl]-1<i>H</i>-indazole-3-carboxamide (<b>11p</b>)</h5><div class="NLM_p last">Acetic anhydride (0.26 mL, 2.75 mmol) was added into a suspension of <b>11l</b> (500 mg, 1.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and the mixture was stirred at room temperature overnight. The solution was treated with 1 N NaOH until pH 8 and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was treated with Et<sub>2</sub>O/HCl, and the hydrochloride that formed was recrystallized from <i>n-</i>hexane/ethyl acetate (280 mg, 42%, 246–247 °C). IR (KBr): ν 3431.82, 2937.44, 2547.28, 1727.70, 1676.48, 1536.32, 1375.93, 1325.32, 1375.93, 1325.45, 1197.07, 1147.76, 953.51, 767.44 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.13 (br s, 1H), 8.96 (t, <i>J</i> = 5.82 Hz, 1H), 8.31 (t, <i>J</i> = 7.35 Hz, 2H), 7.06–7.87 (m, 7H), 2.68–3.90 (m, 13H), 1.37–2.31 (m, 5H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 22.59, 26.82, 29.26, 33.80, 43.45, 51.34, 56.54, 114.75, 122.40, 124.00, 125.34, 126.66, 128.55, 129.86, 137.23, 139.44, 161.01, 171.09. Anal. (C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>·HCl) C, H, N, Cl.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> <i>N</i>-[[1-[2-(4-Aminophenyl)ethyl]-4-piperidinyl]methyl]-1-isopropyl-1<i>H</i>-indazole-3-carboxamide (<b>11aa</b>)</h5><div class="NLM_p last">A solution of <b>11z</b> (2.7 g, 6 mmol) in ethanol (30 mL) was hydrogenated on 10% Pd/C (270 mg) by a Parr apparatus at 40 psi for 5 h at room temperature. The mixture was then filtered, and the filtrate was concentrated at reduced pressure. The crude <b>11aa</b> was treated with 2.5 N HCl in ethanol to afford the corresponding hydrochloride, which was recrystallized from ethyl acetate/ethanol (8:2; 1.4 g, 45%, 278 °C dec). IR (diffuse reflectance with KBr): ν 3504, 3413, 3237, 2634, 2053, 1630, 1547, 1514, 1287, 1210, 941, 762, 642 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.55 (d, <i>J</i> = 7 Hz, 6H), 1.45–2.13 (m, 5H), 2.80–3.84 (m, 12H), 5.08 (sept, <i>J</i> = 7 Hz, 1H), 7.20–7.49 (m, 6H), 7.79 (d, <i>J</i> = 9 Hz, 1H), 8.18 (d, <i>J</i> = 9 Hz, 1H), 8.39 (t, <i>J</i> = 6 Hz, 1H), 9.15–11.18 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.86, 26.90, 28.74, 33.95, 43.21, 50.22, 51.44, 56.32, 110.26, 121.77, 122.20, 122.82, 126.23, 129.77, 131.66, 136.26, 136.65, 139.50, 162.22. Anal. (C<sub>25</sub>H<sub>33</sub>N<sub>5</sub>O·2HCl·H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 4-[[1-[2-(4-Aminophenyl)ethyl]-4-piperidinyl]methoxy]-2-methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12f</b>)</h5><div class="NLM_p last">To a solution of the product <b>30</b> (1.4 mmol, 0.61 g) in ethyl acetate (100 mL) was added 10% Pd/C (200 mg). The mixture was stirred under a H<sub>2</sub> atmosphere at room temperature and pressure for 4 h. A further portion of 10% Pd/C (100 mg) was then added, and the mixture was left under a H<sub>2</sub> atmosphere at room temperature and pressure for 19 h. A stream of H<sub>2</sub> was passed through every 3 h. Then the mixture was filtered under vacuum on a Merck RP18 cartridge to remove the palladium, and the solvent was removed under reduced pressure to give 0.57 g of pure <b>12f</b> (99%, 150–152 °C, from toluene/cyclohexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.69 (m, 2H), 1.98 (m, 3H), 2.21 (m, 2H), 2.69 (m, 2H), 2.87 (m, 2H), 3.20 (m, 2H), 3.64 (br s, 2H), 4.04 (s, 3H), 4.53 (d, 2H), 6.69 (d, <i>J</i> = 8.4 Hz, 2H), 7.07 (d, <i>J</i> = 8.4 Hz, 2H), 7.32–7.47 (m, 4H), 7.79 (dd, <i>J</i> = 7.7 Hz, <i>J</i> = 1.2 Hz, 1H), 7.93 (m, <i>J</i> = 7.7 Hz, <i>J</i> = 1.2 Hz, 1H). Anal. (C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O) C, H, N. The product was converted to the hydrochloride as described for the compound <b>12e</b> (95%, 165–167 °C, from diisopropyl ether/isopropyl alcohol). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.66–1.94 (m, 2H), 1.96–2.29 (m, 3H), 2.86–3.89 (m, 8H), 4.00 (s, 3H), 4.49 (d, <i>J</i> = 6.04 Hz, 2H), 7.22–7.46 (m, 6H), 7.63–7.76 (m, 2H), 7.80 (d, <i>J</i> = 1.83 Hz, 1H), 8.01 (dd, <i>J</i> = 7.50, <i>J</i> = 1.65 Hz, 1H), 10.00 (br s, 3H), 10.68 (br s, 1H).</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 4-[2-[4-[[[(1-Isopropyl-1<i>H</i>-indazol-3-yl)carbonyl]amino]methyl]-1-piperidinyl]ethyl]benzoic Acid (<b>11ab</b>)</h5><div class="NLM_p last"><b>21</b> (3.5 g, 7.3 mmol) was dissolved in THF/EtOH (1:1; 34 mL), and 1 N NaOH (15.8 mL) was added. The reaction was stirred at room temperature overnight. HCl (1 N; 15.8 mL) was added until precipitation, the mixture was cooled in an ice bath, and the resulting solid was filtered and recrystallized twice from ethanol/ethyl acetate (35:25; 1.9 g, 58%, 180–182 °C). IR (UATR): ν 3314, 2980, 2934, 2862, 1659, 1535, 1487, 1463, 1357, 1206, 753, 650 cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 15–9 (very br s, 1H), 8.11–8.24 (m, 2H), 7.85 (d, <i>J</i> = 8.26 Hz, 2H), 7.77 (d, <i>J</i> = 8.59 Hz, 1H), 7.43 (m, <i>J</i> = 0.99, 7.10, 8.42 Hz, 1H), 7.33 (d, <i>J</i> = 8.26 Hz, 2H), 7.21–7.29 (m, 1H), 5.07 (m, <i>J</i> = 6.61 Hz, 1H), 3.21 (t, <i>J</i> = 6.28 Hz, 2H), 2.95 (d, <i>J</i> = 11.23 Hz, 2H), 2.74–2.86 (m, 2H), 2.53–2.61 (m, 2H), 1.99 (t, <i>J</i> = 10.73 Hz, 2H), 1.58–1.75 (m, 3H), 1.54 (d, <i>J</i> = 6.61 Hz, 6H), 1.08–1.32 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 21.84, 29.26, 32.18, 35.60, 43.71, 50.19, 52.50, 58.88, 110.20, 121.85, 122.12, 122.26, 126.20, 128.60, 129.25, 129.69, 136.80, 139.52, 144.89, 162.06, 167.66. Anal. (C<sub>26</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 4-[2-[4-[[(2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]-4-quinolinyl)oxy]methyl]-1-piperidinyl]ethyl]benzoic Acid (<b>12g</b>)</h5><div class="NLM_p last"><b>12g</b> was prepared according to the procedure described for <b>11ab</b> using ethanol as solvent (27%, 155–166 °C, from ethanol). <sup>1</sup>H NMR (DMF-<i>d</i><sub>7</sub>): δ 1.53 (m, 2H), 1.93 (m, 3H), 2.23 (m, 2H), 2.74 (m, 2H), 2.97 (m, 2H), 3.17 (m, 2H), 3.25 (m, 2H), 4.13 (s, 3H), 4.48 (d, 2H), 7.36 (m, 1H), 7.43 (m, 1H), 7.49 (d, <i>J</i> = 8.1 Hz, 2H), 7.62 (d, <i>J</i> = 1.9 Hz, 1H), 7.83 (d, <i>J</i> = 1.9 Hz, 1H), 7.70 (d, 1 H), 8.01 (d, <i>J</i> = 8.1 Hz, 2H), 8.08 (m, 1H), 14–16 (br s, 1H). Anal. (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 2-[2-[4-[[(2-Methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]-4-quinolinyl)oxy]methyl]-1-piperidinyl]ethyl]benzoic Acid (<b>12h</b>)</h5><div class="NLM_p last"><b>12h</b> was prepared according to the procedure described for <b>11ab</b> using ethanol as solvent (50%, 165 °C, from ethyl acetate). <sup>1</sup>H NMR (DMF-<i>d</i><sub>7</sub>): δ 1.30 (m, 2H), 1.51 (m, 2H), 1.79–1.82 (m, 1 H), 2.51 (m, 5H), 2.87–2.92 (m, 2H), 3.07–3.10 (m, 2H), 3.98 (s, 3H), 4.35 (d, 2H), 7.23–7.37 (m, 5H), 7.57–7.62 (m, 3H), 7.72 (d, 1 H), 7.96 (dd, 1 H). Anal. (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> Ethyl 4-(2-Nitrophenyl)-1<i>H</i>-pyrrole-3-carboxylate (<b>23</b>)</h5><div class="NLM_p last">A solution of ethyl 3-(2-nitrophenyl)propanoate (<b>22</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (26.6 g, 120 mmol) and TosMIC (25.4 g, 130 mmol) in anhydrous dimethyl sulfoxide/ethyl ether (1:2; 450 mL) was added dropwise to a well-stirred suspension of 60% sodium hydride in paraffin (10.4 g, 260 mmol) in anhydrous ethyl ether (300 mL) under a stream of argon. After the addition, the mixture was stirred at room temperature for 25 min, water (500 mL) was then added, and the resulting solution was extracted with ethyl acetate (3 × 600 mL). The combined organic phases were washed with brine (3 × 300 mL), dried over anhydrous sodium sulfate, and evaporated under reduced pressure. The crude product obtained was purified by column chromatography on aluminum oxide (chloroform/ethyl acetate (1:1) as eluent) to give 12.8 g of <b>23</b> (41%, 159–161 °C, from ethanol). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.51 (m, 3H), 4.01 (q, 2H), 6.51 (m, 1H), 7.31–7.33 (m, 1H), 7.39–7.41 (m, 2H), 7.49–7.53 (m, 1H), 7.92–7.94 (m, 1H), 12.0 (s, 1H). Anal. (C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 2<i>H</i>-Pyrrolo[3,4-<i>c</i>]quinolin-4(5<i>H</i>)-one (<b>24</b>)</h5><div class="NLM_p last">Iron powder (6.7 g, 120 mmol) was added over 15 min into a solution of <b>23</b> (2.0 g, 7.7 mmol) in glacial acetic acid (100 mL) mechanically stirred at 85 °C. The mixture was stirring at the same temperature for 45 min. After cooling, the iron was removed by filtration and washed several times with tetrahydrofuran, and the filtrate was evaporated under reduced pressure. The crude product was purified by column chromatography on aluminum oxide (ethyl acetate as eluent) to give 1.1 g of <b>24</b> (77%, sublimes at 280 °C from ethanol). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.05–7.28 (m, 3H), 7.57–7.63 (m, 2H), 7.84–7.88 (m, 1H), 10.7 (s, 1H), 12.1 (s, 1H). Anal. (C<sub>11</sub>H<sub>8</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 4-Chloro-2-methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>27</b>)</h5><div class="NLM_p last">A mixture of product <b>25</b> (1.0 g, 5.0 mmol), phosphorus oxychloride (16.2 mL), and triethylamine (1.2 mL) was stirred at 120 °C for 6 h. After cooling, the reaction mixture was poured cautiously into ice and extracted with ethyl acetate (3 × 100 mL). The combined organic phases were washed with brine (1 × 50 mL), with saturated sodium bicarbonate solution (3 × 50 mL), and then again with brine (3 × 50 mL). The organic solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The crude product obtained was purified by column chromatography on silica gel (<i>n</i>-hexane/ethyl acetate (1:1) as eluent) to give 1.0 g of <b>27</b> (92%, 123–124 °C, from benzene). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 4.09 (s, 3H), 7.51–7.58 (m, 2H), 7.76 (m, 1H), 7.82–7.85 (m, 1H), 7.97 (m, 1H), 8.15–8.17 (m, 1H). Anal. (C<sub>12</sub>H<sub>9</sub>N<sub>2</sub>Cl) C, H, N, Cl.</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 4-Chloro-2-isopropyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>28</b>)</h5><div class="NLM_p last"><b>28</b> was obtained according to the procedure used for the preparation of compound <b>27</b> starting from <b>26</b>. The crude product obtained was purified by column chromatography on silica gel (chloroform as eluent) to give pure <b>28</b> (91%, 70–72 °C, from cyclohexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.64 (d, 6H), 4.59 (m, 1H), 7.46–7.49 (m, 3H); 7.55 (m, 1H), 7.93–7.98 (m, 2H). Anal. (C<sub>14</sub>H<sub>13</sub>N<sub>2</sub>Cl) C, H, N, Cl.</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 4-[(1-Butyl-4-piperidinyl)methoxy]-2-methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12b</b>)</h5><div class="NLM_p last">A solution of 1-butyl-4-piperidinemethanol (1.14 g, 6.72 mmol) in anhydrous DMF (14 mL) was added dropwise into a suspension of 60% NaH in paraffin (270 mg, 6.72 mmol) in the same solvent (14 mL). The reaction mixture was stirred at room temperature for 10 min, and then the alkoxide that formed was added into a solution of <b>27</b> (470 mg, 2.17 mmol) in DMF (14 mL) preheated to 146 °C. The reaction mixture was stirred at 146 °C for 1 h. After cooling, it was poured onto ice and extracted with ethyl acetate (3 × 50 mL). The combined organic extracts were washed with brine (3 × 20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The residue was purified by column chromatography on aluminum oxide (chloroform as eluent) to give 520 mg of pure <b>12b</b> (68%, 83–85 °C, from benzene/cyclohexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97 (t, 3H), 1.35–1.59 (m, 6H), 1.90–2.07 (m, 5H), 2.37 (m, 2H), 3.03 (m, 2H), 3.99 (s, 3H), 4.49 (d, 2H), 7.28- 7.49 (m, 4H), 7.75 (m, 1 H), 7.88 (m, 1 H). Anal. (C<sub>22</sub>H<sub>29</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 2-Methyl-4-[[1-(2-phenylethyl)-4-piperidinyl]methoxy]-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12c</b>)</h5><div class="NLM_p last"><b>12c</b> was prepared according to the procedure described for <b>12b</b> starting from <b>27</b> (0.50 g, 2.3 mmol) using 1-(2-phenylethyl)-4-piperidinemethanol (1.77 g, 8.05 mmol) as reactant. The crude product was purified by column chromatography on aluminum oxide (<i>n</i>-hexane/ethyl acetate (4:1) as eluent) to give 620 mg of pure <b>12c</b> (67%, 90–92 °C, recrystallized from benzene/cyclohexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.67 (m, 2H), 1.94–1.97 (m, 3H), 2.17 (m, 2H), 2.69 (m, 2H), 2.90 (m, 2H), 3.15 (m, 2H), 3.98 (s, 3H), 4.49 (d, 2H), 7.20–7.42 (m, 9H), 7.74 (m, 1H), 7.88 (m, 1H). Anal. (C<sub>26</sub>H<sub>29</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 2-Isopropyl-4-[[1-(2-phenylethyl)-4-piperidinyl]methoxy]-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>12d</b>)</h5><div class="NLM_p last">Compound <b>12d</b> was prepared according to the procedure described for <b>12b</b> starting from <b>28</b> using 1-(2-phenylethyl)-4-piperidinemethanol as reactant. The residue was purified by column chromatography on aluminum oxide (<i>n</i>-hexane/ethyl acetate (4:1) as eluent) to give pure <b>12d</b> (73%, 90–93 °C, from <i>n</i>-hexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.61–1.66 (m, 8H), 1.94 (m, 3H), 2.12 (m, 2H), 2.65 (m, 2H), 2.86 (m, 2H), 3.12 (m, 2H), 4.49 (d, 2H), 4.54 (m, 1H), 7.21–7.45 (m, 9H), 7.74 (m, 1H), 7.90 (m, 1H). Anal. (C<sub>28</sub>H<sub>33</sub>N<sub>3</sub>O) C, H, N. A solution of HCl in methanol was prepared by addition dropwise of acetyl chloride (2.67 mmol, 200 mg) to 10 mL of methanol cooled at 0 °C. The solution was gently stirred for a few minutes, followed by addition dropwise of a solution of <b>12d</b> (1.0 g, 2.34 mmol) in methanol (5.0 mL). When the addition was complete, the mixture was stirred at 0 °C for 45 min, followed by addition of anhydrous ethyl ether (about 200 mL) until precipitation of the salt was observed. The obtained salt was filtered, washed with anhydrous ethyl ether (3 × 2 mL), and dried under vacuum at 45 °C for 6 h (630 mg, 63%, 138–140 °C, from diisopropyl ether/isopropyl alcohol). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.57 (d, <i>J</i> = 6.59 Hz, 6H), 1.79–2.29 (m, 5H), 2.86–3.47 (m, 6H), 3.63 (d, <i>J</i> = 11.71 Hz, 2H), 4.55 (d, <i>J</i> = 4.03 Hz, 2H), 4.68 (m, <i>J</i> = 6.59 Hz, 1H), 7.20–7.48 (m, 7H), 7.80 (br s, 1H), 7.95–8.16 (m, 3H), 10.93 (br s, 1H).</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 4-[[1-(Phenylmethyl)-4-piperidyl]methoxy]-2-methyl-2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline (<b>29</b>)</h5><div class="NLM_p last">Compound <b>29</b> was prepared according to the procedure described for <b>12b</b> using 1-(phenylmethyl)-4-piperidinemethanol as reactant. The residue was purified by column chromatography on aluminum oxide (chloroform/petroleum ether (1:1) as eluent) to give pure <b>29</b> as an oil (81%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.58–1.59 (m, 2H), 1.91–2.11 (m, 5H), 2.94–3.02 (m, 2H), 3.59 (s, 2H), 4.02 (s, 3H), 4.50 (d, 2H), 7.31–7.39 (m, 8H), 7.44 (m, 1H), 7.77 (m, 1H), 7.92 (m, 1H). Anal. (C<sub>25</sub>H<sub>27</sub>N<sub>3</sub>O) C, H, N.</div></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Biological Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> In Vitro Binding Assay for 5-HT<sub>4</sub>R</h4><div class="NLM_p">The 5-HT<sub>4</sub>R binding assay was performed on homogenates from human embryonic kidney (HEK-293) cells transfected with the human 5-HT<sub>4</sub>R, using 0.2 nM [<sup>3</sup>H]<b>5</b> as radioligand. Nonspecific binding was measured in the presence of 10 μM <b>4</b>·HCl. Assays were conducted in 25 mM Tris–HCl (pH 7.4), 0.5 mM EDTA, and 10 mM MgSO<sub>4</sub>. Binding was initiated by addition of 200 μL of membrane homogenates (43–61 μg of protein/mL); after 60 min of incubation at 27 °C, the membranes were harvested onto glass fiber (GF/B) filters (Unifilter, Packard) (treated with 0.3% poly(ethylenimine)) using a Filtermate cell harvester (Packard). Subsequently, the filters were washed with 2.5 mL of ice-cold buffer and dried for 30 min in an oven at 45 °C, and 30–35 μL of Microscint 20 (Packard) was added to each well. At least 10 h later the radioactivity was measured using a TopCount (Packard) for 1 min. The compounds were tested in duplicate at eight concentrations ranging from 10<sup>–12</sup> to 10<sup>–5</sup> M in duplicate competition curves. The compounds were dissolved in dimethyl sulfoxide (DMSO), serially diluted 1:10 in DMSO, and further diluted in incubation buffer (1% vehicle DMSO final concentration).</div><div class="NLM_p">The protein concentration was determined by the bicinchoninic acid (BCA) method (Pierce) using bovine serum albumin (BSA) as the standard.</div><div class="NLM_p last">Results at a single concentration are expressed as percent inhibition vs a positive control. The IC<sub>50</sub> values (concentration causing a half-maximal inhibition of control specific binding) with Hill coefficients (<i>n</i><sub>H</sub>) were determined by computer-assisted nonlinear regression analysis of eight concentrations in duplicate competition curves. The inhibition constants p<i>K</i><sub>i</sub> (defined as the negative log of <i>K</i><sub>i</sub>) were calculated from the Cheng–Prusoff equation.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> In Vitro Binding Assay for 5-HT<sub>2A</sub>R</h4><div class="NLM_p">The 5-HT<sub>2A</sub>R binding assay was performed on cell homogenates obtained from a stable recombinant CHO-K1 cell line expressing the human 5-HT<sub>2A</sub>R, using 0.7 nM [<sup>3</sup>H]ketanserin as ligand. Nonspecific binding was measured in the presence of 20 μM mianserin. Assays were conducted in buffer containing 50 mM Tris (pH 7.4), 5 mM CaCl<sub>2,</sub> 0.1% ascorbic acid, and 10 μg/mL saponin. Binding was initiated by addition of 20 μL of membrane homogenates (750 μg/mL protein); after 60 min of incubation at 25 °C, the membranes were harvested onto glass fiber (GF/B) filters (Unifilter, Packard) (treated with 0.3% poly(ethylenimine)) using a Filtermate cell harvester (Packard). Subsequently, the filters were washed with 2.5 mL of ice-cold buffer and dried for 30 min in an oven at 45 °C, and 30–35 μL of Microscint 20 (Packard) was added to each well. At least 10 h later the radioactivity was measured using a TopCount (Packard) for 1 min. The compounds were tested in duplicate at eight concentrations ranging from 10<sup>–12</sup> to 10<sup>–5</sup> M. The compounds were dissolved in DMSO and serially diluted 1:10 in DMSO, and each dilution was further diluted in incubation buffer (final DMSO concentration 1%).</div><div class="NLM_p">The protein concentration was determined by the BCA method (Pierce) using BSA as the standard.</div><div class="NLM_p last">Results at a single concentration are expressed as percent inhibition vs a positive control. The IC<sub>50</sub> values (concentration causing a half-maximal inhibition of control specific binding) with Hill coefficients (<i>n</i><sub>H</sub>) were determined by computer-assisted nonlinear regression analysis of eight concentrations in duplicate competition curves. The inhibition constants p<i>K</i><sub>i</sub> (defined as the negative log of <i>K</i><sub>i</sub>) were calculated from the Cheng–Prusoff equation.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> In Vitro Cross-Species Intrinsic Clearance with Rat and Human Liver Microsomes</h3><div class="NLM_p last">Compounds were incubated at 37 °C at a concentration of 1 μM in Dulbecco’s buffer at pH 7.4 with rat and human liver microsomes for up to 60 min to determine their metabolic stability and intrinsic clearance. Samples (25 μL) were taken at time 0 and after 5, 10, 20, 30, and 60 min and added to 50 μL of cold acetonitrile to stop the reaction and to 20 μL of cold acetonitrile containing the internal standard warfarin. The samples were then centrifuged, and the supernatant was analyzed immediately. Midazolam and propranolol were used as positive controls and incubated under the same conditions as the test compounds. Control tests were performed by incubating the compounds with rat and human liver microsomes in Dulbecco’s buffer in the absence of NADPH for 60 min. The single time point metabolic stability of the test compounds was evaluated by calculating the percentage of parent compound remaining after 60 min of incubation. The intrinsic clearance (CL<sub>int</sub>) of the test compounds was calculated using the half-life approach. The half-life and CL<sub>int</sub> were determined from the concentration remaining at the different sampling points using the LC–MS/MS method.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Cross-Species Metabolic Stability in Liver Microsomes from Mouse, Rat, Dog, Miniature Pig, Monkey, and Human</h3><div class="NLM_p last">The samples consisted of the test articles at 1 and 10 μM, pooled microsomes at 0.5 mg/mL final protein concentration, and NADPH regenerating system in a final volume of 200 μL. DMSO was the test article solvent, and the final DMSO concentration was 0.5%. The assay was standardized for both phosphate buffer (75 mM, pH 7.4) and the NADPH regenerating system (MgCl<sub>2</sub>, 3.3 mM; G6P, 3.3 mM; G6PD, 0.4 U/mL; NADP<sup>+</sup>, 1.3 mM). Positive controls (warfarin, propranolol, and testosterone, incubated as a cocktail) were treated as the test articles. The samples were incubated at 37 °C in a 96-well plate in a humidified incubator. At <i>t</i> = 0, 30, and 60 min, 100 μL of acetonitrile containing the internal standards (0.2 μM metoprolol and 0.4 μM diclofenac) for LC–MS analysis was added to stop the reaction. The samples were diluted 10-fold to bring them within the linear range of the instrumental measures. The samples were centrifuged prior to analyses by LC–MS/MS using positive electronspray ionization (ESI) and selected reaction monitoring (SRM) using a gradient LC method. The LC conditions included a 5–91% acetonitrile gradient in water containing 0.1% formic acid with a total run time of 6.5 min. The LC was isocratic for 0.5 min followed by a linear gradient of acetonitrile from 5% to 91% over 1 min, with a 2.5 min hold at 91% acetonitrile. The eluent flow rate was 0.5 mL/min, and the column was an XDBC18 (2.1 × 50 mm, Agilent). The re-equilibration period was 1.5 min at 1.4 mL/min followed by 0.5 min at 0.5 mL/min. The internal standard for positive mode ESI was metoprolol.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Hot Plate Test</h3><div class="NLM_p last">The method originally described by Woolfe and Mac Donald was used with some modifications.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The hot plate consists of an electrically heated surface with the temperature fixed at 56 ± 0.2 °C. The animals are placed on the hot plate, and the time until a nocifensive response (i.e., licking, flinching, jumping) occurs is recorded by a stopwatch. During the test, latency for nocifensive response was recorded 1 h after drug administration. The maximum latency time was 30 s to minimize tissue damage. The effect on latency was also calculated as a percent response increase with respect to vehicle-treated rats.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Formalin Test</h3><div class="NLM_p last">The formalin test in mice is a valid and reliable model of nociception. The noxious stimulus is a subcutaneous injection of 20 μL of a 1% solution of formalin in saline into the dorsal surface of the right hind paw of the mouse.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The formalin injection produces a distinct biphasic response consisting of licking or biting the paw. The early phase, occurring from 0 to 10 min after the formalin injection, is due to a direct effect on nociceptors, while the late phase from 15 to 40 min seems to be an inflammatory response where pain is responsive to anti-inflammatory drugs. Mice were placed in a Plexiglas cage, utilized as an observation chamber, 1 h before administration of the formalin injections. The tested drugs were orally given 30 min before formalin. The total amount of time (s) that the animal spent licking or biting the paw after the formalin injection was recorded for a period of 40 min within 5 min intervals.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94"><a href="/doi/suppl/10.1021/jm300573d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures regarding the pharmacophore approach, synthetic methods for compounds <b>29</b> and <b>33</b>–<b>35</b>, analyses, 5-HT<sub>4</sub>R functional assay, and in vitro pharmacology profiles. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300573d/suppl_file/jm300573d_si_001.pdf">jm300573d_si_001.pdf (261.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300573d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guido Furlotti</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#94f3baf2e1e6f8fbe0e0fdd4f5faf3f1f8fdfafdbafde0b4e6fbf6f1e6e0fbbaf0fde7f5fae0fbd4e1fafde6fbf9f5a5bafde0"><span class="__cf_email__" data-cfemail="e483ca829196888b90908da4858a8381888d8a8dca8d90">[email protected]</span> <span class="__cf_email__" data-cfemail="c5b7aaa7a0b7b1aaeba1acb6a4abb1aa85b0abacb7aaa8a4f4ebacb1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Di Santo</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b7c357d6e6977746f6f725b7a757c7e7772757235726f3b6974797e696f74357f72687a756f745b6e75726974767a2a35726f"><span class="__cf_email__" data-cfemail="187f367e6d6a74776c6c715879767f7d7471767136716c">[email protected]</span> <span class="__cf_email__" data-cfemail="ea9885888f989e85c48e83998b849e85aa9f84839885878bdbc4839e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Alessandra Alisi</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Apicella</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandra Capezzone de Joannon</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola Cazzolla</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberta Costi</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuliana Cuzzucoli Crucitti</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrice Garrone</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alberto Iacovo</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriele Magarò</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgina Mangano</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gaetano Miele</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosella Ombrato</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Pescatori</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorenzo Polenzani</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Rosi</span> - <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Vitiello</span> - <span class="hlFld-Affiliation affiliation">†Department
of Chemistry and § Department of Pharmacology, Angelini Santa
Palomba Research Center, Piazzale della
Stazione snc, 00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Istituto Pasteur—Fondazione
Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, “Sapienza” Università di Roma,
Piazzale Aldo Moro 5, 00185 Rome, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d938e6986-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Claudio Dagostin and Katie Ellard for their help in reviewing the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i97" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i97"> Abbreviations Used</h2><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine or serotonin</p></td></tr><tr><td class="NLM_term">5-HTR</td><td class="NLM_def"><p class="first last">5-HT receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>4</sub>R</td><td class="NLM_def"><p class="first last">serotonin 4 receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>2A</sub>R</td><td class="NLM_def"><p class="first last">serotonin 2A receptor</p></td></tr><tr><td class="NLM_term">VS</td><td class="NLM_def"><p class="first last">virtual screening</p></td></tr><tr><td class="NLM_term">EF</td><td class="NLM_def"><p class="first last">enrichment factor</p></td></tr><tr><td class="NLM_term">TosMIC</td><td class="NLM_def"><p class="first last">(4-tolylsulfonyl)methyl isocyanide</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovarian</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G.</span><span> </span><span class="NLM_article-title">5-HT receptor classification and nomenclature: towards a harmonization with the human genome</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=419-428&author=D.+Hoyerauthor=G.+Martin&title=5-HT+receptor+classification+and+nomenclature%3A+towards+a+harmonization+with+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DG.%26atitle%3D5-HT%2520receptor%2520classification%2520and%2520nomenclature%253A%2520towards%2520a%2520harmonization%2520with%2520the%2520human%2520genome%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D419%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Humphrey, P. P. A.</span><span> </span><span class="NLM_article-title">The characterization and classification of neurotransmitter receptors</span>.  <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">812</span>, <span class="NLM_issue">1–13</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=812&publication_year=1997&issue=1%E2%80%9313&author=P.+P.+A.+Humphrey&title=The+characterization+and+classification+of+neurotransmitter+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%2BA.%26atitle%3DThe%2520characterization%2520and%2520classification%2520of%2520neurotransmitter%2520receptors%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1997%26volume%3D812%26issue%3D1%25E2%2580%259313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. D.</span><span> </span><span class="NLM_article-title">Serotonin receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr078224o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1614-1641&issue=5&author=D.+E.+Nicholsauthor=C.+D.+Nichols&title=Serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin Receptors</span></div><div class="casAuthors">Nichols, David E.; Nichols, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1614-1641</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on phylogeny, structural features, oligomerization, classification and functions of serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnlR5CHbuX7Vg90H21EOLACvtfcHk0linIQVDHPaT5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D&md5=55b70829f6be71cbfe4de05c5ef665d8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr078224o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr078224o%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DNichols%26aufirst%3DC.%2BD.%26atitle%3DSerotonin%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26issue%3D5%26spage%3D1614%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Curr. Drug. Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F1568007043482615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=14965243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=39-51&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors</span></div><div class="casAuthors">Bockaert, J.; Claeysen, S.; Compan, V.; Dumuis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-51</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin 4 receptors (5-HT4Rs) were discovered 15 yr ago.  They are coded by a very complex gene (700Kb, 38 exons) which generates 8 C-terminal variants (a, b, c, d, e, f, g, and n).  Their sequences differ after position L358.  Another variant is characterized by a 14 residue insertion within the extracellular loop 2.  Highly selective potent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studies is still missing.  Based on physiol. and behavioral expts., 5-HT4Rs may be targets to treat cognitive deficits, abdominal pain, and feeding disorders.  One 5-HT4R-directed drug (SL65.0155) is already in phase II to treat patients suffering from memory deficits or dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemFXFD0xNLrVg90H21EOLACvtfcHk0lidUvK7R6bmqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D&md5=b9139c95c9d832dd89b51d45fc3bde96</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1568007043482615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482615%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%26jtitle%3DCurr.%2520Drug.%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D39%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors: history, molecular pharmacology and brain functions</span> <span class="citation_source-journal">Neuropharmacaology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">922</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2Fj.neuropharm.2008.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=18603269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Knu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=922-931&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors%3A+history%2C+molecular+pharmacology+and+brain+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors: History, molecular pharmacology and brain functions</span></div><div class="casAuthors">Bockaert, Joel; Claeysen, Sylvie; Compan, Valerie; Dumuis, Aline</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">922-931</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Twenty years ago, the authors started the characterization of a 5-HT receptor coupled to cAMP prodn. in neurons.  This receptor obviously had a different pharmacol. to the other 5-HT receptors described at that time, i.e., the 5-HT1, 5-HT2, 5-HT3 receptors.  The authors proposed to name it the 5-HT4 receptor.  Nowadays, 5-HT4 receptors are one of the most studied GPCRs belonging to the "rhodopsin" family.  Thanks to the existence of a great variety of ligands with inverse agonist, partial agonist, agonist and antagonist profiles, the pharmacol. and physiol. properties of this receptor are beginning to emerge.  Although some 5-HT4 partial agonists have been on the market for gastro-intestinal pathologies, 5-HT4 receptor drugs have still to be commercialized for brain disorders.  However, since 5-HT4 receptors have recognized effects on memory, depression and feeding in animal models, there is still hope for a therapeutic destiny of this interesting target in brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl1VfQpC_B0bVg90H21EOLACvtfcHk0lidUvK7R6bmqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Knu7jN&md5=d451b92ef3e3c8fa8b0953b69c873789</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%253A%2520history%252C%2520molecular%2520pharmacology%2520and%2520brain%2520functions%26jtitle%3DNeuropharmacaology%26date%3D2008%26volume%3D55%26spage%3D922%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Eglen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span> </span><span class="NLM_article-title">Central 5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=391-398&author=R.+M.+Eglenauthor=E.+H.+F.+Wongauthor=A.+Dumuisauthor=J.+Bockaert&title=Central+5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEglen%26aufirst%3DR.%2BM.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26atitle%3DCentral%25205-HT4%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1995%26volume%3D16%26spage%3D391%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglen, R. M.</span><span> </span><span class="NLM_article-title">Peripheral 5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=1398-1407&author=S.+Hegdeauthor=R.+M.+Eglen&title=Peripheral+5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DEglen%26aufirst%3DR.%2BM.%26atitle%3DPeripheral%25205-HT4%2520receptors%26jtitle%3DFASEB%2520J.%26date%3D1996%26volume%3D10%26spage%3D1398%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Langlois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmeister, R.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors ligands: application and new prospects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020099f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=319-344&issue=3&author=M.+Langloisauthor=R.+Fischmeister&title=5-HT4+receptors+ligands%3A+application+and+new+prospects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm020099f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020099f%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3D5-HT4%2520receptors%2520ligands%253A%2520application%2520and%2520new%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D3%26spage%3D319%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>3</sub> and 5-HT<sub>4</sub> receptor antagonists</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1002%2F%28SICI%291098-1128%28199703%2917%3A2%3C163%3A%3AAID-MED2%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=9057164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK2sXhvFCitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=163-214&issue=2&author=L.+M.+Gasterauthor=F.+D.+King&title=Serotonin+5-HT3+and+5-HT4+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT3 and 5-HT4 receptor antagonists</span></div><div class="casAuthors">Gaster, Laramie M.; King, Frank D.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-214</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 311 refs., concs. on the more recent aspects of medicinal chem., receptor structure and clin. findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VBcqaBf7VrVg90H21EOLACvtfcHk0lj5MpDghD1d0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvFCitb4%253D&md5=8bf0abd24866bb415e8883f8637f936c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199703%2917%3A2%3C163%3A%3AAID-MED2%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199703%252917%253A2%253C163%253A%253AAID-MED2%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DKing%26aufirst%3DF.%2BD.%26atitle%3DSerotonin%25205-HT3%2520and%25205-HT4%2520receptor%2520antagonists%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26issue%3D2%26spage%3D163%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Van Outryve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toussaint, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eeghem, P.</span><span> </span><span class="NLM_article-title">“Prokinetic” treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride</span> <span class="citation_source-journal">J. Clin. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1097%2F00004836-199102000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=2007745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A280%3ADyaK3M7nvVaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1991&pages=49-57&issue=1&author=M.+Van+Outryveauthor=R.+Miloauthor=J.+Toussaintauthor=P.+Van+Eeghem&title=%E2%80%9CProkinetic%E2%80%9D+treatment+of+constipation-predominant+irritable+bowel+syndrome%3A+a+placebo-controlled+study+of+cisapride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride</span></div><div class="casAuthors">Van Outryve M; Milo R; Toussaint J; Van Eeghem P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical gastroenterology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>
        ISSN:<span class="NLM_cas:issn">0192-0790</span>.
    </div><div class="casAbstract">The effects of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome (IBS) were evaluated in a randomized, double-blind, placebo-controlled study.  Sixty-nine IBS patients were assigned to a 12-week treatment with either 5 mg cisapride or placebo t.i.d.; this dosage could be changed if necessary.  The mean weekly number of days on which a stool was passed in the cisapride and placebo group increased to 5.3 and 4.4 (p less than 0.05) during weeks 8-12 of treatment, and the number of days with stools of normal consistency increased to 3.5 and 1.9 (p less than 0.05), respectively.  At week 12, the reduction in severity and frequency scores for abdominal pain was significantly greater (p less than or equal to 0.05) in the cisapride group (60 and 61%) than in the placebo group (40 and 32%), as it was for abdominal distension (p less than 0.05).  Cisapride tended to be better than placebo in diminishing flatulence.  In 71% versus 39% of the patients the overall rating for the response to treatment was good or excellent at week 12.  Cisapride was well tolerated.  These results suggest that the drug will be useful for the management of constipation-predominant IBS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQM6t45GwYBNuxsqfvU0ziafW6udTcc2eZK8OiXfKUXuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7nvVaitw%253D%253D&md5=42937520b98fec720575bbe9c28f4f63</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2F00004836-199102000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004836-199102000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BOutryve%26aufirst%3DM.%26aulast%3DMilo%26aufirst%3DR.%26aulast%3DToussaint%26aufirst%3DJ.%26aulast%3DVan%2BEeghem%26aufirst%3DP.%26atitle%3D%25E2%2580%259CProkinetic%25E2%2580%259D%2520treatment%2520of%2520constipation-predominant%2520irritable%2520bowel%2520syndrome%253A%2520a%2520placebo-controlled%2520study%2520of%2520cisapride%26jtitle%3DJ.%2520Clin.%2520Gastroenterol.%26date%3D1991%26volume%3D13%26issue%3D1%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Appel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span> </span><span class="NLM_article-title">Clinical pharmacodynamics of SDZ HTF919, a new 5-HT<sub>4</sub> receptor agonist, in a model of slow colonic transit</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2FS0009-9236%2897%2990050-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=9390111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK2sXnvVGrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=546-55&issue=5&author=S.+Appelauthor=A.+Kumleauthor=R.+Meier&title=Clinical+pharmacodynamics+of+SDZ+HTF919%2C+a+new+5-HT4+receptor+agonist%2C+in+a+model+of+slow+colonic+transit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit</span></div><div class="casAuthors">Appel, Silke; Kumle, Anette; Meier, Remy</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology and Therapeutics (St. Louis)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">546-555</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby-Year Book, Inc.</span>)
        </div><div class="casAbstract">To explore the pharmacodynamic effects of the new promotile agent SDZ HTF 919, a selective partial 5-HT4 receptor agonist, in healthy subjects.  A pharmacodynamic model was applied to prolong colonic transit by dietary means.  Subsequently, the effects of twice-daily multiple doses of SDZ HTF 919 (1, 5, 25, and 100 mg) were investigated in a randomized, double-blind, placebo-controlled parallel-group study with 12 subjects per dose level.  The sequential design with three study periods of 7 days each included intake of a self-selected diet, a liq. formula diet with sol. fiber supplementation, and a fiber-supplemented diet together with either SDZ HTF 919 or placebo administration.  Stool characteristics (frequency and consistency) and total colonic transit times (with use of radiopaque markers) were recorded in each study period.  SDZ HTF 919 was well tolerated at all dose levels.  The frequency of loose stool and headache increased with higher doses.  After a fiber-supplemented diet intake, the median stool frequency decreased from 81/2-9 to 5-7 defecations per study period.  SDZ HTF 919 in doses of 25 and 100 mg twice a day increased the stool frequency (p < 0.05). Stool consistency was softened by all but the lowest SDZ HTF 919 dose.  A fiber-supplemented diet prolonged total colonic transit time in all groups by 45 h on av.  Twice-a-day administration of SDZ HTF 919 for 6 days in addn. to a fiber-supplemented diet significantly shortened the total colonic transit time only at the 5 mg dose.  The lack of effect at lower and higher SDZ HTF 919 doses suggests a biphasic dose-response relationship for total colonic transit time.  The suitability of total colonic transit time measurements in healthy subjects as a surrogate marker should be confirmed by patient studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTaiDCLd0aLVg90H21EOLACvtfcHk0lii0R4d2jcQTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvVGrtLY%253D&md5=5153f4575aec5757eb25a059132eacc7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0009-9236%2897%2990050-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-9236%252897%252990050-3%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DS.%26aulast%3DKumle%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DR.%26atitle%3DClinical%2520pharmacodynamics%2520of%2520SDZ%2520HTF919%252C%2520a%2520new%25205-HT4%2520receptor%2520agonist%252C%2520in%2520a%2520model%2520of%2520slow%2520colonic%2520transit%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1997%26volume%3D62%26issue%3D5%26spage%3D546%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bouras, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camilleri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, S.</span><span> </span><span class="NLM_article-title">Selective stimulation of colonic transit by the benzofuran 5-HT<sub>4</sub> agonist, prucalopride, in healthy humans</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1999&pages=682-686&issue=5&author=E.+P.+Bourasauthor=M.+Camilleriauthor=D.+D.+Burtonauthor=S.+McKinzie&title=Selective+stimulation+of+colonic+transit+by+the+benzofuran+5-HT4+agonist%2C+prucalopride%2C+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouras%26aufirst%3DE.%2BP.%26aulast%3DCamilleri%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DD.%2BD.%26aulast%3DMcKinzie%26aufirst%3DS.%26atitle%3DSelective%2520stimulation%2520of%2520colonic%2520transit%2520by%2520the%2520benzofuran%25205-HT4%2520agonist%252C%2520prucalopride%252C%2520in%2520healthy%2520humans%26jtitle%3DGut%26date%3D1999%26volume%3D44%26issue%3D5%26spage%3D682%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kjekshus, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torp-Pedersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullestad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Køber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edvardsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjaastad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qvigstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skomedal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osnes, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, F. O.</span><span> </span><span class="NLM_article-title">Effect of piboserod, a 5-HT<sub>4</sub> serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure</span> <span class="citation_source-journal">Eur. J. Heart Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1093%2Feurjhf%2Fhfp087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=19567409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFCntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=771-778&issue=8&author=J.+K.+Kjekshusauthor=C.+Torp-Pedersenauthor=L.+Gullestadauthor=L.+K%C3%B8berauthor=T.+Edvardsenauthor=I.+C.+Olsenauthor=I.+Sjaastadauthor=E.+Qvigstadauthor=T.+Skomedalauthor=J.+B.+Osnesauthor=F.+O.+Levy&title=Effect+of+piboserod%2C+a+5-HT4+serotonin+receptor+antagonist%2C+on+left+ventricular+function+in+patients+with+symptomatic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure</span></div><div class="casAuthors">Kjekshus, John K.; Torp-Pedersen, Christian; Gullestad, Lars; Kober, Lars; Edvardsen, Thor; Olsen, Inge C.; Sjaastad, Ivar; Qvigstad, Eirik; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Heart Failure</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">771-778</span>CODEN:
                <span class="NLM_cas:coden">EJHFFS</span>;
        ISSN:<span class="NLM_cas:issn">1388-9842</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Myocardial 5-HT4 serotonin (5-HT) receptors are increased and activated in heart failure (HF).  Blockade of 5-HT4 receptors reduced left ventricular (LV) remodelling in HF rats.  We evaluated the effect of piboserod, a potent, selective, 5-HT4 serotonin receptor antagonist, on LV function in patients with HF.  This was a prospective, double-blind, parallel group trial in patients with NYHA class II-IV HF and LV ejection fraction (EF) ≤0.35.  Patients receiving std. HF treatment were randomized to placebo (n = 70) or piboserod 80 mg (n = 67) for 24 wk including 4 wk up titrn.  The primary endpoint was LVEF measured by cardiac magnetic resonance imaging (MRI).  Secondary endpoints were LV vols., N-terminal pro-brain natriuretic peptide, norepinephrine, quality of life, and 6 min walk test.  Piboserod significantly increased LVEF by 1.7% vs. placebo (CI 0.3, 3.2, P = 0.020), primarily through reduced end-systolic vol. from 165 to 158 mL (P = 0.060).  There was a trend for greater increase in LVEF (2.7%, CI -1.1, 6.6, P = 0.15) in a small subset of patients not on chronic β-blocker therapy.  There was no significant effect on neurohormones, quality of life, or exercise tolerance.  Patients on piboserod reported more adverse events, but nos. were too small to identify specific safety issues.  Although patients with chronic HF had a small but significant improvement in LVEF when treated with piboserod for 24 wk, the result was not reflected in significant changes in other efficacy parameters, and its clin. relevance remains uncertain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6g8p72EAObVg90H21EOLACvtfcHk0ljfQh_t1l91LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFCntrg%253D&md5=d6af66f3105192dd11626ddbad76a030</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Feurjhf%2Fhfp087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurjhf%252Fhfp087%26sid%3Dliteratum%253Aachs%26aulast%3DKjekshus%26aufirst%3DJ.%2BK.%26aulast%3DTorp-Pedersen%26aufirst%3DC.%26aulast%3DGullestad%26aufirst%3DL.%26aulast%3DK%25C3%25B8ber%26aufirst%3DL.%26aulast%3DEdvardsen%26aufirst%3DT.%26aulast%3DOlsen%26aufirst%3DI.%2BC.%26aulast%3DSjaastad%26aufirst%3DI.%26aulast%3DQvigstad%26aufirst%3DE.%26aulast%3DSkomedal%26aufirst%3DT.%26aulast%3DOsnes%26aufirst%3DJ.%2BB.%26aulast%3DLevy%26aufirst%3DF.%2BO.%26atitle%3DEffect%2520of%2520piboserod%252C%2520a%25205-HT4%2520serotonin%2520receptor%2520antagonist%252C%2520on%2520left%2520ventricular%2520function%2520in%2520patients%2520with%2520symptomatic%2520heart%2520failure%26jtitle%3DEur.%2520J.%2520Heart%2520Failure%26date%3D2009%26volume%3D11%26issue%3D8%26spage%3D771%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lòpezz-Rodrìguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamù, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosado, M. L.</span><span> </span><span class="NLM_article-title">Comparative receptor mapping of serotoninergic 5-HT<sub>3</sub> and 5-HT<sub>4</sub> binding sites</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=589-599&author=M.+L.+L%C3%B2pezz-Rodr%C3%ACguezauthor=M.+J.+Morcilloauthor=B.+Benham%C3%B9author=M.+L.+Rosado&title=Comparative+receptor+mapping+of+serotoninergic+5-HT3+and+5-HT4+binding+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B2pezz-Rodr%25C3%25ACguez%26aufirst%3DM.%2BL.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DBenham%25C3%25B9%26aufirst%3DB.%26aulast%3DRosado%26aufirst%3DM.%2BL.%26atitle%3DComparative%2520receptor%2520mapping%2520of%2520serotoninergic%25205-HT3%2520and%25205-HT4%2520binding%2520sites%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">López-Rodriguez, M. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardob, L.</span><span> </span><span class="NLM_article-title">5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F1568026023393769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=12052197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=625-641&issue=6&author=M.+L+L%C3%B3pez-Rodriguezauthor=B.+Benham%C3%BAauthor=M.+J.+Morcilloauthor=M.+Murciaauthor=A.+Visoauthor=M.+Campilloauthor=L.+Pardob&title=5-HT%284%29+receptor+antagonists%3A+structure-affinity+relationships+and+ligand-receptor+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor antagonists: structure-affinity relationships and ligand-receptor interactions</span></div><div class="casAuthors">Lopez-Rodriguez, M. L.; Benhamu, B.; Morcillo, M. J.; Murcia, M.; Viso, A.; Campillo, M.; Pardo, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-641</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among serotonin receptors (5-HTRs), the 5-HT4 subtype is of considerable interest because it is involved in (patho)physiol. processes both in peripheral and central nervous systems.  In addn. to the clin. use of 5-HT4R agonists in the treatment of gastrointestinal motility disorders, the potential use of antagonists in the treatment of irritable bowel syndrome, arrhythmias and micturition disturbances are currently under investigation.  This article will review the development of the most important classes of 5-HT4R antagonists with an emphasis on benzimidazole derivs., their structure-affinity relationships, ligand-receptor interactions and pharmacol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4a6CfKMjstbVg90H21EOLACvtfcHk0ljfQh_t1l91LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7c%253D&md5=a5221764c9b779605d029c6e1b03acad</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.2174%2F1568026023393769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393769%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodriguez%26aufirst%3DM.%2BL%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DMurcia%26aufirst%3DM.%26aulast%3DViso%26aufirst%3DA.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardob%26aufirst%3DL.%26atitle%3D5-HT%25284%2529%2520receptor%2520antagonists%253A%2520structure-affinity%2520relationships%2520and%2520ligand-receptor%2520interactions%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26issue%3D6%26spage%3D625%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daveu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Molecular design based on 3D-pharmacophore. Application to 5-HT<sub>4</sub> receptor</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci0101354" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFajtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=962-967&issue=2&author=R.+Bureauauthor=C.+Daveuauthor=J.+C.+Lancelotauthor=S.+Rault&title=Molecular+design+based+on+3D-pharmacophore.+Application+to+5-HT4+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Design Based on 3D-Pharmacophore. Application to 5-HT4 Receptor</span></div><div class="casAuthors">Bureau, Ronan; Daveu, Cyril; Lemaitre, Stephane; Dauphin, Francois; Landelle, Henriette; Lancelot, Jean-Charles; Rault, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">962-967</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A definition of a pharmacophore for the 5-HT4 antagonist was carried out by considering a three-dimensional model which correlates the chem. structures of series of antagonists with their biol. affinities.  A mol. design is described by analyzing the differences between two 3D serotonin pharmacophores.  This successful structural modification demonstrates the efficiency of this approach to design new serotonin ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoH_YGD0JLorVg90H21EOLACvtfcHk0lhbowZAFp2o6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFajtrg%253D&md5=6e7eaabc36c12329dbbfee878282e240</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fci0101354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0101354%26sid%3Dliteratum%253Aachs%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DDaveu%26aufirst%3DC.%26aulast%3DLancelot%26aufirst%3DJ.%2BC.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DMolecular%2520design%2520based%2520on%25203D-pharmacophore.%2520Application%2520to%25205-HT4%2520receptor%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2002%26volume%3D42%26issue%3D2%26spage%3D962%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeotti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casamenti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg-Aiello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, A.</span><span> </span><span class="NLM_article-title">Central cholinergic antinociception induced by 5HT4 agonists: BIMU1 and BIMU8</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=2297-2309&issue=25&author=C.+Ghelardiniauthor=N.+Galeottiauthor=F.+Casamentiauthor=P.+Malmberg-Aielloauthor=G.+Pepeuauthor=F.+Gualtieriauthor=A.+Bartolini&title=Central+cholinergic+antinociception+induced+by+5HT4+agonists%3A+BIMU1+and+BIMU8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGaleotti%26aufirst%3DN.%26aulast%3DCasamenti%26aufirst%3DF.%26aulast%3DMalmberg-Aiello%26aufirst%3DP.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DGualtieri%26aufirst%3DF.%26aulast%3DBartolini%26aufirst%3DA.%26atitle%3DCentral%2520cholinergic%2520antinociception%2520induced%2520by%25205HT4%2520agonists%253A%2520BIMU1%2520and%2520BIMU8%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26issue%3D25%26spage%3D2297%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Doak, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawynok, J.</span><span> </span><span class="NLM_article-title">Formalin-induced nociceptive behaviour and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1997&pages=939-949&issue=3&author=G.+J.+Doakauthor=J.+Sawynok&title=Formalin-induced+nociceptive+behaviour+and+edema%3A+involvement+of+multiple+peripheral+5-hydroxytryptamine+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DG.%2BJ.%26aulast%3DSawynok%26aufirst%3DJ.%26atitle%3DFormalin-induced%2520nociceptive%2520behaviour%2520and%2520edema%253A%2520involvement%2520of%2520multiple%2520peripheral%25205-hydroxytryptamine%2520receptor%2520subtypes%26jtitle%3DNeuroscience%26date%3D1997%26volume%3D80%26issue%3D3%26spage%3D939%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Espejo, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, E.</span><span> </span><span class="NLM_article-title">Antagonism of peripheral 5-HT<sub>4</sub> receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT<sub>3</sub> receptors</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">788</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2FS0006-8993%2897%2901510-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=9554939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK1cXhvVSjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=788&publication_year=1998&pages=20-24&author=E.+F.+Espejoauthor=E.+Gil&title=Antagonism+of+peripheral+5-HT4+receptors+reduces+visceral+and+cutaneous+pain+in+mice%2C+and+induces+visceral+analgesia+after+simultaneous+inactivation+of+5-HT3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of peripheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors</span></div><div class="casAuthors">Espejo, Emilio F.; Gil, Eladio</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">788</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">20-24</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The role of 5-HT4 receptors on cutaneous and visceral pain remains largely unexplored.  The objective of this study was to establish the activity profile of SDZ 205-557, a 5-HT4 antagonist, on cutaneous (hotplate) and visceral (writhing) models of pain, after peripheral administration.  Since SDZ 205-557 possesses some affinity for 5-HT3 receptors at high doses, nociceptive effects of a 1:1 combination of SDZ 205-557 and MDL 72222, a 5-HT3 antagonist, were also evaluated.  Drugs were injected 30 min before tests (0, 0.001, 0.01, 0.1 or 1 mg/kg, i.p.).  A hypoalgesic effect of SDZ 205-557 on cutaneous pain was found at 0.1 and 1 mg/kg doses, as revealed through an enhanced nociceptive threshold in rats placed on the hotplate.  This effect was likely mediated through inactivation of peripheral 5-HT4 receptors.  After the 1:1 combination, the hypoalgesic effect disappeared, which indicates that simultaneous inactivation of 5-HT3 and 5-HT4 receptors antagonized peripherally 5-HT4-mediated hypoalgesia by an unknown mechanism.  SDZ 205-557 also induced hypoalgesia in the writhing test over the entire dose range tested, and visceral hypoalgesia turned out to be analgesia after 1:1 combination.  In summary, findings of the present study imply that: (i) antagonism of 5-HT4 receptors mediates antinociception in enteric viscera and, to a lesser extent, in cutaneous terminals, and (ii) dual inactivation of both 5-HT4 and 5-HT3 receptors induces visceral analgesia, a fact which might have clin. importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBi6Y3knPl-LVg90H21EOLACvtfcHk0lg3ziO89qHHcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvVSjtbY%253D&md5=4c6abf73acb79954838fe1eb9b9e99bf</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2897%2901510-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252897%252901510-2%26sid%3Dliteratum%253Aachs%26aulast%3DEspejo%26aufirst%3DE.%2BF.%26aulast%3DGil%26aufirst%3DE.%26atitle%3DAntagonism%2520of%2520peripheral%25205-HT4%2520receptors%2520reduces%2520visceral%2520and%2520cutaneous%2520pain%2520in%2520mice%252C%2520and%2520induces%2520visceral%2520analgesia%2520after%2520simultaneous%2520inactivation%2520of%25205-HT3%2520receptors%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D788%26spage%3D20%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Muller-Lissner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardhan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruegg, P.</span><span> </span><span class="NLM_article-title">Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1046%2Fj.1365-2036.2001.01094.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=11564007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVCgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=1655-1666&author=S.+A.+Muller-Lissnerauthor=I.+Fumagalliauthor=K.+D.+Bardhanauthor=F.+Paceauthor=E.+Pecherauthor=B.+Naultauthor=P.+Ruegg&title=Tegaserod%2C+a+5-HT4+receptor+partial+agonist%2C+relieves+symptoms+in+irritable+bowel+syndrome+patients+with+abdominal+pain%2C+bloating+and+constipation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation</span></div><div class="casAuthors">Muller-Lissner, S. A.; Fumagalli, I.; Bardhan, K. D.; Pace, F.; Pecher, E.; Nault, B.; Ruegg, P.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1655-1666</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Aim of this study was to investigate the efficacy and safety of tegaserod, a novel 5-HT4 receptor partial agonist, in a randomized, double-blind, placebo-controlled, 12-wk treatment, multicenter study.  Eight hundred and eighty-one patients with irritable bowel syndrome, characterized by abdominal pain, bloating and constipation, received tegaserod, 2 mg b.d. or 6 mg b.d., or placebo for 12 wk.  Tegaserod, 2 mg b.d. and 6 mg b.d., showed a statistically significant relief of overall irritable bowel syndrome symptoms, measured by a weekly, selfadministered questionnaire.  At end-point, treatment differences from placebo were 12.7% and 11.8% for 2 mg b.d. and 6 mg b.d., resp.  The effect of tegaserod was noted as early as week 1, and was sustained over the 12-wk treatment period.  Individual irritable bowel syndrome symptoms assessed daily also showed a statistically significant improvement of abdominal discomfort/pain, no. of bowel movements and stool consistency, and a favorable trend for reducing days with significant bloating.  Adverse events were similar in all groups, with transient diarrhea being the only adverse event seen more frequently with tegaserod than placebo.  Based upon the results of this study, tegaserod offers rapid and sustained relief of the abdominal pain and constipation assocd. with irritable bowel syndrome.  Tegaserod is also well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2s5MHLyskbVg90H21EOLACvtfcHk0lg3ziO89qHHcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVCgsL4%253D&md5=89b9b37b1e993da668c553a20b0c1c72</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2036.2001.01094.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2036.2001.01094.x%26sid%3Dliteratum%253Aachs%26aulast%3DMuller-Lissner%26aufirst%3DS.%2BA.%26aulast%3DFumagalli%26aufirst%3DI.%26aulast%3DBardhan%26aufirst%3DK.%2BD.%26aulast%3DPace%26aufirst%3DF.%26aulast%3DPecher%26aufirst%3DE.%26aulast%3DNault%26aufirst%3DB.%26aulast%3DRuegg%26aufirst%3DP.%26atitle%3DTegaserod%252C%2520a%25205-HT4%2520receptor%2520partial%2520agonist%252C%2520relieves%2520symptoms%2520in%2520irritable%2520bowel%2520syndrome%2520patients%2520with%2520abdominal%2520pain%252C%2520bloating%2520and%2520constipation%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2001%26volume%3D15%26spage%3D1655%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hinschberger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">New benzo[<i>h</i>][1,6]naphthyridine and azepino[3,2-<i>c</i>]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020954v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=138-147&author=A.+Hinschbergerauthor=S.+Buttauthor=V.+Lelongauthor=M.+Boulouardauthor=A.+Dumuisauthor=F.+Dauphinauthor=R.+Bureauauthor=B.+Pfeifferauthor=P.+Renardauthor=S.+Rault&title=New+benzo%5Bh%5D%5B1%2C6%5Dnaphthyridine+and+azepino%5B3%2C2-c%5Dquinoline+derivatives+as+selective+antagonists+of+5-HT4+receptors%3A+binding+profile+and+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm020954v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020954v%26sid%3Dliteratum%253Aachs%26aulast%3DHinschberger%26aufirst%3DA.%26aulast%3DButt%26aufirst%3DS.%26aulast%3DLelong%26aufirst%3DV.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DRenard%26aufirst%3DP.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DNew%2520benzo%255Bh%255D%255B1%252C6%255Dnaphthyridine%2520and%2520azepino%255B3%252C2-c%255Dquinoline%2520derivatives%2520as%2520selective%2520antagonists%2520of%25205-HT4%2520receptors%253A%2520binding%2520profile%2520and%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D138%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lemaitre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepailleur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt-Gueulle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelong-Boulouard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchatelle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daveu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lezoualc’h, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2607</span><span class="NLM_x">–</span> <span class="NLM_lpage">2622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2607-2622&author=S.+Lemaitreauthor=A.+Lepailleurauthor=R.+Bureauauthor=S.+Butt-Gueulleauthor=V.+Lelong-Boulouardauthor=P.+Duchatelleauthor=M.+Boulouardauthor=A.+Dumuisauthor=C.+Daveuauthor=F.+Lezoualc%E2%80%99hauthor=B.+Pfeifferauthor=F.+Dauphinauthor=S.+Rault&title=Novel+antagonists+of+serotonin-4+receptors%3A+synthesis+and+biological+evaluation+of+pyrrolothienopyrazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLemaitre%26aufirst%3DS.%26aulast%3DLepailleur%26aufirst%3DA.%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DButt-Gueulle%26aufirst%3DS.%26aulast%3DLelong-Boulouard%26aufirst%3DV.%26aulast%3DDuchatelle%26aufirst%3DP.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DDaveu%26aufirst%3DC.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DNovel%2520antagonists%2520of%2520serotonin-4%2520receptors%253A%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520pyrrolothienopyrazines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2607%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">De Maeyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurkes, J. A.</span><span> </span><span class="NLM_article-title">5-HT4 receptor agonists: similar but not the same</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1111%2Fj.1365-2982.2007.01059.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=18199093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=99-112&author=J.+H.+De+Maeyerauthor=R.+A.+Lefebvreauthor=J.+A.+Schuurkes&title=5-HT4+receptor+agonists%3A+similar+but+not+the+same"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor agonists: similar but not the same</span></div><div class="casAuthors">De Maeyer, J. H.; Lefebvre, R. A.; Schuurkes, J. A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology & Motility</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-112</span>CODEN:
                <span class="NLM_cas:coden">NMOTEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-1925</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  5-Hydroxytryptamine4 (5-HT4) receptors are an interesting target for the management of patients in need of gastrointestinal (GI) promotility treatment.  They have proven therapeutic potential to treat patients with GI motility disorders.  Lack of selectivity for the 5-HT4 receptor has limited the clin. success of the agonists used until now.  For instance, next to their affinity for 5-HT4 receptors, both cisapride and tegaserod have appreciable affinity for other receptors, channels or transporters [e.g. cisapride: human ether-a-go-go-related gene (hERG) is K+ channel and tegaserod: 5-HT1 and S-HT2 receptors].  Adverse cardiovascular events obsd. with these compds. are not 5-HT4 receptor-related.  Recent efforts have led to the discovery of a series of selective 5-HT4 receptor ligands, with prucalopride being the most advanced in clin. development.  The selectivity of these new compds. clearly differentiates them from the older generation compds. by minimizing the potential of target-unrelated side effects.  The availability of selective agonists enables the focus to shift to the exploration of 5-HT4 receptor-related differences between agonists.  Based on drug- and tissue-related properties (e.g. differences in receptor binding, receptor d., effectors, coupling efficiency), 5-HT4 receptor agonists are able to express tissue selectivity, i.e. behave as a partial agonist in some and as a full agonist in other tissues.  Furthermore, the concept of ligand-directed signalling offers great opportunities for future drug development by enlarging the scientific basis for the generation of agonist-specific effects in different cell types, tissues or organs.  Selective 5-HT4 receptor agonists might thus prove to be innovative drugs with an attractive safety profile for better treatment of patients suffering from hypomotility disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3mVBES_26DLVg90H21EOLACvtfcHk0liYVm04wZlqYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCjtLw%253D&md5=85042809b6a7d78cc95ae9b2e0155940</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2982.2007.01059.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2982.2007.01059.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMaeyer%26aufirst%3DJ.%2BH.%26aulast%3DLefebvre%26aufirst%3DR.%2BA.%26aulast%3DSchuurkes%26aufirst%3DJ.%2BA.%26atitle%3D5-HT4%2520receptor%2520agonists%253A%2520similar%2520but%2520not%2520the%2520same%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2008%26volume%3D20%26spage%3D99%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Toga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohmura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawatsu, R.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>4</sub> agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1254%2Fjphs.SC0070243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=17928736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ygtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=207-210&author=T.+Togaauthor=Y.+Kohmuraauthor=R.+Kawatsu&title=The+5-HT4+agonists+cisapride%2C+mosapride%2C+and+CJ-033466%2C+a+novel+potent+compound%2C+exhibit+different+human+ether-a-go-go-related+gene+%28hERG%29-blocking+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT4 agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities</span></div><div class="casAuthors">Toga, Tetsuo; Kohmura, Yumi; Kawatsu, Ryoichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-210</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">The blocking effect of three 5-HT4 agonists, cisapride, mosapride, and the newly discovered CJ-033466 on the human ether-a-go-go-related gene (hERG) channel was studied using a whole cell patch-clamp technique in HEK293 cells.  Cisapride was the most potent of the hERG blockers.  CJ-033466 had the widest safety margin between its hERG blocking activity and 5-HT4 agonism among the tested compds.  This suggests a lower clin. risk of cardiac arrhythmia in CJ-033466 compared with the other 2 agonists.  Therefore, CJ-033466 has the potential to be a drug with higher therapeutic efficacy and less cardiac risk than both cisapride and mosapride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2YS2QUkupbVg90H21EOLACvtfcHk0lhu_opUxNEDSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ygtLfN&md5=128df9d0f4ba5a6f818c905f3746876c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1254%2Fjphs.SC0070243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.SC0070243%26sid%3Dliteratum%253Aachs%26aulast%3DToga%26aufirst%3DT.%26aulast%3DKohmura%26aufirst%3DY.%26aulast%3DKawatsu%26aufirst%3DR.%26atitle%3DThe%25205-HT4%2520agonists%2520cisapride%252C%2520mosapride%252C%2520and%2520CJ-033466%252C%2520a%2520novel%2520potent%2520compound%252C%2520exhibit%2520different%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529-blocking%2520activities%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D105%26spage%3D207%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tonini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ponti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crema, F.</span><span> </span><span class="NLM_article-title">Review article: cardiac adverse effects of gastrointestinal prokinetics</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1046%2Fj.1365-2036.1999.00655.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=10594392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1585-1591&author=M.+Toniniauthor=F.+De+Pontiauthor=A.+Di+Nucciauthor=F.+Crema&title=Review+article%3A+cardiac+adverse+effects+of+gastrointestinal+prokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: cardiac adverse effects of gastrointestinal prokinetics</span></div><div class="casAuthors">Tonini, M.; De Ponti, F.; Di Nucci, A.; Crema, F.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1585-1591</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 68 refs.  Gastrointestinal prokinetics, such as metoclopramide, cisapride and levosulpiride, are widely used for the management of functional gut disorders.  Recently, several studies have shown that cisapride (a partial 5-HT4 receptor agonist) can induce dose-dependent cardiac adverse effects, including lengthening of the electrocardiog. QT interval, syncopal episodes and ventricular dysarrhythmias.  Until recently, it was not clear whether these effects were dependent on 5-HT4 receptor activation or related to peculiar characteristics in the mol. structure of single agents within the benzamide class.  Exptl. evidence now favors the second hypothesis: cisapride possesses Class III antiarrhythmic properties and prolongs the action potential duration through blockade of distinct voltage-dependent K+ channels, thus delaying cardiac repolarization and prolonging the QT interval.  Patients at risk of cardiac adverse effects are children, subjects with idiopathic, congenital or acquired long QT syndrome and, in particular, those receiving concomitant medication with Class III antiarrhythmic agents, some H1-receptor antagonists (e.g. terfenadine), or drugs such as azole antifungals (e.g. ketoconazole, itraconazole, miconazole and fluconazole) and macrolide antibacterials (e.g. erythromycin, clarithromycin and troleandomycin), which can inhibit cisapride metab. by interfering with the CYP3A4 isoenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf0dcyPdGAQbVg90H21EOLACvtfcHk0lhu_opUxNEDSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWntg%253D%253D&md5=4b6fff26045336666b34718373bb3a49</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2036.1999.00655.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2036.1999.00655.x%26sid%3Dliteratum%253Aachs%26aulast%3DTonini%26aufirst%3DM.%26aulast%3DDe%2BPonti%26aufirst%3DF.%26aulast%3DDi%2BNucci%26aufirst%3DA.%26aulast%3DCrema%26aufirst%3DF.%26atitle%3DReview%2520article%253A%2520cardiac%2520adverse%2520effects%2520of%2520gastrointestinal%2520prokinetics%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D1999%26volume%3D13%26spage%3D1585%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F1568007043482598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=14965241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=11-26&author=J.+E.+Leysen&title=5-HT2+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2 receptors</span></div><div class="casAuthors">Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT2 receptors are G-protein coupled receptors that currently comprise 3 subtypes: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  The subtypes are related in their mol. structure, amino acid sequence, and signaling properties.  5-HT2A and 5-HT2C receptors have a widespread distribution and function in the central nervous system.  5-HT2A and 5-HT2C receptor antagonism is a property of certain antipsychotic and antidepressant drugs.  5-HT2B receptors have a restricted expression in the central nervous system.  They have an important role in embryogenesis and in the periphery.  In this article, selected aspects of 5-HT2 receptor research are reviewed for each subtype under 3 main headings: (1) genes, protein structure, and receptor signaling; (2) receptor localization with emphasis on the CNS, and (3) compds.  The general discussion reflects on the reasons for the limited success in the clinic of 5-HT2 receptor subtype selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGTjJwjn8erVg90H21EOLACvtfcHk0lhu_opUxNEDSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D&md5=9f7316c92e674a8c1cf7b13f48d9711a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1568007043482598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482598%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3D5-HT2%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Trudeau, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmke, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganetzky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. A.</span><span> </span><span class="NLM_article-title">HERG, a human inward rectifier in the voltage-gated potassium channel family</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x"> (</span><span class="NLM_issue">5220</span><span class="NLM_x">) </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1995&pages=92-95&issue=5220&author=M.+C.+Trudeauauthor=J.+W.+Warmkeauthor=B.+Ganetzkyauthor=G.+A.+Robertson&title=HERG%2C+a+human+inward+rectifier+in+the+voltage-gated+potassium+channel+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrudeau%26aufirst%3DM.%2BC.%26aulast%3DWarmke%26aufirst%3DJ.%2BW.%26aulast%3DGanetzky%26aufirst%3DB.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26atitle%3DHERG%252C%2520a%2520human%2520inward%2520rectifier%2520in%2520the%2520voltage-gated%2520potassium%2520channel%2520family%26jtitle%3DScience%26date%3D1995%26volume%3D269%26issue%3D5220%26spage%3D92%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Wysowski, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Torres, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talarico, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, E. M.</span><span> </span><span class="NLM_article-title">Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1111%2Fj.1572-0241.2001.03927.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=11419817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A280%3ADC%252BD3MzlvFSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2001&pages=1698-1703&author=D.+K.+Wysowskiauthor=A.+Corkenauthor=H.+Gallo-Torresauthor=L.+Talaricoauthor=E.+M.+Rodriguez&title=Postmarketing+reports+of+QT+prolongation+and+ventricular+arrhythmia+in+association+with+cisapride+and+Food+and+Drug+Administration+regulatory+actions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions</span></div><div class="casAuthors">Wysowski D K; Corken A; Gallo-Torres H; Talarico L; Rodriguez E M</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1698-703</span>
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    </div><div class="casAbstract">OBJECTIVE:  To describe the postmarketing safety data used in the risk assessment of cisapride and to summarize the regulatory actions of the Food and Drug Administration (FDA).  METHODS:  The FDA analyzed reports of patients who developed QT prolongation, torsades de pointes, and ventricular arrhythmia in association with the use of cisapride to assess probable etiology and risk factors.  RESULTS:  While cisapride was being marketed from 1993-1999, the FDA received reports of the following patients: 117 who developed QT prolongation; 107, torsades de pointes; 16, polymorphic ventricular tachycardia; 18, ventricular fibrillation; 27, ventricular tachycardia; 25, cardiac arrest; 16, serious (unspecified) arrhythmia; and 15, sudden death; for a total of 341 individual patients affected, following use of cisapride.  Eighty (23%) of the 341 patients died.  Deaths were directly or indirectly associated with an arrhythmic event.  Factors that suggested an association with cisapride included a temporal relationship between use of cisapride and arrhythmia, the absence of identified risk factors and other explanations for arrhythmia in some patients, and cases of positive dechallenge and rechallenge.  In most individuals, the arrhythmia occurred in the presence of risk factors (other drugs and/or medical conditions).  CONCLUSIONS:  Postmarketing reports and pharmacokinetic and electrophysiological data provided evidence that cisapride is associated with the occurrence of QT prolongation and torsades de pointes.  The risk of fatal arrhythmia with cisapride was believed to outweigh the benefit for the approved indication, treatment of nocturnal heartburn due to gastroesophageal reflux disease, leading to the drug's discontinuation in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa_s532o1yAZPq5LRczm8ffW6udTcc2eZrElvWEToHIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzlvFSktw%253D%253D&md5=fe88c8545fdcf2a603d75b5e73a33db5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1572-0241.2001.03927.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1572-0241.2001.03927.x%26sid%3Dliteratum%253Aachs%26aulast%3DWysowski%26aufirst%3DD.%2BK.%26aulast%3DCorken%26aufirst%3DA.%26aulast%3DGallo-Torres%26aufirst%3DH.%26aulast%3DTalarico%26aufirst%3DL.%26aulast%3DRodriguez%26aufirst%3DE.%2BM.%26atitle%3DPostmarketing%2520reports%2520of%2520QT%2520prolongation%2520and%2520ventricular%2520arrhythmia%2520in%2520association%2520with%2520cisapride%2520and%2520Food%2520and%2520Drug%2520Administration%2520regulatory%2520actions%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2001%26volume%3D96%26spage%3D1698%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fermini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossa, A. A.</span><span> </span><span class="NLM_article-title">The impact of drug-induced QT interval prolongation on drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=439-447&issue=6&author=B.+Ferminiauthor=A.+A.+Fossa&title=The+impact+of+drug-induced+QT+interval+prolongation+on+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFermini%26aufirst%3DB.%26aulast%3DFossa%26aufirst%3DA.%2BA.%26atitle%3DThe%2520impact%2520of%2520drug-induced%2520QT%2520interval%2520prolongation%2520on%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D6%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Schaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomquist, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susemichel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. L.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970857f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1943-1955&author=J.+M.+Schausauthor=D.+C.+Thompsonauthor=W.+E.+Bloomquistauthor=A.+D.+Susemichelauthor=D.+O.+Calligaroauthor=M.+L.+Cohen&title=Synthesis+and+structure-activity+relationships+of+potent+and+orally+active+5-HT4+receptor+antagonists%3A+indazole+and+benzimidazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm970857f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970857f%26sid%3Dliteratum%253Aachs%26aulast%3DSchaus%26aufirst%3DJ.%2BM.%26aulast%3DThompson%26aufirst%3DD.%2BC.%26aulast%3DBloomquist%26aufirst%3DW.%2BE.%26aulast%3DSusemichel%26aufirst%3DA.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520potent%2520and%2520orally%2520active%25205-HT4%2520receptor%2520antagonists%253A%2520indazole%2520and%2520benzimidazolone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1943%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardle, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2<i>H</i>-[1,3]oxazino[3,2-<i>a</i>]indole-10-carboxamide hydrochloride: the first potent and selective 5-HT<sub>4</sub> receptor antagonist amide with oral activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4760</span><span class="NLM_x">–</span> <span class="NLM_lpage">4763</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00024a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4760-4763&author=L.+M.+Gasterauthor=G.+F.+Joinerauthor=F.+D.+Kingauthor=P.+A.+Wymanauthor=J.+M.+Suttonauthor=S.+Binghamauthor=E.+S.+Ellisauthor=G.+J.+Sangerauthor=K.+A.+Wardle&title=N-%5B%281-Butyl-4-piperidinyl%29methyl%5D-3%2C4-dihydro-2H-%5B1%2C3%5Doxazino%5B3%2C2-a%5Dindole-10-carboxamide+hydrochloride%3A+the+first+potent+and+selective+5-HT4+receptor+antagonist+amide+with+oral+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00024a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00024a002%26sid%3Dliteratum%253Aachs%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26aulast%3DSutton%26aufirst%3DJ.%2BM.%26aulast%3DBingham%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DE.%2BS.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26aulast%3DWardle%26aufirst%3DK.%2BA.%26atitle%3DN-%255B%25281-Butyl-4-piperidinyl%2529methyl%255D-3%252C4-dihydro-2H-%255B1%252C3%255Doxazino%255B3%252C2-a%255Dindole-10-carboxamide%2520hydrochloride%253A%2520the%2520first%2520potent%2520and%2520selective%25205-HT4%2520receptor%2520antagonist%2520amide%2520with%2520oral%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4760%26epage%3D4763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Alisi, A.; Brufani, M.; Cazzolla, N.; Giannangeli, M.; Pinza, M.</span><span> </span><span class="NLM_article-title">Preparation of indazoleamide compounds as serotoninergic agents</span>. PCT Int. Appl. WO 9846589,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=A.+Alisi&author=M.+Brufani&author=N.+Cazzolla&author=M.+Giannangeli&author=M.+Pinza&title=Preparation+of+indazoleamide+compounds+as+serotoninergic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlisi%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520indazoleamide%2520compounds%2520as%2520serotoninergic%2520agents%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Xie, W.; Herbert, B.; Schumacher, R.; Nguyen, T. M.; Ma, J.; Gauss, C. M.; Tehim, A.</span><span> </span><span class="NLM_article-title">Preparation of quinuclidine indazole, benzothiazole, benzisothiazole and benzisoxazoles as ligands for the α7 nicotinic acetylcholine receptor</span>. PCT Int. Appl. WO 2005092890,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Xie&author=B.+Herbert&author=R.+Schumacher&author=T.+M.+Nguyen&author=J.+Ma&author=C.+M.+Gauss&author=A.+Tehim&title=Preparation+of+quinuclidine+indazole%2C+benzothiazole%2C+benzisothiazole+and+benzisoxazoles+as+ligands+for+the+%CE%B17+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26atitle%3DPreparation%2520of%2520quinuclidine%2520indazole%252C%2520benzothiazole%252C%2520benzisothiazole%2520and%2520benzisoxazoles%2520as%2520ligands%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Inoue, T.; Watanabe, S.; Yamagishi, T.; Arano, Y.; Morita, M.; Shimada, K.</span><span> </span><span class="NLM_article-title">Preparation of pyridinylcarboxamide derivatives and analogs for use as calcium or sodium channel blockers</span>. PCT Int. Appl. WO 2010137351,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Inoue&author=S.+Watanabe&author=T.+Yamagishi&author=Y.+Arano&author=M.+Morita&author=K.+Shimada&title=Preparation+of+pyridinylcarboxamide+derivatives+and+analogs+for+use+as+calcium+or+sodium+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520pyridinylcarboxamide%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520calcium%2520or%2520sodium%2520channel%2520blockers%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Foreman, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvain, S. M.</span><span> </span><span class="NLM_article-title">Reaction of organic halides with piperidine. V. Negatively substituted ethyl bromides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1940</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1435</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01863a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1940&pages=1435-1438&author=E.+L.+Foremanauthor=S.+M.+McElvain&title=Reaction+of+organic+halides+with+piperidine.+V.+Negatively+substituted+ethyl+bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja01863a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01863a029%26sid%3Dliteratum%253Aachs%26aulast%3DForeman%26aufirst%3DE.%2BL.%26aulast%3DMcElvain%26aufirst%3DS.%2BM.%26atitle%3DReaction%2520of%2520organic%2520halides%2520with%2520piperidine.%2520V.%2520Negatively%2520substituted%2520ethyl%2520bromides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1940%26volume%3D62%26spage%3D1435%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Di Santo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeffi, C.</span><span> </span><span class="NLM_article-title">A general, versatile synthesis of 2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolines via tosylmethylisocyanide reaction</span> <span class="citation_source-journal">ARKIVOC</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span><span class="NLM_issue">v</span><span class="NLM_x">) </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=181-195&issue=v&author=R.+Di+Santoauthor=R.+Costiauthor=M.+Forteauthor=C.+Galeffi&title=A+general%2C+versatile+synthesis+of+2H-pyrrolo%5B3%2C4-c%5Dquinolines+via+tosylmethylisocyanide+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DForte%26aufirst%3DM.%26aulast%3DGaleffi%26aufirst%3DC.%26atitle%3DA%2520general%252C%2520versatile%2520synthesis%2520of%25202H-pyrrolo%255B3%252C4-c%255Dquinolines%2520via%2520tosylmethylisocyanide%2520reaction%26jtitle%3DARKIVOC%26date%3D2004%26issue%3Dv%26spage%3D181%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Diaz, P.; Millois Barbuis, C.</span><span> </span><span class="NLM_article-title">Preparation of bi-aromatic compounds, particularly 4-[(3-aminocarbonylhydrazono-2-oxo-2,3-dihydro-1<i>H</i>-indol-5-yl)sulfanylalkyl]benzoic acid derivatives, as PPAR modulators, and their use in cosmetic and pharmaceutical compositions</span>. PCT Int. Appl. WO 2006063863,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+Diaz&author=C.+Millois+Barbuis&title=Preparation+of+bi-aromatic+compounds%2C+particularly+4-%5B%283-aminocarbonylhydrazono-2-oxo-2%2C3-dihydro-1H-indol-5-yl%29sulfanylalkyl%5Dbenzoic+acid+derivatives%2C+as+PPAR+modulators%2C+and+their+use+in+cosmetic+and+pharmaceutical+compositions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520bi-aromatic%2520compounds%252C%2520particularly%25204-%255B%25283-aminocarbonylhydrazono-2-oxo-2%252C3-dihydro-1H-indol-5-yl%2529sulfanylalkyl%255Dbenzoic%2520acid%2520derivatives%252C%2520as%2520PPAR%2520modulators%252C%2520and%2520their%2520use%2520in%2520cosmetic%2520and%2520pharmaceutical%2520compositions%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moormann, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullikson, G. W.</span><span> </span><span class="NLM_article-title">SC-53606, a potent and selective antagonist of 5-hydroxytryptamine 4 receptors in isolated rat esophageal tunica muscularis mucosae</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">1339</span><span class="NLM_x">–</span> <span class="NLM_lpage">1347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=8396633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK2cXitlektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1993&pages=1339-1347&author=D.+Yangauthor=B.+Goldstinauthor=A.+E.+Moormannauthor=D.+L.+Flynnauthor=G.+W.+Gullikson&title=SC-53606%2C+a+potent+and+selective+antagonist+of+5-hydroxytryptamine+4+receptors+in+isolated+rat+esophageal+tunica+muscularis+mucosae"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae</span></div><div class="casAuthors">Yang, Dai Chang; Goldstin, Bela; Moormann, Alan E.; Flynn, Daniel L.; Gullikson, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1339-47</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">SC-53606 (I) acts as an antagonist of 5-hydroxytryptamine4 (5-HT4) receptor-mediated relaxation of carbachol-induced contractions in rat esophageal tunica muscular mucosae, but does not possess 5-HT4 agonist activity.  I demonstrated a pA2 value against 5-HT in this tissue of 7.91 ± 0.08 (Ki = 12.3 ± 1.17 nM).  Similar pA2 values of 7.68 ± 0.06, 7.67 ± 0.06 and 7.63 ± 0.05 were detd. for the synthetic 5-HT4 receptor agonists SC-53116, 5-methoxytryptamine and renzapride, resp.  In addn., slopes of Schild plots for antagonism of these four agonists by I were 1.07 ± 0.02, 0.98 ± 0.03, 1.04 ± 0.02 and 0.96 ± 0.06, resp., and did not deviate from unity.  The pA2 values for 5-HT4 antagonism against 5-HT were detd. to be 6.80 ± 0.09 for tropisetron and 7.36 ± 0.08 for 2-methoxy-4-amino-S-chlorobenzoic acid-2-(diethylamino)ethyl ester SDZ 205-557), indicating that I is more a potent 5-HT4 antagonist than either of the ref. antagonists.  Radioligand binding studies also demonstrated that I is a selective antagonist with more affinity for 5-HT4 than for other 5-HT receptors.  Displacement of radioligand binding from 5-HT1 and 5-HT2 receptors by I was less than 50% at a 10 μM concn.  Similarly, I displayed little binding affinity at alpha1, alpha2 and beta adrenergic, dopamine1, dopamine2 and muscarinic cholinergic receptors.  The Ki for binding to rat cortical 5-HT3 receptors was 259 ± 28 nM, which was 21 times less than the pA2 concn. in the rat esophageal tunica muscular mucosae assay.  I was also a weaker antagonist at 5-HT3 receptors in guinea pig ileum than either tropisetron or SDZ 205-557 (IC50 values of 40 μM, 0.05 μM and 10 μM, resp., against 10 μM of 2-methyl-5-HT).  These results demonstrate that I is a potent antagonist at the 5-HT4 receptor and possesses selectivity that makes it a useful pharmacol. tool for studying 5-HT4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQrw_JeQx7XrVg90H21EOLACvtfcHk0lj2Voovsfgq_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlektg%253D%253D&md5=f62e05ddd4f19c66b7bcea4feb55bfbe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DGoldstin%26aufirst%3DB.%26aulast%3DMoormann%26aufirst%3DA.%2BE.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26aulast%3DGullikson%26aufirst%3DG.%2BW.%26atitle%3DSC-53606%252C%2520a%2520potent%2520and%2520selective%2520antagonist%2520of%25205-hydroxytryptamine%25204%2520receptors%2520in%2520isolated%2520rat%2520esophageal%2520tunica%2520muscularis%2520mucosae%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D266%26spage%3D1339%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The functional hERG/Kv11.1 potassium ion channel assay was performed at Ricerca Biosciences (Bothell, WA).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mialet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmoune, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lezoualc’h, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berque-Bestel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eftekhari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebeke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicsic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishmeister, R.</span><span> </span><span class="NLM_article-title">Exploration of the ligand binding site of the human 5-HT4 receptor by site-directed mutagenesis and molecular modeling</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1038%2Fsj.bjp.0703356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=10821780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVGjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=527-538&author=J.+Mialetauthor=Y.+Dahmouneauthor=F.+Lezoualc%E2%80%99hauthor=I.+Berque-Bestelauthor=P.+Eftekhariauthor=J.+Hoebekeauthor=S.+Sicsicauthor=M.+Langloisauthor=R.+Fishmeister&title=Exploration+of+the+ligand+binding+site+of+the+human+5-HT4+receptor+by+site-directed+mutagenesis+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the ligand binding site of the human 5-HT4 receptor by site-directed mutagenesis and molecular modeling</span></div><div class="casAuthors">Mialet, Jeanne; Dahmoune, Yamina; Lezoualc'h, Frank; Berque-Bestel, Isabelle; Eftekhari, Pierre; Hoebeke, Johan; Sicsic, Sames; Langlois, Michel; Fischmeister, Rodolphe</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-538</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Among the five human 5-HT4 (h5-HT4) receptor isoforms, the h5-HT4(a) receptor was studied with a particular emphasis on the mol. interactions involved in ligand binding.  For this purpose, we used site-directed mutagenesis of the transmembrane domain.  Twelve mutants were constructed with a special focus on the residue P4.53 of helix IV which substitutes in h5-HT4 receptors the highly conserved S residue among the rhodopsin family receptors.  The mutated receptors were transiently expressed in COS-7 cells.  2 Ligand binding or competition studies with two h5-HT4 receptor agonists, serotonin and ML10302 and two h5-HT4 receptor antagonists, [3H]-GR113808 and ML10375 were performed on wild type and mutant receptors.  Functional activity of the receptors was evaluated by measuring the ability of serotonin to stimulate adenylyl cyclase.  3 Ligand binding expts. revealed that [3H]-GR113808 did not bind to mutants P4.53A, S5.43A, F6.51A, Y7.43A and to double mutant F6.52V/N6.55L.  On the other hand mutations D3.32N, S5.43A and Y7.43A appeared to promote a dramatic decrease of h5-HT4(a) receptor functional activity.  From these studies, S5.43 and Y7.43 clearly emerged as common anchoring sites to antagonist [3H]-GR113808 and to serotonin.  4 According to these results, we propose ligand-receptor complex models with serotonin and [3H]-GR113808.  For serotonin, three interaction points were selected including ionic interaction with D3.32, a stabilizing interaction of this ion pair by Y7.43 and a hydrogen bond with S5.43.  [3H]-GR113808 was also docked, based on the same type of interactions with S5.43 and D3.32: the proposed model suggested a possible role of P4.53 in helix IV structure allowing the involvement of a close hydrophobic residue, W4.50, in a hydrophobic pocket for hydrophobic interactions with the indole ring of [3H]-GR113808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEm6BTPYUgX7Vg90H21EOLACvtfcHk0ljiwhxOoeBnAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVGjs78%253D&md5=a188fb16d4d316c476b1093aaa526ca9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703356%26sid%3Dliteratum%253Aachs%26aulast%3DMialet%26aufirst%3DJ.%26aulast%3DDahmoune%26aufirst%3DY.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DBerque-Bestel%26aufirst%3DI.%26aulast%3DEftekhari%26aufirst%3DP.%26aulast%3DHoebeke%26aufirst%3DJ.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DFishmeister%26aufirst%3DR.%26atitle%3DExploration%2520of%2520the%2520ligand%2520binding%2520site%2520of%2520the%2520human%25205-HT4%2520receptor%2520by%2520site-directed%2520mutagenesis%2520and%2520molecular%2520modeling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D527%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rivail, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastineau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthouze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishmeister, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lezoualc’h, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicsic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berque-Bestel, I.</span><span> </span><span class="NLM_article-title">New insights into the human 5-HT<sub>4</sub> receptor binding site: exploration of a hydrophobic pocket</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1038%2Fsj.bjp.0705950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=15351779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVyis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=361-370&author=L.+Rivailauthor=M.+Ginerauthor=M.+Gastineauauthor=M.+Berthouzeauthor=J.+L.+Soulierauthor=R.+Fishmeisterauthor=F.+Lezoualc%E2%80%99hauthor=B.+Maigretauthor=S.+Sicsicauthor=I.+Berque-Bestel&title=New+insights+into+the+human+5-HT4+receptor+binding+site%3A+exploration+of+a+hydrophobic+pocket"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the human 5-HT4 receptor binding site: Exploration of a hydrophobic pocket</span></div><div class="casAuthors">Rivail, Lucie; Giner, Mireille; Gastineau, Monique; Berthouze, Magali; Soulier, Jean-Louis; Fischmeister, Rodolphe; Lezoualc'h, Frank; Maigret, Bernard; Sicsic, Sames; Berque-Bestel, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A body of evidences suggests that a hydrophobic pocket of the human 5-HT4 receptor contributes to the high affinity of some bulky 5-HT4 ligands.  A thorough study of this pocket was performed using mutagenesis and mol. modeling.  Ligand binding or competition studies with selected bulky ligands (RS 39604, RS 100235, [3H]GR 113808 and ML 11411) and small ligands (5-HT and ML 10375) were carried out on wild-type and mutant receptors (W7.40A/F, Y7.43F, R3.28L) transiently transfected in COS-7 cells.  The functional activity of the mutated receptors was evaluated by measuring the ability of 5-HT to stimulate adenylyl cyclase.  For W7.40F mutation, no changes in the affinity of studied ligands and in the functional activity of the mutant receptor were obsd., in contrary to W7.40A mutation, which abolished both binding of ligands and 5-HT-induced cAMP prodn.  Mutation R3.28L revealed a totally silent receptor with a basal level of cAMP prodn. similar to the mock control despite its ability to product cAMP in the presence of 5-HT.  Moreover, a one order loss of affinity of RS 39604 and a 45-fold increase of ML 11411 affinity were obsd.  Mutation Y7.43F modified the affinity of GR 113808, which displays a 13-fold lower affinity for the mutant than for the wild-type receptor.  In conclusion, in the hydrophobic pocket, two polar amino acids are able to interact through hydrogen bonds with bulky ligands depending on their chem. properties.  Moreover, these exptl. data may validate the proposed new three-dimensional model of the human 5-HT4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkPqbDWez4MLVg90H21EOLACvtfcHk0ljiwhxOoeBnAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVyis7c%253D&md5=de43001334ea4d88f90d4dfb8dacdac1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705950%26sid%3Dliteratum%253Aachs%26aulast%3DRivail%26aufirst%3DL.%26aulast%3DGiner%26aufirst%3DM.%26aulast%3DGastineau%26aufirst%3DM.%26aulast%3DBerthouze%26aufirst%3DM.%26aulast%3DSoulier%26aufirst%3DJ.%2BL.%26aulast%3DFishmeister%26aufirst%3DR.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DBerque-Bestel%26aufirst%3DI.%26atitle%3DNew%2520insights%2520into%2520the%2520human%25205-HT4%2520receptor%2520binding%2520site%253A%2520exploration%2520of%2520a%2520hydrophobic%2520pocket%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bojarski, A. J.</span><span> </span><span class="NLM_article-title">Pharmacophore models for metabotropic 5-HT receptor ligands</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2005</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F156802606778522186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=17017971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFens7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=2005-2026&author=A.+J.+Bojarski&title=Pharmacophore+models+for+metabotropic+5-HT+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore models for metabotropic 5-HT receptor ligands</span></div><div class="casAuthors">Bojarski, Andrzej J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2005-2026</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  An overview of pharmacophore models, developed for different subtypes of serotonin receptors belonging to the GPCR family, is presented.  Starting with early models for 5-HT1A and 5-HT2 receptor ligands, and ending with the latest ones for 5-HT6- and 5-HT7 receptors, as many as fifty others are briefly summarized.  No models have been developed for 5-HT1F-, 5-HT2B- and 5-HT5B receptor ligands, and in the case of 5-HT1E- and 5-HT5ARs only single pilot studies with non-selective tryptamine derivs. are reported.  For all the other subtypes of 5-HTRs, various pharmacophore hypotheses - either qual. and/or quant. - are characterized by sets of ligands used for their generation, a templates for alignment, the computational methods applied and, eventually, interfeature distances and/or statistical results - if available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaQnt4eol1NrVg90H21EOLACvtfcHk0lhvLqscT7IVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFens7fE&md5=c70400be602bf0be330047f128f2615e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F156802606778522186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778522186%26sid%3Dliteratum%253Aachs%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26atitle%3DPharmacophore%2520models%2520for%2520metabotropic%25205-HT%2520receptor%2520ligands%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D2005%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lhvLqscT7IVUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zhu, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadambi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Inhibitory effect of carboxylic acid group on hERG binding</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5507</span><span class="NLM_x">–</span> <span class="NLM_lpage">5512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5507-5512&author=B.+Y.+Zhuauthor=Z.+J.+Jiaauthor=P.+Zhangauthor=T.+Suauthor=W.+Huangauthor=E.+Goldmanauthor=D.+Tumasauthor=V.+Kadambiauthor=P.+Eddyauthor=U.+Sinhaauthor=R.+M.+Scarboroughauthor=Y.+Song&title=Inhibitory+effect+of+carboxylic+acid+group+on+hERG+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BY.%26aulast%3DJia%26aufirst%3DZ.%2BJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DGoldman%26aufirst%3DE.%26aulast%3DTumas%26aufirst%3DD.%26aulast%3DKadambi%26aufirst%3DV.%26aulast%3DEddy%26aufirst%3DP.%26aulast%3DSinha%26aufirst%3DU.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibitory%2520effect%2520of%2520carboxylic%2520acid%2520group%2520on%2520hERG%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5507%26epage%3D5512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brudeli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltzau, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andressen, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krobert, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaveness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, F. O.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">8600</span><span class="NLM_x">–</span> <span class="NLM_lpage">8613</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=8600-8613&author=B.+Brudeliauthor=L.+R.+Moltzauauthor=K.+W.+Andressenauthor=K.+A.+Krobertauthor=J.+Klavenessauthor=F.+O.+Levy&title=Synthesis+and+pharmacological+properties+of+novel+hydrophilic+5-HT4+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrudeli%26aufirst%3DB.%26aulast%3DMoltzau%26aufirst%3DL.%2BR.%26aulast%3DAndressen%26aufirst%3DK.%2BW.%26aulast%3DKrobert%26aufirst%3DK.%2BA.%26aulast%3DKlaveness%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DF.%2BO.%26atitle%3DSynthesis%2520and%2520pharmacological%2520properties%2520of%2520novel%2520hydrophilic%25205-HT4%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D18%26spage%3D8600%26epage%3D8613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="note"><p class="first last">The large in vitro pharmacologic profile was performed at Ricerca Biosciences (Bothell, WA) on the following assays: (receptor binding) adrenergic α1 (nonselective) (rat), adrenergic α1A (rat), adrenergic α1B (rat), adrenergic α1D (human), chemokine CCR2B (human), cholecystokinin CK1 (CCKA) (human), cholecystokinin CCK2 (CCKB) (human), muscarinic nonselective (rat), muscarinic oxotremorine M (rat), serotonin 5-HT1A (human), serotonin 5-HT1B (rat), serotonin 5-HT2A (human), serotonin 5-HT2B (human), serotonin 5-HT2C (human), serotonin 5-HT3 (human), serotonin 5-HT4 (guinea pig), serotonin 5-HT5A (human), serotonin 5-HT6 (human), serotonin 5-HT7 (human), σ1 (human), σ2 (rat), sodium channel, site 2 (rat), serotonin transporter (SERT) (human); (enzymatic assays) catechol-<i>O</i>-methyltransferase (COMT) (pig), monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) (human); (cell-based assay) serotonin uptake (human).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamataki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, R.</span><span> </span><span class="NLM_article-title">CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=477-486&author=Y.+Unoauthor=H.+Fujinoauthor=G.+Kitoauthor=T.+Kamatakiauthor=R.+Nagata&title=CYP2C76%2C+a+novel+cytochrome+P450+in+cynomolgus+monkey%2C+is+a+major+CYP2C+in+liver%2C+metabolizing+tolbutamide+and+testosterone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUno%26aufirst%3DY.%26aulast%3DFujino%26aufirst%3DH.%26aulast%3DKito%26aufirst%3DG.%26aulast%3DKamataki%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DR.%26atitle%3DCYP2C76%252C%2520a%2520novel%2520cytochrome%2520P450%2520in%2520cynomolgus%2520monkey%252C%2520is%2520a%2520major%2520CYP2C%2520in%2520liver%252C%2520metabolizing%2520tolbutamide%2520and%2520testosterone%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D79%26spage%3D477%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and non specific binding to microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&issue=11&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+non+specific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520non%2520specific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26issue%3D11%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Eddy, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimbach, D.</span><span> </span><span class="NLM_article-title">Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=13035677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaG3sXjvVCgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1953&pages=385-393&author=N.+B.+Eddyauthor=D.+Leimbach&title=Synthetic+analgesics.+II.+Dithienylbutenyl-+and+dithienylbutylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic analgesics. II. Dithienylbutenylamines and dithienylbutylamines</span></div><div class="casAuthors">Eddy, Nathan B.; Leimbach, Dorothy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-93</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">cf. C.A. 44, 4579h.  Compds. studied were the 3-(diethylamino), 3-(ethylmethylamino), 3-(dimethylamino), and 3-(1-pyrryl) derivs. of 1,1-bis(2-thienyl)-1-butene and the corresponding derivs. of butane.  All were highly analgesic when administered subcutaneously to mice.  The toxicity was also detd.  The butane derivs. were less toxic and less analgesic than their butene analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobVb8xQBXx2bVg90H21EOLACvtfcHk0lgDTsIx1ZPY_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXjvVCgsg%253D%253D&md5=f10e46ab856034f792285afac0e448f3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEddy%26aufirst%3DN.%2BB.%26aulast%3DLeimbach%26aufirst%3DD.%26atitle%3DSynthetic%2520analgesics.%2520II.%2520Dithienylbutenyl-%2520and%2520dithienylbutylamines%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1953%26volume%3D107%26spage%3D385%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Dubuisson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, S. G.</span><span> </span><span class="NLM_article-title">The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+formalin+test%3A+a+quantitative+study+of+the+analgesic+effects+of+morphine%2C+meperidine+and+brain+stem+stimulation+in+rats+and+cats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520formalin%2520test%253A%2520a%2520quantitative%2520study%2520of%2520the%2520analgesic%2520effects%2520of%2520morphine%252C%2520meperidine%2520and%2520brain%2520stem%2520stimulation%2520in%2520rats%2520and%2520cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Irwin, S.</span><span> </span><span class="NLM_article-title">Comprehensive observational assessment: a systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse</span> <span class="citation_source-journal">Pychopharmacologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1007%2FBF00401402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=5679627" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1968&pages=222-257&author=S.+Irwin&title=Comprehensive+observational+assessment%3A+a+systematic%2C+quantitative+procedure+for+assessing+the+behavioral+and+physiologic+state+of+the+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2FBF00401402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00401402%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DS.%26atitle%3DComprehensive%2520observational%2520assessment%253A%2520a%2520systematic%252C%2520quantitative%2520procedure%2520for%2520assessing%2520the%2520behavioral%2520and%2520physiologic%2520state%2520of%2520the%2520mouse%26jtitle%3DPychopharmacologica%26date%3D1968%26volume%3D13%26spage%3D222%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Roux, S.; Sable, E.; Porsolt, R. D.</span><span> </span><span class="NLM_article-title">Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effect on behaviour and physiological function</span>. In  <span class="citation_source-book">Current Protocols in Pharmacology</span>; <span class="NLM_contrib-group">Enna, S. J.; Williams, M.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>Suppl. 27, Unit 10.10, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1-23&author=S.+Roux&author=E.+Sable&author=R.+D.+Porsoltauthor=S.+J.+Enna&author=M.+Williams&title=Current+Protocols+in+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DS.%26atitle%3DPrimary%2520observation%2520%2528Irwin%2529%2520test%2520in%2520rodents%2520for%2520assessing%2520acute%2520toxicity%2520of%2520a%2520test%2520agent%2520and%2520its%2520effect%2520on%2520behaviour%2520and%2520physiological%2520function%26btitle%3DCurrent%2520Protocols%2520in%2520Pharmacology%26aulast%3DEnna%26aufirst%3DS.%2BJ.%26pub%3DWiley%26date%3D2004%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Dixon, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smondyrev, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">10–11</span><span class="NLM_x">) </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=647-671&issue=10%E2%80%9311&author=S.+L.+Dixonauthor=A.+M.+Smondyrevauthor=E.+H.+Knollauthor=S.+N.+Raoauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=PHASE%3A+a+new+engine+for+pharmacophore+perception%2C+3D+QSAR+model+development%2C+and+3D+database+screening%3A+1.+Methodology+and+preliminary+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BL.%26aulast%3DSmondyrev%26aufirst%3DA.%2BM.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DPHASE%253A%2520a%2520new%2520engine%2520for%2520pharmacophore%2520perception%252C%25203D%2520QSAR%2520model%2520development%252C%2520and%25203D%2520database%2520screening%253A%25201.%2520Methodology%2520and%2520preliminary%2520results%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2006%26volume%3D20%26issue%3D10%25E2%2580%259311%26spage%3D647%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glide, J. L.</span><span> </span><span class="NLM_article-title">A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&issue=7&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=+Banksauthor=J.+L.+Glide&title=A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lgzNiXdofWZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aulast%3DGlide%26aufirst%3DJ.%2BL.%26atitle%3DA%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D7%26spage%3D1750%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Woolfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Donald, A. D.</span><span> </span><span class="NLM_article-title">The evaluation of the analgesic action of pethidine hydrochloride (DEMEROL)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1944</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaH2cXhs1KjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1944&pages=300-307&author=G.+Woolfeauthor=A.+D.+Mac+Donald&title=The+evaluation+of+the+analgesic+action+of+pethidine+hydrochloride+%28DEMEROL%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the analgesic action of pethidine hydrochloride (demerol)</span></div><div class="casAuthors">Woolfe, G.; Macdonald, A. A.</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1944</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">300-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A new method for evaluation of analgesics is described, based on the behavior of mice when placed on a metal plate heated to various temps. above 50°.  By this method subcutaneously injected demerol is found to have 17-20% of the analgesic activity of morphine against mild pain stimuli, but to be ineffective against severe pain.  Aminopyrine and antipyrine are effective only in very large doses, and phenobarbital-Na and acetylsalicylic acid have no analgesic action that can be detected by this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDG8L_V7hxwbVg90H21EOLACvtfcHk0lgzNiXdofWZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH2cXhs1KjsQ%253D%253D&md5=88adc110a721335ba2f1d20aecf4534b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoolfe%26aufirst%3DG.%26aulast%3DMac%2BDonald%26aufirst%3DA.%2BD.%26atitle%3DThe%2520evaluation%2520of%2520the%2520analgesic%2520action%2520of%2520pethidine%2520hydrochloride%2520%2528DEMEROL%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1944%26volume%3D80%26spage%3D300%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Colucci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonito, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscopo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giannuario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span> </span><span class="NLM_article-title">New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2Fj.phrs.2008.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=18508278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=419-425&author=M.+Colucciauthor=F.+Maioneauthor=M.+C.+Bonitoauthor=A.+Piscopoauthor=A.+Di+Giannuarioauthor=S.+Pieretti&title=New+insights+of+dimethyl+sulphoxide+effects+%28DMSO%29+on+experimental+in+vivo+models+of+nociception+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation</span></div><div class="casAuthors">Colucci, Mariantonella; Maione, Francesco; Bonito, Maria Carmela; Piscopo, Alessandro; Di Giannuario, Amalia; Pieretti, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-425</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">DMSO is one of the most common solvents used exptl. to dissolve hydrophobic substances for in vivo and in vitro purposes.  A wide range of pharmacol. effects exerted by DMSO has been documented in both animal and human exptl. models.  However, only a few and sometimes contrasting data about the effects of DMSO in animal models of nociception and inflammation are presently available.  In this study, we evaluated the effects induced by DMSO and a DMSO-contg. saline on thermal and chem. nociception, inflammation and locomotor activity in CD1 mice.  We demonstrated that centrally or orally administered DMSO displayed anti-nociceptive effects to thermal (hot plate and tail-flick test) and chem. (formalin test) stimuli.  Conversely, DMSO was able to increase both nociceptive phases in the formalin test when applied s.c. in the dorsal surface of the mouse hind paws 10 min before formalin administration.  Oral administration of DMSO produced anti-inflammatory effects on zymosan-induced edema in the mouse paw, whereas local administration potentiated the inflammatory action exerted by zymosan.  Oral and central, but not local, administration of DMSO improved the mouse locomotor activity.  These results suggest that DMSO displayed opposite effects on nociception and inflammation, depending on the route of administration.  New and helpful evidence about DMSO lab. applications need to be considered in the in vivo studies to assess correctly the pharmacol. properties of investigated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIPra2SUYh27Vg90H21EOLACvtfcHk0lj6aN_MTMmYuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWmsLk%253D&md5=b82b7797f9069c122e70284a276518ae</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DColucci%26aufirst%3DM.%26aulast%3DMaione%26aufirst%3DF.%26aulast%3DBonito%26aufirst%3DM.%2BC.%26aulast%3DPiscopo%26aufirst%3DA.%26aulast%3DDi%2BGiannuario%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26atitle%3DNew%2520insights%2520of%2520dimethyl%2520sulphoxide%2520effects%2520%2528DMSO%2529%2520on%2520experimental%2520in%2520vivo%2520models%2520of%2520nociception%2520and%2520inflammation%26jtitle%3DPharmacol.%2520Res.%26date%3D2008%26volume%3D57%26spage%3D419%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':[],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Karbhari Shinde, Shankar Reddy Gagginapally, Durga Malleshwari Kancharla, Srinivasa Rao Ravella, Narsimha Bogaraju, Vanaja Reddy Middekadi, Ramkumar Subramanian, Raghava Choudary Palacharla, Vijay Benade, Nageswararao Muddana, Renny Abraham, Rajesh Babu Medapati, Jagadeesh Babu Thentu, Venkat Reddy Mekala, Surendra Petlu, Bujji Babu Lingavarapu, Sivasekhar Yarra, Narendra Kagita, Vinod Kumar Goyal, Santosh Kumar Pandey, <span class="NLM_string-name hlFld-ContribAuthor">Venkat Jasti</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00703%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPreclinical%252BCharacterization%252Bof%252BUsmarapride%252B%252528SUVN-D4010%252529%25253A%252BA%252BPotent%25252C%252BSelective%252B5-HT4%252BReceptor%252BPartial%252BAgonist%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDeficits%252BAssociated%252Bwith%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DNirogi%26aufirst%3DRamakrishna%26date%3D2021%26date%3D2021%26date%3D17042021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Grychowska</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Tomasz  Kos</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>, <span class="hlFld-ContribAuthor ">Severine  Chaumont-Dubel</span>, <span class="hlFld-ContribAuthor ">Xavier  Bantreil</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Gilles  Subra</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>, <span class="hlFld-ContribAuthor ">Piotr  Popik</span>, and <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (7)
                                     , 972-983. <a href="https://doi.org/10.1021/acschemneuro.6b00090" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00090%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252B1H-Pyrrolo%25255B3%25252C2-c%25255Dquinoline%252BBased%252B5-HT6%252BReceptor%252BAntagonists%252Bwith%252BPotential%252BApplication%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDisorders%252BAssociated%252Bwith%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGrychowska%26aufirst%3DKatarzyna%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D23032016%26date%3D21042016%26date%3D05052016%26date%3D20072016%26date%3D21042016%26volume%3D7%26issue%3D7%26spage%3D972%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan-Hui  Ouyang</span>, <span class="hlFld-ContribAuthor ">Ren-Jie  Song</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Ming  Hu</span>, and <span class="hlFld-ContribAuthor ">Jin-Heng  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Radical [2 + 2 + 1] Annulation of Benzene-Linked 1,n-Enynes with Azide: Fused Pyrroline Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (24)
                                     , 6038-6041. <a href="https://doi.org/10.1021/acs.orglett.5b03040" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b03040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b03040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b03040%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BRadical%252B%25255B2%252B%25252B%252B2%252B%25252B%252B1%25255D%252BAnnulation%252Bof%252BBenzene-Linked%252B1%25252Cn-Enynes%252Bwith%252BAzide%25253A%252BFused%252BPyrroline%252BCompounds%26aulast%3DOuyang%26aufirst%3DXuan-Hui%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D20102015%26date%3D08122015%26date%3D18122015%26volume%3D17%26issue%3D24%26spage%3D6038%26epage%3D6041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas M.  Barnes</span>, <span class="hlFld-ContribAuthor ">Gerard P.  Ahern</span>, <span class="hlFld-ContribAuthor ">Carine  Becamel</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Michael  Camilleri</span>, <span class="hlFld-ContribAuthor ">Severine  Chaumont-Dubel</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Kevin C.  Fone</span>, <span class="hlFld-ContribAuthor ">Michael  Gershon</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Di Giovanni</span>, <span class="hlFld-ContribAuthor ">Nathalie M.  Goodfellow</span>, <span class="hlFld-ContribAuthor ">Adam L.  Halberstadt</span>, <span class="hlFld-ContribAuthor ">Rachel M.  Hartley</span>, <span class="hlFld-ContribAuthor ">Ghérici  Hassaine</span>, <span class="hlFld-ContribAuthor ">Katharine  Herrick-Davis</span>, <span class="hlFld-ContribAuthor ">Ruud  Hovius</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Evelyn K.  Lambe</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Finn Olav  Levy</span>, <span class="hlFld-ContribAuthor ">Sarah C. R.  Lummis</span>, <span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Luc  Maroteaux</span>, <span class="hlFld-ContribAuthor ">Andrew C.  McCreary</span>, <span class="hlFld-ContribAuthor ">David L.  Nelson</span>, <span class="hlFld-ContribAuthor ">John F.  Neumaier</span>, <span class="hlFld-ContribAuthor ">Adrian  Newman-Tancredi</span>, <span class="hlFld-ContribAuthor ">Hugues  Nury</span>, <span class="hlFld-ContribAuthor ">Alexander  Roberts</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Anne  Roumier</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Sanger</span>, <span class="hlFld-ContribAuthor ">Milt  Teitler</span>, <span class="hlFld-ContribAuthor ">Trevor  Sharp</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Villalón</span>, <span class="hlFld-ContribAuthor ">Horst  Vogel</span>, <span class="hlFld-ContribAuthor ">Stephanie W.  Watts</span>, <span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, . </span><span class="cited-content_cbyCitation_article-title">International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (1)
                                     , 310-520. <a href="https://doi.org/10.1124/pr.118.015552" title="DOI URL">https://doi.org/10.1124/pr.118.015552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.015552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.015552%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DInternational%252BUnion%252Bof%252BBasic%252Band%252BClinical%252BPharmacology.%252BCX.%252BClassification%252Bof%252BReceptors%252Bfor%252B5-hydroxytryptamine%25253B%252BPharmacology%252Band%252BFunction%26aulast%3DBarnes%26aufirst%3DNicholas%2BM.%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D310%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ksenia  Szmigiel-Bakalarz</span>, <span class="hlFld-ContribAuthor ">Markus  Nentwig</span>, <span class="hlFld-ContribAuthor ">Daniel  Günther</span>, <span class="hlFld-ContribAuthor ">Oliver  Oeckler</span>, <span class="hlFld-ContribAuthor ">Magdalena  Malik-Gajewska</span>, <span class="hlFld-ContribAuthor ">Danuta  Michalska</span>, <span class="hlFld-ContribAuthor ">Barbara  Morzyk-Ociepa</span>. </span><span class="cited-content_cbyCitation_article-title">Sodium and lithium one-dimensional coordination polymers with 1H-indazole-3-carboxylic acid: Crystal structures, vibrational spectra and DFT calculations. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2020,</strong> <em>187 </em>, 114661. <a href="https://doi.org/10.1016/j.poly.2020.114661" title="DOI URL">https://doi.org/10.1016/j.poly.2020.114661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.114661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.114661%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DSodium%252Band%252Blithium%252Bone-dimensional%252Bcoordination%252Bpolymers%252Bwith%252B1H-indazole-3-carboxylic%252Bacid%25253A%252BCrystal%252Bstructures%25252C%252Bvibrational%252Bspectra%252Band%252BDFT%252Bcalculations%26aulast%3DSzmigiel-Bakalarz%26aufirst%3DKsenia%26date%3D2020%26volume%3D187%26spage%3D114661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lokesh  Agrawal</span>, <span class="hlFld-ContribAuthor ">Mustafa  Korkutata</span>, <span class="hlFld-ContribAuthor ">Sunil Kumar  Vimal</span>, <span class="hlFld-ContribAuthor ">Manoj Kumar  Yadav</span>, <span class="hlFld-ContribAuthor ">Sanjib  Bhattacharyya</span>, <span class="hlFld-ContribAuthor ">Takashi  Shiga</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>166 </em>, 107969. <a href="https://doi.org/10.1016/j.neuropharm.2020.107969" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.107969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.107969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.107969%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DTherapeutic%252Bpotential%252Bof%252Bserotonin%252B4%252Breceptor%252Bfor%252Bchronic%252Bdepression%252Band%252Bits%252Bassociated%252Bcomorbidity%252Bin%252Bthe%252Bgut%26aulast%3DAgrawal%26aufirst%3DLokesh%26date%3D2020%26volume%3D166%26spage%3D107969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gopathi  Ramu</span>, <span class="hlFld-ContribAuthor ">Srinivas  Ambala</span>, <span class="hlFld-ContribAuthor ">Jagadeesh Babu  Nanubolu</span>, <span class="hlFld-ContribAuthor ">Bathini  Nagendra Babu</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective ring expansion followed by H-shift of 3-ylidene oxindoles: a convenient synthesis of N-substituted/un-substituted pyrrolo[2,3-
              c
              ] quinolines and marinoquinolines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (60)
                                     , 35068-35072. <a href="https://doi.org/10.1039/C9RA07831B" title="DOI URL">https://doi.org/10.1039/C9RA07831B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA07831B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA07831B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRegioselective%252Bring%252Bexpansion%252Bfollowed%252Bby%252BH-shift%252Bof%252B3-ylidene%252Boxindoles%25253A%252Ba%252Bconvenient%252Bsynthesis%252Bof%252BN-substituted%25252Fun-substituted%252Bpyrrolo%25255B2%25252C3-%252Bc%252B%25255D%252Bquinolines%252Band%252Bmarinoquinolines%26aulast%3DRamu%26aufirst%3DGopathi%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D60%26spage%3D35068%26epage%3D35072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaimin  Mao</span>, <span class="hlFld-ContribAuthor ">Lei  Dai</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Liangce  Rong</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Five‐Component Reaction for the Synthesis of 4,4′‐((2‐Oxoindoline‐3,3‐diyl)bis(methylene))bis(2‐aryl‐1
              H
              ‐pyrrolo[3,4‐
              c
              ]quinoline‐1,3(2
              H
              )‐dione) Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (8)
                                     , 2111-2120. <a href="https://doi.org/10.1002/jhet.3592" title="DOI URL">https://doi.org/10.1002/jhet.3592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3592%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAn%252BEfficient%252BFive%2525E2%252580%252590Component%252BReaction%252Bfor%252Bthe%252BSynthesis%252Bof%252B4%25252C4%2525E2%252580%2525B2%2525E2%252580%252590%252528%2525282%2525E2%252580%252590Oxoindoline%2525E2%252580%2525903%25252C3%2525E2%252580%252590diyl%252529bis%252528methylene%252529%252529bis%2525282%2525E2%252580%252590aryl%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590pyrrolo%25255B3%25252C4%2525E2%252580%252590%252Bc%252B%25255Dquinoline%2525E2%252580%2525901%25252C3%2525282%252BH%252B%252529%2525E2%252580%252590dione%252529%252BDerivatives%26aulast%3DMao%26aufirst%3DKaimin%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D8%26spage%3D2111%26epage%3D2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengning  Ma</span>, <span class="hlFld-ContribAuthor ">Zicheng  Ma</span>, <span class="hlFld-ContribAuthor ">Dawei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Multi-Substituted Pyrrole Derivatives Through [3+2] Cycloaddition with Tosylmethyl Isocyanides (TosMICs) and Electron-Deficient Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (10)
                                     , 2666. <a href="https://doi.org/10.3390/molecules23102666" title="DOI URL">https://doi.org/10.3390/molecules23102666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23102666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23102666%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252BMulti-Substituted%252BPyrrole%252BDerivatives%252BThrough%252B%25255B3%25252B2%25255D%252BCycloaddition%252Bwith%252BTosylmethyl%252BIsocyanides%252B%252528TosMICs%252529%252Band%252BElectron-Deficient%252BCompounds%26aulast%3DMa%26aufirst%3DZhengning%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D10%26spage%3D2666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guido  Furlotti</span>, <span class="hlFld-ContribAuthor ">Maria Alessandra  Alisi</span>, <span class="hlFld-ContribAuthor ">Nicola  Cazzolla</span>, <span class="hlFld-ContribAuthor ">Francesca  Ceccacci</span>, <span class="hlFld-ContribAuthor ">Beatrice  Garrone</span>, <span class="hlFld-ContribAuthor ">Tecla  Gasperi</span>, <span class="hlFld-ContribAuthor ">Angela  La Bella</span>, <span class="hlFld-ContribAuthor ">Francesca  Leonelli</span>, <span class="hlFld-ContribAuthor ">Maria Antonietta  Loreto</span>, <span class="hlFld-ContribAuthor ">Gabriele  Magarò</span>, <span class="hlFld-ContribAuthor ">Giorgina  Mangano</span>, <span class="hlFld-ContribAuthor ">Rinaldo Marini  Bettolo</span>, <span class="hlFld-ContribAuthor ">Emanuela  Masini</span>, <span class="hlFld-ContribAuthor ">Martina  Miceli</span>, <span class="hlFld-ContribAuthor ">Luisa Maria  Migneco</span>, <span class="hlFld-ContribAuthor ">Marco  Vitiello</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Serotonin 2A and Adrenergic α
              1
              Receptors for Ocular Antihypertensive Agents: Discovery of 3,4‐Dihydropyrazino[1,2‐
              b
              ]indazol‐1(2
              H
              )‐one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1597-1607. <a href="https://doi.org/10.1002/cmdc.201800199" title="DOI URL">https://doi.org/10.1002/cmdc.201800199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800199%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeting%252BSerotonin%252B2A%252Band%252BAdrenergic%252B%2525CE%2525B1%252B1%252BReceptors%252Bfor%252BOcular%252BAntihypertensive%252BAgents%25253A%252BDiscovery%252Bof%252B3%25252C4%2525E2%252580%252590Dihydropyrazino%25255B1%25252C2%2525E2%252580%252590%252Bb%252B%25255Dindazol%2525E2%252580%2525901%2525282%252BH%252B%252529%2525E2%252580%252590one%252BDerivatives%26aulast%3DFurlotti%26aufirst%3DGuido%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1597%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Grychowska</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Paweł  Śliwa</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Dubiel</span>, <span class="hlFld-ContribAuthor ">Mikołaj  Matłoka</span>, <span class="hlFld-ContribAuthor ">Rafał  Moszczyński-Pętkowski</span>, <span class="hlFld-ContribAuthor ">Jerzy  Pieczykolan</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3588-3595. <a href="https://doi.org/10.1016/j.bmc.2018.05.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPyrroloquinoline%252Bscaffold-based%252B5-HT6R%252Bligands%25253A%252BSynthesis%25252C%252Bquantum%252Bchemical%252Band%252Bmolecular%252Bdynamic%252Bstudies%25252C%252Band%252Binfluence%252Bof%252Bnitrogen%252Batom%252Bposition%252Bin%252Bthe%252Bscaffold%252Bon%252Baffinity%26aulast%3DGrychowska%26aufirst%3DKatarzyna%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3588%26epage%3D3595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anoop  Singh</span>, <span class="hlFld-ContribAuthor ">Nisar A.  Mir</span>, <span class="hlFld-ContribAuthor ">Sachin  Choudhary</span>, <span class="hlFld-ContribAuthor ">Deepika  Singh</span>, <span class="hlFld-ContribAuthor ">Preetika  Sharma</span>, <span class="hlFld-ContribAuthor ">Rajni  Kant</span>, <span class="hlFld-ContribAuthor ">Indresh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot sequential multicomponent reaction between
              in situ
              generated aldimines and succinaldehyde: facile synthesis of substituted pyrrole-3-carbaldehydes and applications towards medicinally important fused heterocycles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (28)
                                     , 15448-15458. <a href="https://doi.org/10.1039/C8RA01637B" title="DOI URL">https://doi.org/10.1039/C8RA01637B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01637B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01637B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DOne-pot%252Bsequential%252Bmulticomponent%252Breaction%252Bbetween%252Bin%252Bsitu%252Bgenerated%252Baldimines%252Band%252Bsuccinaldehyde%25253A%252Bfacile%252Bsynthesis%252Bof%252Bsubstituted%252Bpyrrole-3-carbaldehydes%252Band%252Bapplications%252Btowards%252Bmedicinally%252Bimportant%252Bfused%252Bheterocycles%26aulast%3DSingh%26aufirst%3DAnoop%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D28%26spage%3D15448%26epage%3D15458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Qing  Shi</span>, <span class="hlFld-ContribAuthor ">Li-De  Liao</span>, <span class="hlFld-ContribAuthor ">Ping  He</span>, <span class="hlFld-ContribAuthor ">Yang-Gen  Hu</span>, <span class="hlFld-ContribAuthor ">Hua  Cheng</span>, <span class="hlFld-ContribAuthor ">Song  Wang</span>, <span class="hlFld-ContribAuthor ">Jun-Jun  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2H-pyrrolo[3,4-C]quinoline via an Aldol/Van Leusen/Staudinger/aza-Wittig sequence. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2016,</strong> <em>46 </em>
                                    (16)
                                     , 1357-1363. <a href="https://doi.org/10.1080/00397911.2016.1204462" title="DOI URL">https://doi.org/10.1080/00397911.2016.1204462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2016.1204462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2016.1204462%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252B2H-pyrrolo%25255B3%25252C4-C%25255Dquinoline%252Bvia%252Ban%252BAldol%25252FVan%252BLeusen%25252FStaudinger%25252Faza-Wittig%252Bsequence%26aulast%3DShi%26aufirst%3DYu-Qing%26date%3D2016%26date%3D2016%26volume%3D46%26issue%3D16%26spage%3D1357%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bao Vy  Lam</span>, <span class="hlFld-ContribAuthor ">Yohann  Berhault</span>, <span class="hlFld-ContribAuthor ">Silvia  Stiebing</span>, <span class="hlFld-ContribAuthor ">Christine  Fossey</span>, <span class="hlFld-ContribAuthor ">Thomas  Cailly</span>, <span class="hlFld-ContribAuthor ">Valérie  Collot</span>, <span class="hlFld-ContribAuthor ">Frédéric  Fabis</span>. </span><span class="cited-content_cbyCitation_article-title">Iodoindazoles with Selective Magnesiation at Position 3: A Route to Highly Functionalized Indazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (13)
                                     , 4440-4446. <a href="https://doi.org/10.1002/chem.201504828" title="DOI URL">https://doi.org/10.1002/chem.201504828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201504828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201504828%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DIodoindazoles%252Bwith%252BSelective%252BMagnesiation%252Bat%252BPosition%252B3%25253A%252BA%252BRoute%252Bto%252BHighly%252BFunctionalized%252BIndazoles%26aulast%3DLam%26aufirst%3DBao%2BVy%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D13%26spage%3D4440%26epage%3D4446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisar A.  Mir</span>, <span class="hlFld-ContribAuthor ">Sachin  Choudhary</span>, <span class="hlFld-ContribAuthor ">Panduga  Ramaraju</span>, <span class="hlFld-ContribAuthor ">Deepika  Singh</span>, <span class="hlFld-ContribAuthor ">Indresh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave assisted aminocatalyzed [3 + 2] annulation between α-iminonitriles and succinaldehyde: synthesis of pyrrole-3-methanols and related polycyclic ring systems. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (46)
                                     , 39741-39749. <a href="https://doi.org/10.1039/C6RA06831F" title="DOI URL">https://doi.org/10.1039/C6RA06831F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA06831F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA06831F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMicrowave%252Bassisted%252Baminocatalyzed%252B%25255B3%252B%25252B%252B2%25255D%252Bannulation%252Bbetween%252B%2525CE%2525B1-iminonitriles%252Band%252Bsuccinaldehyde%25253A%252Bsynthesis%252Bof%252Bpyrrole-3-methanols%252Band%252Brelated%252Bpolycyclic%252Bring%252Bsystems%26aulast%3DMir%26aufirst%3DNisar%2BA.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D46%26spage%3D39741%26epage%3D39749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Pan  Zhou</span>, <span class="hlFld-ContribAuthor ">Bei  Zhou</span>, <span class="hlFld-ContribAuthor ">Jie  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuehai  Shen</span>, <span class="hlFld-ContribAuthor ">Ling-Ling  Lu</span>, <span class="hlFld-ContribAuthor ">Fu-Chao  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient one-step synthesis of pyrrolo[3,4-c]quinolin-1-ones via TMSCl-catalyzed cascade reactions of isatins and β-enamino ketones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (77)
                                     , 73760-73768. <a href="https://doi.org/10.1039/C6RA15492A" title="DOI URL">https://doi.org/10.1039/C6RA15492A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA15492A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA15492A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DConvenient%252Bone-step%252Bsynthesis%252Bof%252Bpyrrolo%25255B3%25252C4-c%25255Dquinolin-1-ones%252Bvia%252BTMSCl-catalyzed%252Bcascade%252Breactions%252Bof%252Bisatins%252Band%252B%2525CE%2525B2-enamino%252Bketones%26aulast%3DXu%26aufirst%3DHui%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D77%26spage%3D73760%26epage%3D73768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fu-Chao  Yu</span>, <span class="hlFld-ContribAuthor ">Bei  Zhou</span>, <span class="hlFld-ContribAuthor ">Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Ya-Min  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>, <span class="hlFld-ContribAuthor ">Yuehai  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component synthesis of functionalized pyrrolo[3,4-c]quinolin-1-ones by an unusual reductive cascade reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (7)
                                     , 1036-1044. <a href="https://doi.org/10.1016/j.tet.2014.12.100" title="DOI URL">https://doi.org/10.1016/j.tet.2014.12.100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.12.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.12.100%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DThree-component%252Bsynthesis%252Bof%252Bfunctionalized%252Bpyrrolo%25255B3%25252C4-c%25255Dquinolin-1-ones%252Bby%252Ban%252Bunusual%252Breductive%252Bcascade%252Breaction%26aulast%3DYu%26aufirst%3DFu-Chao%26date%3D2015%26volume%3D71%26issue%3D7%26spage%3D1036%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Castriconi</span>, <span class="hlFld-ContribAuthor ">Marco  Paolino</span>, <span class="hlFld-ContribAuthor ">Germano  Giuliani</span>, <span class="hlFld-ContribAuthor ">Maurizio  Anzini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Laura  Mennuni</span>, <span class="hlFld-ContribAuthor ">Chiara  Sabatini</span>, <span class="hlFld-ContribAuthor ">Marco  Lanza</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Caselli</span>, <span class="hlFld-ContribAuthor ">Francesca  De Rienzo</span>, <span class="hlFld-ContribAuthor ">Maria Cristina  Menziani</span>, <span class="hlFld-ContribAuthor ">Maria  Sbraccia</span>, <span class="hlFld-ContribAuthor ">Paola  Molinari</span>, <span class="hlFld-ContribAuthor ">Tommaso  Costa</span>, <span class="hlFld-ContribAuthor ">Andrea  Cappelli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>82 </em>, 36-46. <a href="https://doi.org/10.1016/j.ejmech.2014.05.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bin%252Bserotonin%252B5-HT4%252Breceptor%252Bligands%252Bbased%252Bon%252Ba%252Bbenzo%25255Bde%25255D%25255B2%25252C6%25255Dnaphthridine%252Bscaffold%26aulast%3DCastriconi%26aufirst%3DFederica%26date%3D2014%26volume%3D82%26spage%3D36%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin-Mou  Lu</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Jian  Cai</span>, <span class="hlFld-ContribAuthor ">Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Shun-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Shun-Jun  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">One pot synthesis of pyrrolo[3,4-c]quinolinone/pyrrolo[3,4-c]quinoline derivatives from 2-aminoarylacrylates/2-aminochalcones and tosylmethyl isocyanide (TosMIC). </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (46)
                                     , 9471-9477. <a href="https://doi.org/10.1039/C4OB01580K" title="DOI URL">https://doi.org/10.1039/C4OB01580K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01580K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01580K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DOne%252Bpot%252Bsynthesis%252Bof%252Bpyrrolo%25255B3%25252C4-c%25255Dquinolinone%25252Fpyrrolo%25255B3%25252C4-c%25255Dquinoline%252Bderivatives%252Bfrom%252B2-aminoarylacrylates%25252F2-aminochalcones%252Band%252Btosylmethyl%252Bisocyanide%252B%252528TosMIC%252529%26aulast%3DLu%26aufirst%3DXin-Mou%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D46%26spage%3D9471%26epage%3D9477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bjarne  Brudeli</span>, <span class="hlFld-ContribAuthor ">Kjetil Wessel  Andressen</span>, <span class="hlFld-ContribAuthor ">Lise Román  Moltzau</span>, <span class="hlFld-ContribAuthor ">Nils Olav  Nilsen</span>, <span class="hlFld-ContribAuthor ">Finn Olav  Levy</span>, <span class="hlFld-ContribAuthor ">Jo  Klaveness</span>. </span><span class="cited-content_cbyCitation_article-title">Acidic biphenyl derivatives: Synthesis and biological activity of a new series of potent 5-HT4 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (22)
                                     , 7134-7145. <a href="https://doi.org/10.1016/j.bmc.2013.09.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAcidic%252Bbiphenyl%252Bderivatives%25253A%252BSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bpotent%252B5-HT4%252Breceptor%252Bantagonists%26aulast%3DBrudeli%26aufirst%3DBjarne%26date%3D2013%26volume%3D21%26issue%3D22%26spage%3D7134%26epage%3D7145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara L.S.  Kishbaugh</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 319-355. <a href="https://doi.org/10.1016/B978-0-08-099406-2.00006-6" title="DOI URL">https://doi.org/10.1016/B978-0-08-099406-2.00006-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099406-2.00006-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099406-2.00006-6%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DKishbaugh%26aufirst%3DTara%2BL.S.%26date%3D2013%26spage%3D319%26epage%3D355%26pub%3DElsevier%26date%3D2013%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. 5-HT<sub>4</sub>R Ligands Currently Used in Clinical Practice or Trials, <b>1</b>–<b>10</b>, Including Compounds <b>4</b>–<b>9</b> Used To Develop Pharmacophore Models, and Hit Compounds <b>11b</b> and <b>12a</b> Found in the Present Study by a VS Approach</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Enrichment for the top 2%, 5%, and 10% of the data set for the AAP29, APR29, and HPR32 hypotheses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pharmacophore model APR29 for 5-HT<sub>4</sub> antagonists <b>7</b> and <b>8</b>: aromatic ring (R12, brown), positive ionizable group (P11, blue), and acceptor H-bond group (A4, red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Match of compounds <b>11b</b> (orange) and <b>12a</b> (green) with the three pharmacophore features of the APR29 hypothesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Compounds <b>11a–g,m,q–y</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, room temperature; (b) H<sub>2</sub>, 10% Pd/C, CH<sub>3</sub>CO<sub>2</sub>H; (c) alkyl bromide, K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux (or DMF, 80 °C); (d) 2-vinylpyridine, CH<sub>3</sub>CO<sub>2</sub>H, H<sub>2</sub>O, reflux → room temperature; (e) CH<sub>3</sub>I, CH<sub>3</sub>COCH<sub>3</sub>, room temperature; (f) CH<sub>3</sub>I, acetone, room temperature.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Compounds <b>11h</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) SOCl<sub>2</sub>, toluene, reflux; (ii) 1-(1-butyl-4-piperidinyl)methylamine, toluene, room temperature.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to Compounds <b>11l,n–p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-[1-(2-phenylethyl)-4-piperidinyl]methylamine, toluene, reflux; (b) alkyl bromide, DMF, NaH, 0 °C → room temperature; (c) (CH<sub>3</sub>CO)<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Compounds <b>11z,aa,ab</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-(2-bromoethyl)-1-nitrobenzene, EtOH, K<sub>2</sub>CO<sub>3</sub>, reflux; (b) ethyl 4-(2-bromoethyl)benzoate,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> KI, triethylamine, 2-butanone, reflux; (c) 10% Pd/C, H<sub>2</sub>, EtOH, room temperature; (d) 1 N NaOH, THF, EtOH, room temperature.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to Compounds <b>12a–e,i–k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TosMIC, NaH, DMSO, Et<sub>2</sub>O, room temperature; (b) Fe, CH<sub>3</sub>CO<sub>2</sub>H, 85 °C; (c) XR<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C; (d) POCl<sub>3</sub>, Et<sub>3</sub>N, 120 °C; (e) (1-alkyl-4-piperidinyl)methanol, NaH, DMF, 146 °C; (f) H<sub>2</sub>, 10% Pd/C, EtOH; (g) XR<sub>1</sub>, K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux; (h) XR<sub>1</sub>, EtOH, NaHCO<sub>3</sub>, reflux; (i) XR<sub>1</sub>, NaI, Et<sub>3</sub>N, 2-butanone, reflux; (j) 4-(2-bromoethyl)benzyl alcohol (<b>33</b>) or [4-(methoxymethyl)phenyl]ethyl bromide (<b>34</b>), Et<sub>3</sub>N, 2-butanone, reflux.</p></p></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to Compounds <b>12f</b>–<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 4-(2-chloroethyl)benzoate<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or methyl 2-(2-bromoethyl)benzoate (<b>35</b>), NaI, Et<sub>3</sub>N, 2-butanone, reflux; (b) 4-(2-bromoethyl)-1-nitrobenzene, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (c) H<sub>2</sub>, 10% Pd/C, EtOAc (d) 1 N NaOH, THF, EtOH.</p></p></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/medium/jm-2012-00573d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>11ab</b> and <b>12g</b> oral administration in the formalin test in mice: (A) time-course curve, (B) area under time-course curve (0–40 min). The asterisk indicates <i>p</i> < 0.05 vs vehicle group by ANOVA followed by Dunnet’s test for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300573d/production/images/large/jm-2012-00573d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300573d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G.</span><span> </span><span class="NLM_article-title">5-HT receptor classification and nomenclature: towards a harmonization with the human genome</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=419-428&author=D.+Hoyerauthor=G.+Martin&title=5-HT+receptor+classification+and+nomenclature%3A+towards+a+harmonization+with+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DG.%26atitle%3D5-HT%2520receptor%2520classification%2520and%2520nomenclature%253A%2520towards%2520a%2520harmonization%2520with%2520the%2520human%2520genome%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D419%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Humphrey, P. P. A.</span><span> </span><span class="NLM_article-title">The characterization and classification of neurotransmitter receptors</span>.  <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">812</span>, <span class="NLM_issue">1–13</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=812&publication_year=1997&issue=1%E2%80%9313&author=P.+P.+A.+Humphrey&title=The+characterization+and+classification+of+neurotransmitter+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%2BA.%26atitle%3DThe%2520characterization%2520and%2520classification%2520of%2520neurotransmitter%2520receptors%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1997%26volume%3D812%26issue%3D1%25E2%2580%259313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. D.</span><span> </span><span class="NLM_article-title">Serotonin receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr078224o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1614-1641&issue=5&author=D.+E.+Nicholsauthor=C.+D.+Nichols&title=Serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin Receptors</span></div><div class="casAuthors">Nichols, David E.; Nichols, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1614-1641</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on phylogeny, structural features, oligomerization, classification and functions of serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnlR5CHbuX7Vg90H21EOLACvtfcHk0ljRYzKr8fMcpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D&md5=55b70829f6be71cbfe4de05c5ef665d8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr078224o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr078224o%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DNichols%26aufirst%3DC.%2BD.%26atitle%3DSerotonin%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26issue%3D5%26spage%3D1614%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Curr. Drug. Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F1568007043482615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=14965243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=39-51&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors</span></div><div class="casAuthors">Bockaert, J.; Claeysen, S.; Compan, V.; Dumuis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-51</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin 4 receptors (5-HT4Rs) were discovered 15 yr ago.  They are coded by a very complex gene (700Kb, 38 exons) which generates 8 C-terminal variants (a, b, c, d, e, f, g, and n).  Their sequences differ after position L358.  Another variant is characterized by a 14 residue insertion within the extracellular loop 2.  Highly selective potent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studies is still missing.  Based on physiol. and behavioral expts., 5-HT4Rs may be targets to treat cognitive deficits, abdominal pain, and feeding disorders.  One 5-HT4R-directed drug (SL65.0155) is already in phase II to treat patients suffering from memory deficits or dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemFXFD0xNLrVg90H21EOLACvtfcHk0li08oSxWtTrTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D&md5=b9139c95c9d832dd89b51d45fc3bde96</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1568007043482615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482615%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%26jtitle%3DCurr.%2520Drug.%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D39%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors: history, molecular pharmacology and brain functions</span> <span class="citation_source-journal">Neuropharmacaology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">922</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2Fj.neuropharm.2008.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=18603269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Knu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=922-931&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors%3A+history%2C+molecular+pharmacology+and+brain+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors: History, molecular pharmacology and brain functions</span></div><div class="casAuthors">Bockaert, Joel; Claeysen, Sylvie; Compan, Valerie; Dumuis, Aline</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">922-931</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Twenty years ago, the authors started the characterization of a 5-HT receptor coupled to cAMP prodn. in neurons.  This receptor obviously had a different pharmacol. to the other 5-HT receptors described at that time, i.e., the 5-HT1, 5-HT2, 5-HT3 receptors.  The authors proposed to name it the 5-HT4 receptor.  Nowadays, 5-HT4 receptors are one of the most studied GPCRs belonging to the "rhodopsin" family.  Thanks to the existence of a great variety of ligands with inverse agonist, partial agonist, agonist and antagonist profiles, the pharmacol. and physiol. properties of this receptor are beginning to emerge.  Although some 5-HT4 partial agonists have been on the market for gastro-intestinal pathologies, 5-HT4 receptor drugs have still to be commercialized for brain disorders.  However, since 5-HT4 receptors have recognized effects on memory, depression and feeding in animal models, there is still hope for a therapeutic destiny of this interesting target in brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl1VfQpC_B0bVg90H21EOLACvtfcHk0li08oSxWtTrTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Knu7jN&md5=d451b92ef3e3c8fa8b0953b69c873789</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%253A%2520history%252C%2520molecular%2520pharmacology%2520and%2520brain%2520functions%26jtitle%3DNeuropharmacaology%26date%3D2008%26volume%3D55%26spage%3D922%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Eglen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span> </span><span class="NLM_article-title">Central 5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=391-398&author=R.+M.+Eglenauthor=E.+H.+F.+Wongauthor=A.+Dumuisauthor=J.+Bockaert&title=Central+5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEglen%26aufirst%3DR.%2BM.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26atitle%3DCentral%25205-HT4%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1995%26volume%3D16%26spage%3D391%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglen, R. M.</span><span> </span><span class="NLM_article-title">Peripheral 5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=1398-1407&author=S.+Hegdeauthor=R.+M.+Eglen&title=Peripheral+5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DEglen%26aufirst%3DR.%2BM.%26atitle%3DPeripheral%25205-HT4%2520receptors%26jtitle%3DFASEB%2520J.%26date%3D1996%26volume%3D10%26spage%3D1398%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Langlois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmeister, R.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors ligands: application and new prospects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020099f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=319-344&issue=3&author=M.+Langloisauthor=R.+Fischmeister&title=5-HT4+receptors+ligands%3A+application+and+new+prospects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm020099f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020099f%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3D5-HT4%2520receptors%2520ligands%253A%2520application%2520and%2520new%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D3%26spage%3D319%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>3</sub> and 5-HT<sub>4</sub> receptor antagonists</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1002%2F%28SICI%291098-1128%28199703%2917%3A2%3C163%3A%3AAID-MED2%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=9057164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK2sXhvFCitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=163-214&issue=2&author=L.+M.+Gasterauthor=F.+D.+King&title=Serotonin+5-HT3+and+5-HT4+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT3 and 5-HT4 receptor antagonists</span></div><div class="casAuthors">Gaster, Laramie M.; King, Frank D.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-214</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 311 refs., concs. on the more recent aspects of medicinal chem., receptor structure and clin. findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VBcqaBf7VrVg90H21EOLACvtfcHk0ljfUvnvtVprkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvFCitb4%253D&md5=8bf0abd24866bb415e8883f8637f936c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199703%2917%3A2%3C163%3A%3AAID-MED2%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199703%252917%253A2%253C163%253A%253AAID-MED2%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DKing%26aufirst%3DF.%2BD.%26atitle%3DSerotonin%25205-HT3%2520and%25205-HT4%2520receptor%2520antagonists%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26issue%3D2%26spage%3D163%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Van Outryve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toussaint, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eeghem, P.</span><span> </span><span class="NLM_article-title">“Prokinetic” treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride</span> <span class="citation_source-journal">J. Clin. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1097%2F00004836-199102000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=2007745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A280%3ADyaK3M7nvVaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1991&pages=49-57&issue=1&author=M.+Van+Outryveauthor=R.+Miloauthor=J.+Toussaintauthor=P.+Van+Eeghem&title=%E2%80%9CProkinetic%E2%80%9D+treatment+of+constipation-predominant+irritable+bowel+syndrome%3A+a+placebo-controlled+study+of+cisapride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride</span></div><div class="casAuthors">Van Outryve M; Milo R; Toussaint J; Van Eeghem P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical gastroenterology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>
        ISSN:<span class="NLM_cas:issn">0192-0790</span>.
    </div><div class="casAbstract">The effects of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome (IBS) were evaluated in a randomized, double-blind, placebo-controlled study.  Sixty-nine IBS patients were assigned to a 12-week treatment with either 5 mg cisapride or placebo t.i.d.; this dosage could be changed if necessary.  The mean weekly number of days on which a stool was passed in the cisapride and placebo group increased to 5.3 and 4.4 (p less than 0.05) during weeks 8-12 of treatment, and the number of days with stools of normal consistency increased to 3.5 and 1.9 (p less than 0.05), respectively.  At week 12, the reduction in severity and frequency scores for abdominal pain was significantly greater (p less than or equal to 0.05) in the cisapride group (60 and 61%) than in the placebo group (40 and 32%), as it was for abdominal distension (p less than 0.05).  Cisapride tended to be better than placebo in diminishing flatulence.  In 71% versus 39% of the patients the overall rating for the response to treatment was good or excellent at week 12.  Cisapride was well tolerated.  These results suggest that the drug will be useful for the management of constipation-predominant IBS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQM6t45GwYBNuxsqfvU0ziafW6udTcc2ebum9wJKDyZCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7nvVaitw%253D%253D&md5=42937520b98fec720575bbe9c28f4f63</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2F00004836-199102000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004836-199102000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BOutryve%26aufirst%3DM.%26aulast%3DMilo%26aufirst%3DR.%26aulast%3DToussaint%26aufirst%3DJ.%26aulast%3DVan%2BEeghem%26aufirst%3DP.%26atitle%3D%25E2%2580%259CProkinetic%25E2%2580%259D%2520treatment%2520of%2520constipation-predominant%2520irritable%2520bowel%2520syndrome%253A%2520a%2520placebo-controlled%2520study%2520of%2520cisapride%26jtitle%3DJ.%2520Clin.%2520Gastroenterol.%26date%3D1991%26volume%3D13%26issue%3D1%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Appel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span> </span><span class="NLM_article-title">Clinical pharmacodynamics of SDZ HTF919, a new 5-HT<sub>4</sub> receptor agonist, in a model of slow colonic transit</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2FS0009-9236%2897%2990050-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=9390111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK2sXnvVGrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=546-55&issue=5&author=S.+Appelauthor=A.+Kumleauthor=R.+Meier&title=Clinical+pharmacodynamics+of+SDZ+HTF919%2C+a+new+5-HT4+receptor+agonist%2C+in+a+model+of+slow+colonic+transit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit</span></div><div class="casAuthors">Appel, Silke; Kumle, Anette; Meier, Remy</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology and Therapeutics (St. Louis)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">546-555</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby-Year Book, Inc.</span>)
        </div><div class="casAbstract">To explore the pharmacodynamic effects of the new promotile agent SDZ HTF 919, a selective partial 5-HT4 receptor agonist, in healthy subjects.  A pharmacodynamic model was applied to prolong colonic transit by dietary means.  Subsequently, the effects of twice-daily multiple doses of SDZ HTF 919 (1, 5, 25, and 100 mg) were investigated in a randomized, double-blind, placebo-controlled parallel-group study with 12 subjects per dose level.  The sequential design with three study periods of 7 days each included intake of a self-selected diet, a liq. formula diet with sol. fiber supplementation, and a fiber-supplemented diet together with either SDZ HTF 919 or placebo administration.  Stool characteristics (frequency and consistency) and total colonic transit times (with use of radiopaque markers) were recorded in each study period.  SDZ HTF 919 was well tolerated at all dose levels.  The frequency of loose stool and headache increased with higher doses.  After a fiber-supplemented diet intake, the median stool frequency decreased from 81/2-9 to 5-7 defecations per study period.  SDZ HTF 919 in doses of 25 and 100 mg twice a day increased the stool frequency (p < 0.05). Stool consistency was softened by all but the lowest SDZ HTF 919 dose.  A fiber-supplemented diet prolonged total colonic transit time in all groups by 45 h on av.  Twice-a-day administration of SDZ HTF 919 for 6 days in addn. to a fiber-supplemented diet significantly shortened the total colonic transit time only at the 5 mg dose.  The lack of effect at lower and higher SDZ HTF 919 doses suggests a biphasic dose-response relationship for total colonic transit time.  The suitability of total colonic transit time measurements in healthy subjects as a surrogate marker should be confirmed by patient studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTaiDCLd0aLVg90H21EOLACvtfcHk0lhbN5xHPRENYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvVGrtLY%253D&md5=5153f4575aec5757eb25a059132eacc7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0009-9236%2897%2990050-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-9236%252897%252990050-3%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DS.%26aulast%3DKumle%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DR.%26atitle%3DClinical%2520pharmacodynamics%2520of%2520SDZ%2520HTF919%252C%2520a%2520new%25205-HT4%2520receptor%2520agonist%252C%2520in%2520a%2520model%2520of%2520slow%2520colonic%2520transit%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1997%26volume%3D62%26issue%3D5%26spage%3D546%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bouras, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camilleri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, S.</span><span> </span><span class="NLM_article-title">Selective stimulation of colonic transit by the benzofuran 5-HT<sub>4</sub> agonist, prucalopride, in healthy humans</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1999&pages=682-686&issue=5&author=E.+P.+Bourasauthor=M.+Camilleriauthor=D.+D.+Burtonauthor=S.+McKinzie&title=Selective+stimulation+of+colonic+transit+by+the+benzofuran+5-HT4+agonist%2C+prucalopride%2C+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouras%26aufirst%3DE.%2BP.%26aulast%3DCamilleri%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DD.%2BD.%26aulast%3DMcKinzie%26aufirst%3DS.%26atitle%3DSelective%2520stimulation%2520of%2520colonic%2520transit%2520by%2520the%2520benzofuran%25205-HT4%2520agonist%252C%2520prucalopride%252C%2520in%2520healthy%2520humans%26jtitle%3DGut%26date%3D1999%26volume%3D44%26issue%3D5%26spage%3D682%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kjekshus, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torp-Pedersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullestad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Køber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edvardsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjaastad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qvigstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skomedal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osnes, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, F. O.</span><span> </span><span class="NLM_article-title">Effect of piboserod, a 5-HT<sub>4</sub> serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure</span> <span class="citation_source-journal">Eur. J. Heart Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1093%2Feurjhf%2Fhfp087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=19567409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFCntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=771-778&issue=8&author=J.+K.+Kjekshusauthor=C.+Torp-Pedersenauthor=L.+Gullestadauthor=L.+K%C3%B8berauthor=T.+Edvardsenauthor=I.+C.+Olsenauthor=I.+Sjaastadauthor=E.+Qvigstadauthor=T.+Skomedalauthor=J.+B.+Osnesauthor=F.+O.+Levy&title=Effect+of+piboserod%2C+a+5-HT4+serotonin+receptor+antagonist%2C+on+left+ventricular+function+in+patients+with+symptomatic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure</span></div><div class="casAuthors">Kjekshus, John K.; Torp-Pedersen, Christian; Gullestad, Lars; Kober, Lars; Edvardsen, Thor; Olsen, Inge C.; Sjaastad, Ivar; Qvigstad, Eirik; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Heart Failure</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">771-778</span>CODEN:
                <span class="NLM_cas:coden">EJHFFS</span>;
        ISSN:<span class="NLM_cas:issn">1388-9842</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Myocardial 5-HT4 serotonin (5-HT) receptors are increased and activated in heart failure (HF).  Blockade of 5-HT4 receptors reduced left ventricular (LV) remodelling in HF rats.  We evaluated the effect of piboserod, a potent, selective, 5-HT4 serotonin receptor antagonist, on LV function in patients with HF.  This was a prospective, double-blind, parallel group trial in patients with NYHA class II-IV HF and LV ejection fraction (EF) ≤0.35.  Patients receiving std. HF treatment were randomized to placebo (n = 70) or piboserod 80 mg (n = 67) for 24 wk including 4 wk up titrn.  The primary endpoint was LVEF measured by cardiac magnetic resonance imaging (MRI).  Secondary endpoints were LV vols., N-terminal pro-brain natriuretic peptide, norepinephrine, quality of life, and 6 min walk test.  Piboserod significantly increased LVEF by 1.7% vs. placebo (CI 0.3, 3.2, P = 0.020), primarily through reduced end-systolic vol. from 165 to 158 mL (P = 0.060).  There was a trend for greater increase in LVEF (2.7%, CI -1.1, 6.6, P = 0.15) in a small subset of patients not on chronic β-blocker therapy.  There was no significant effect on neurohormones, quality of life, or exercise tolerance.  Patients on piboserod reported more adverse events, but nos. were too small to identify specific safety issues.  Although patients with chronic HF had a small but significant improvement in LVEF when treated with piboserod for 24 wk, the result was not reflected in significant changes in other efficacy parameters, and its clin. relevance remains uncertain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6g8p72EAObVg90H21EOLACvtfcHk0lhbN5xHPRENYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFCntrg%253D&md5=d6af66f3105192dd11626ddbad76a030</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Feurjhf%2Fhfp087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurjhf%252Fhfp087%26sid%3Dliteratum%253Aachs%26aulast%3DKjekshus%26aufirst%3DJ.%2BK.%26aulast%3DTorp-Pedersen%26aufirst%3DC.%26aulast%3DGullestad%26aufirst%3DL.%26aulast%3DK%25C3%25B8ber%26aufirst%3DL.%26aulast%3DEdvardsen%26aufirst%3DT.%26aulast%3DOlsen%26aufirst%3DI.%2BC.%26aulast%3DSjaastad%26aufirst%3DI.%26aulast%3DQvigstad%26aufirst%3DE.%26aulast%3DSkomedal%26aufirst%3DT.%26aulast%3DOsnes%26aufirst%3DJ.%2BB.%26aulast%3DLevy%26aufirst%3DF.%2BO.%26atitle%3DEffect%2520of%2520piboserod%252C%2520a%25205-HT4%2520serotonin%2520receptor%2520antagonist%252C%2520on%2520left%2520ventricular%2520function%2520in%2520patients%2520with%2520symptomatic%2520heart%2520failure%26jtitle%3DEur.%2520J.%2520Heart%2520Failure%26date%3D2009%26volume%3D11%26issue%3D8%26spage%3D771%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lòpezz-Rodrìguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamù, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosado, M. L.</span><span> </span><span class="NLM_article-title">Comparative receptor mapping of serotoninergic 5-HT<sub>3</sub> and 5-HT<sub>4</sub> binding sites</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=589-599&author=M.+L.+L%C3%B2pezz-Rodr%C3%ACguezauthor=M.+J.+Morcilloauthor=B.+Benham%C3%B9author=M.+L.+Rosado&title=Comparative+receptor+mapping+of+serotoninergic+5-HT3+and+5-HT4+binding+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B2pezz-Rodr%25C3%25ACguez%26aufirst%3DM.%2BL.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DBenham%25C3%25B9%26aufirst%3DB.%26aulast%3DRosado%26aufirst%3DM.%2BL.%26atitle%3DComparative%2520receptor%2520mapping%2520of%2520serotoninergic%25205-HT3%2520and%25205-HT4%2520binding%2520sites%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">López-Rodriguez, M. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardob, L.</span><span> </span><span class="NLM_article-title">5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F1568026023393769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=12052197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=625-641&issue=6&author=M.+L+L%C3%B3pez-Rodriguezauthor=B.+Benham%C3%BAauthor=M.+J.+Morcilloauthor=M.+Murciaauthor=A.+Visoauthor=M.+Campilloauthor=L.+Pardob&title=5-HT%284%29+receptor+antagonists%3A+structure-affinity+relationships+and+ligand-receptor+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor antagonists: structure-affinity relationships and ligand-receptor interactions</span></div><div class="casAuthors">Lopez-Rodriguez, M. L.; Benhamu, B.; Morcillo, M. J.; Murcia, M.; Viso, A.; Campillo, M.; Pardo, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-641</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among serotonin receptors (5-HTRs), the 5-HT4 subtype is of considerable interest because it is involved in (patho)physiol. processes both in peripheral and central nervous systems.  In addn. to the clin. use of 5-HT4R agonists in the treatment of gastrointestinal motility disorders, the potential use of antagonists in the treatment of irritable bowel syndrome, arrhythmias and micturition disturbances are currently under investigation.  This article will review the development of the most important classes of 5-HT4R antagonists with an emphasis on benzimidazole derivs., their structure-affinity relationships, ligand-receptor interactions and pharmacol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4a6CfKMjstbVg90H21EOLACvtfcHk0liLKC_--h6Gnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7c%253D&md5=a5221764c9b779605d029c6e1b03acad</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.2174%2F1568026023393769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393769%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodriguez%26aufirst%3DM.%2BL%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DMurcia%26aufirst%3DM.%26aulast%3DViso%26aufirst%3DA.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardob%26aufirst%3DL.%26atitle%3D5-HT%25284%2529%2520receptor%2520antagonists%253A%2520structure-affinity%2520relationships%2520and%2520ligand-receptor%2520interactions%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26issue%3D6%26spage%3D625%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daveu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Molecular design based on 3D-pharmacophore. Application to 5-HT<sub>4</sub> receptor</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci0101354" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFajtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=962-967&issue=2&author=R.+Bureauauthor=C.+Daveuauthor=J.+C.+Lancelotauthor=S.+Rault&title=Molecular+design+based+on+3D-pharmacophore.+Application+to+5-HT4+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Design Based on 3D-Pharmacophore. Application to 5-HT4 Receptor</span></div><div class="casAuthors">Bureau, Ronan; Daveu, Cyril; Lemaitre, Stephane; Dauphin, Francois; Landelle, Henriette; Lancelot, Jean-Charles; Rault, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">962-967</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A definition of a pharmacophore for the 5-HT4 antagonist was carried out by considering a three-dimensional model which correlates the chem. structures of series of antagonists with their biol. affinities.  A mol. design is described by analyzing the differences between two 3D serotonin pharmacophores.  This successful structural modification demonstrates the efficiency of this approach to design new serotonin ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoH_YGD0JLorVg90H21EOLACvtfcHk0liLKC_--h6Gnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFajtrg%253D&md5=6e7eaabc36c12329dbbfee878282e240</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fci0101354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0101354%26sid%3Dliteratum%253Aachs%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DDaveu%26aufirst%3DC.%26aulast%3DLancelot%26aufirst%3DJ.%2BC.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DMolecular%2520design%2520based%2520on%25203D-pharmacophore.%2520Application%2520to%25205-HT4%2520receptor%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2002%26volume%3D42%26issue%3D2%26spage%3D962%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeotti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casamenti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg-Aiello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, A.</span><span> </span><span class="NLM_article-title">Central cholinergic antinociception induced by 5HT4 agonists: BIMU1 and BIMU8</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=2297-2309&issue=25&author=C.+Ghelardiniauthor=N.+Galeottiauthor=F.+Casamentiauthor=P.+Malmberg-Aielloauthor=G.+Pepeuauthor=F.+Gualtieriauthor=A.+Bartolini&title=Central+cholinergic+antinociception+induced+by+5HT4+agonists%3A+BIMU1+and+BIMU8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGaleotti%26aufirst%3DN.%26aulast%3DCasamenti%26aufirst%3DF.%26aulast%3DMalmberg-Aiello%26aufirst%3DP.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DGualtieri%26aufirst%3DF.%26aulast%3DBartolini%26aufirst%3DA.%26atitle%3DCentral%2520cholinergic%2520antinociception%2520induced%2520by%25205HT4%2520agonists%253A%2520BIMU1%2520and%2520BIMU8%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26issue%3D25%26spage%3D2297%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Doak, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawynok, J.</span><span> </span><span class="NLM_article-title">Formalin-induced nociceptive behaviour and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1997&pages=939-949&issue=3&author=G.+J.+Doakauthor=J.+Sawynok&title=Formalin-induced+nociceptive+behaviour+and+edema%3A+involvement+of+multiple+peripheral+5-hydroxytryptamine+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DG.%2BJ.%26aulast%3DSawynok%26aufirst%3DJ.%26atitle%3DFormalin-induced%2520nociceptive%2520behaviour%2520and%2520edema%253A%2520involvement%2520of%2520multiple%2520peripheral%25205-hydroxytryptamine%2520receptor%2520subtypes%26jtitle%3DNeuroscience%26date%3D1997%26volume%3D80%26issue%3D3%26spage%3D939%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Espejo, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, E.</span><span> </span><span class="NLM_article-title">Antagonism of peripheral 5-HT<sub>4</sub> receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT<sub>3</sub> receptors</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">788</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2FS0006-8993%2897%2901510-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=9554939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK1cXhvVSjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=788&publication_year=1998&pages=20-24&author=E.+F.+Espejoauthor=E.+Gil&title=Antagonism+of+peripheral+5-HT4+receptors+reduces+visceral+and+cutaneous+pain+in+mice%2C+and+induces+visceral+analgesia+after+simultaneous+inactivation+of+5-HT3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of peripheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors</span></div><div class="casAuthors">Espejo, Emilio F.; Gil, Eladio</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">788</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">20-24</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The role of 5-HT4 receptors on cutaneous and visceral pain remains largely unexplored.  The objective of this study was to establish the activity profile of SDZ 205-557, a 5-HT4 antagonist, on cutaneous (hotplate) and visceral (writhing) models of pain, after peripheral administration.  Since SDZ 205-557 possesses some affinity for 5-HT3 receptors at high doses, nociceptive effects of a 1:1 combination of SDZ 205-557 and MDL 72222, a 5-HT3 antagonist, were also evaluated.  Drugs were injected 30 min before tests (0, 0.001, 0.01, 0.1 or 1 mg/kg, i.p.).  A hypoalgesic effect of SDZ 205-557 on cutaneous pain was found at 0.1 and 1 mg/kg doses, as revealed through an enhanced nociceptive threshold in rats placed on the hotplate.  This effect was likely mediated through inactivation of peripheral 5-HT4 receptors.  After the 1:1 combination, the hypoalgesic effect disappeared, which indicates that simultaneous inactivation of 5-HT3 and 5-HT4 receptors antagonized peripherally 5-HT4-mediated hypoalgesia by an unknown mechanism.  SDZ 205-557 also induced hypoalgesia in the writhing test over the entire dose range tested, and visceral hypoalgesia turned out to be analgesia after 1:1 combination.  In summary, findings of the present study imply that: (i) antagonism of 5-HT4 receptors mediates antinociception in enteric viscera and, to a lesser extent, in cutaneous terminals, and (ii) dual inactivation of both 5-HT4 and 5-HT3 receptors induces visceral analgesia, a fact which might have clin. importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBi6Y3knPl-LVg90H21EOLACvtfcHk0ljRWVPolgFV-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvVSjtbY%253D&md5=4c6abf73acb79954838fe1eb9b9e99bf</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2897%2901510-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252897%252901510-2%26sid%3Dliteratum%253Aachs%26aulast%3DEspejo%26aufirst%3DE.%2BF.%26aulast%3DGil%26aufirst%3DE.%26atitle%3DAntagonism%2520of%2520peripheral%25205-HT4%2520receptors%2520reduces%2520visceral%2520and%2520cutaneous%2520pain%2520in%2520mice%252C%2520and%2520induces%2520visceral%2520analgesia%2520after%2520simultaneous%2520inactivation%2520of%25205-HT3%2520receptors%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D788%26spage%3D20%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Muller-Lissner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardhan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruegg, P.</span><span> </span><span class="NLM_article-title">Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1046%2Fj.1365-2036.2001.01094.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=11564007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVCgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=1655-1666&author=S.+A.+Muller-Lissnerauthor=I.+Fumagalliauthor=K.+D.+Bardhanauthor=F.+Paceauthor=E.+Pecherauthor=B.+Naultauthor=P.+Ruegg&title=Tegaserod%2C+a+5-HT4+receptor+partial+agonist%2C+relieves+symptoms+in+irritable+bowel+syndrome+patients+with+abdominal+pain%2C+bloating+and+constipation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation</span></div><div class="casAuthors">Muller-Lissner, S. A.; Fumagalli, I.; Bardhan, K. D.; Pace, F.; Pecher, E.; Nault, B.; Ruegg, P.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1655-1666</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Aim of this study was to investigate the efficacy and safety of tegaserod, a novel 5-HT4 receptor partial agonist, in a randomized, double-blind, placebo-controlled, 12-wk treatment, multicenter study.  Eight hundred and eighty-one patients with irritable bowel syndrome, characterized by abdominal pain, bloating and constipation, received tegaserod, 2 mg b.d. or 6 mg b.d., or placebo for 12 wk.  Tegaserod, 2 mg b.d. and 6 mg b.d., showed a statistically significant relief of overall irritable bowel syndrome symptoms, measured by a weekly, selfadministered questionnaire.  At end-point, treatment differences from placebo were 12.7% and 11.8% for 2 mg b.d. and 6 mg b.d., resp.  The effect of tegaserod was noted as early as week 1, and was sustained over the 12-wk treatment period.  Individual irritable bowel syndrome symptoms assessed daily also showed a statistically significant improvement of abdominal discomfort/pain, no. of bowel movements and stool consistency, and a favorable trend for reducing days with significant bloating.  Adverse events were similar in all groups, with transient diarrhea being the only adverse event seen more frequently with tegaserod than placebo.  Based upon the results of this study, tegaserod offers rapid and sustained relief of the abdominal pain and constipation assocd. with irritable bowel syndrome.  Tegaserod is also well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2s5MHLyskbVg90H21EOLACvtfcHk0li62jmWGt_xGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVCgsL4%253D&md5=89b9b37b1e993da668c553a20b0c1c72</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2036.2001.01094.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2036.2001.01094.x%26sid%3Dliteratum%253Aachs%26aulast%3DMuller-Lissner%26aufirst%3DS.%2BA.%26aulast%3DFumagalli%26aufirst%3DI.%26aulast%3DBardhan%26aufirst%3DK.%2BD.%26aulast%3DPace%26aufirst%3DF.%26aulast%3DPecher%26aufirst%3DE.%26aulast%3DNault%26aufirst%3DB.%26aulast%3DRuegg%26aufirst%3DP.%26atitle%3DTegaserod%252C%2520a%25205-HT4%2520receptor%2520partial%2520agonist%252C%2520relieves%2520symptoms%2520in%2520irritable%2520bowel%2520syndrome%2520patients%2520with%2520abdominal%2520pain%252C%2520bloating%2520and%2520constipation%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2001%26volume%3D15%26spage%3D1655%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hinschberger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">New benzo[<i>h</i>][1,6]naphthyridine and azepino[3,2-<i>c</i>]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020954v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=138-147&author=A.+Hinschbergerauthor=S.+Buttauthor=V.+Lelongauthor=M.+Boulouardauthor=A.+Dumuisauthor=F.+Dauphinauthor=R.+Bureauauthor=B.+Pfeifferauthor=P.+Renardauthor=S.+Rault&title=New+benzo%5Bh%5D%5B1%2C6%5Dnaphthyridine+and+azepino%5B3%2C2-c%5Dquinoline+derivatives+as+selective+antagonists+of+5-HT4+receptors%3A+binding+profile+and+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm020954v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020954v%26sid%3Dliteratum%253Aachs%26aulast%3DHinschberger%26aufirst%3DA.%26aulast%3DButt%26aufirst%3DS.%26aulast%3DLelong%26aufirst%3DV.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DRenard%26aufirst%3DP.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DNew%2520benzo%255Bh%255D%255B1%252C6%255Dnaphthyridine%2520and%2520azepino%255B3%252C2-c%255Dquinoline%2520derivatives%2520as%2520selective%2520antagonists%2520of%25205-HT4%2520receptors%253A%2520binding%2520profile%2520and%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D138%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lemaitre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepailleur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt-Gueulle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelong-Boulouard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchatelle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daveu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lezoualc’h, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2607</span><span class="NLM_x">–</span> <span class="NLM_lpage">2622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2607-2622&author=S.+Lemaitreauthor=A.+Lepailleurauthor=R.+Bureauauthor=S.+Butt-Gueulleauthor=V.+Lelong-Boulouardauthor=P.+Duchatelleauthor=M.+Boulouardauthor=A.+Dumuisauthor=C.+Daveuauthor=F.+Lezoualc%E2%80%99hauthor=B.+Pfeifferauthor=F.+Dauphinauthor=S.+Rault&title=Novel+antagonists+of+serotonin-4+receptors%3A+synthesis+and+biological+evaluation+of+pyrrolothienopyrazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLemaitre%26aufirst%3DS.%26aulast%3DLepailleur%26aufirst%3DA.%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DButt-Gueulle%26aufirst%3DS.%26aulast%3DLelong-Boulouard%26aufirst%3DV.%26aulast%3DDuchatelle%26aufirst%3DP.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DDaveu%26aufirst%3DC.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DNovel%2520antagonists%2520of%2520serotonin-4%2520receptors%253A%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520pyrrolothienopyrazines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2607%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">De Maeyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurkes, J. A.</span><span> </span><span class="NLM_article-title">5-HT4 receptor agonists: similar but not the same</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1111%2Fj.1365-2982.2007.01059.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=18199093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=99-112&author=J.+H.+De+Maeyerauthor=R.+A.+Lefebvreauthor=J.+A.+Schuurkes&title=5-HT4+receptor+agonists%3A+similar+but+not+the+same"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor agonists: similar but not the same</span></div><div class="casAuthors">De Maeyer, J. H.; Lefebvre, R. A.; Schuurkes, J. A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology & Motility</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-112</span>CODEN:
                <span class="NLM_cas:coden">NMOTEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-1925</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  5-Hydroxytryptamine4 (5-HT4) receptors are an interesting target for the management of patients in need of gastrointestinal (GI) promotility treatment.  They have proven therapeutic potential to treat patients with GI motility disorders.  Lack of selectivity for the 5-HT4 receptor has limited the clin. success of the agonists used until now.  For instance, next to their affinity for 5-HT4 receptors, both cisapride and tegaserod have appreciable affinity for other receptors, channels or transporters [e.g. cisapride: human ether-a-go-go-related gene (hERG) is K+ channel and tegaserod: 5-HT1 and S-HT2 receptors].  Adverse cardiovascular events obsd. with these compds. are not 5-HT4 receptor-related.  Recent efforts have led to the discovery of a series of selective 5-HT4 receptor ligands, with prucalopride being the most advanced in clin. development.  The selectivity of these new compds. clearly differentiates them from the older generation compds. by minimizing the potential of target-unrelated side effects.  The availability of selective agonists enables the focus to shift to the exploration of 5-HT4 receptor-related differences between agonists.  Based on drug- and tissue-related properties (e.g. differences in receptor binding, receptor d., effectors, coupling efficiency), 5-HT4 receptor agonists are able to express tissue selectivity, i.e. behave as a partial agonist in some and as a full agonist in other tissues.  Furthermore, the concept of ligand-directed signalling offers great opportunities for future drug development by enlarging the scientific basis for the generation of agonist-specific effects in different cell types, tissues or organs.  Selective 5-HT4 receptor agonists might thus prove to be innovative drugs with an attractive safety profile for better treatment of patients suffering from hypomotility disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3mVBES_26DLVg90H21EOLACvtfcHk0lgXH0o0FN7a9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCjtLw%253D&md5=85042809b6a7d78cc95ae9b2e0155940</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2982.2007.01059.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2982.2007.01059.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMaeyer%26aufirst%3DJ.%2BH.%26aulast%3DLefebvre%26aufirst%3DR.%2BA.%26aulast%3DSchuurkes%26aufirst%3DJ.%2BA.%26atitle%3D5-HT4%2520receptor%2520agonists%253A%2520similar%2520but%2520not%2520the%2520same%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2008%26volume%3D20%26spage%3D99%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Toga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohmura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawatsu, R.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>4</sub> agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1254%2Fjphs.SC0070243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=17928736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ygtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=207-210&author=T.+Togaauthor=Y.+Kohmuraauthor=R.+Kawatsu&title=The+5-HT4+agonists+cisapride%2C+mosapride%2C+and+CJ-033466%2C+a+novel+potent+compound%2C+exhibit+different+human+ether-a-go-go-related+gene+%28hERG%29-blocking+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT4 agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities</span></div><div class="casAuthors">Toga, Tetsuo; Kohmura, Yumi; Kawatsu, Ryoichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-210</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">The blocking effect of three 5-HT4 agonists, cisapride, mosapride, and the newly discovered CJ-033466 on the human ether-a-go-go-related gene (hERG) channel was studied using a whole cell patch-clamp technique in HEK293 cells.  Cisapride was the most potent of the hERG blockers.  CJ-033466 had the widest safety margin between its hERG blocking activity and 5-HT4 agonism among the tested compds.  This suggests a lower clin. risk of cardiac arrhythmia in CJ-033466 compared with the other 2 agonists.  Therefore, CJ-033466 has the potential to be a drug with higher therapeutic efficacy and less cardiac risk than both cisapride and mosapride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2YS2QUkupbVg90H21EOLACvtfcHk0lgXH0o0FN7a9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ygtLfN&md5=128df9d0f4ba5a6f818c905f3746876c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1254%2Fjphs.SC0070243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.SC0070243%26sid%3Dliteratum%253Aachs%26aulast%3DToga%26aufirst%3DT.%26aulast%3DKohmura%26aufirst%3DY.%26aulast%3DKawatsu%26aufirst%3DR.%26atitle%3DThe%25205-HT4%2520agonists%2520cisapride%252C%2520mosapride%252C%2520and%2520CJ-033466%252C%2520a%2520novel%2520potent%2520compound%252C%2520exhibit%2520different%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529-blocking%2520activities%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D105%26spage%3D207%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tonini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ponti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crema, F.</span><span> </span><span class="NLM_article-title">Review article: cardiac adverse effects of gastrointestinal prokinetics</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1046%2Fj.1365-2036.1999.00655.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=10594392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1585-1591&author=M.+Toniniauthor=F.+De+Pontiauthor=A.+Di+Nucciauthor=F.+Crema&title=Review+article%3A+cardiac+adverse+effects+of+gastrointestinal+prokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: cardiac adverse effects of gastrointestinal prokinetics</span></div><div class="casAuthors">Tonini, M.; De Ponti, F.; Di Nucci, A.; Crema, F.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1585-1591</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 68 refs.  Gastrointestinal prokinetics, such as metoclopramide, cisapride and levosulpiride, are widely used for the management of functional gut disorders.  Recently, several studies have shown that cisapride (a partial 5-HT4 receptor agonist) can induce dose-dependent cardiac adverse effects, including lengthening of the electrocardiog. QT interval, syncopal episodes and ventricular dysarrhythmias.  Until recently, it was not clear whether these effects were dependent on 5-HT4 receptor activation or related to peculiar characteristics in the mol. structure of single agents within the benzamide class.  Exptl. evidence now favors the second hypothesis: cisapride possesses Class III antiarrhythmic properties and prolongs the action potential duration through blockade of distinct voltage-dependent K+ channels, thus delaying cardiac repolarization and prolonging the QT interval.  Patients at risk of cardiac adverse effects are children, subjects with idiopathic, congenital or acquired long QT syndrome and, in particular, those receiving concomitant medication with Class III antiarrhythmic agents, some H1-receptor antagonists (e.g. terfenadine), or drugs such as azole antifungals (e.g. ketoconazole, itraconazole, miconazole and fluconazole) and macrolide antibacterials (e.g. erythromycin, clarithromycin and troleandomycin), which can inhibit cisapride metab. by interfering with the CYP3A4 isoenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf0dcyPdGAQbVg90H21EOLACvtfcHk0lgXH0o0FN7a9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWntg%253D%253D&md5=4b6fff26045336666b34718373bb3a49</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2036.1999.00655.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2036.1999.00655.x%26sid%3Dliteratum%253Aachs%26aulast%3DTonini%26aufirst%3DM.%26aulast%3DDe%2BPonti%26aufirst%3DF.%26aulast%3DDi%2BNucci%26aufirst%3DA.%26aulast%3DCrema%26aufirst%3DF.%26atitle%3DReview%2520article%253A%2520cardiac%2520adverse%2520effects%2520of%2520gastrointestinal%2520prokinetics%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D1999%26volume%3D13%26spage%3D1585%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F1568007043482598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=14965241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=11-26&author=J.+E.+Leysen&title=5-HT2+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2 receptors</span></div><div class="casAuthors">Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT2 receptors are G-protein coupled receptors that currently comprise 3 subtypes: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  The subtypes are related in their mol. structure, amino acid sequence, and signaling properties.  5-HT2A and 5-HT2C receptors have a widespread distribution and function in the central nervous system.  5-HT2A and 5-HT2C receptor antagonism is a property of certain antipsychotic and antidepressant drugs.  5-HT2B receptors have a restricted expression in the central nervous system.  They have an important role in embryogenesis and in the periphery.  In this article, selected aspects of 5-HT2 receptor research are reviewed for each subtype under 3 main headings: (1) genes, protein structure, and receptor signaling; (2) receptor localization with emphasis on the CNS, and (3) compds.  The general discussion reflects on the reasons for the limited success in the clinic of 5-HT2 receptor subtype selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGTjJwjn8erVg90H21EOLACvtfcHk0lgDCRqv3qc4Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D&md5=9f7316c92e674a8c1cf7b13f48d9711a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1568007043482598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482598%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3D5-HT2%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Trudeau, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmke, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganetzky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. A.</span><span> </span><span class="NLM_article-title">HERG, a human inward rectifier in the voltage-gated potassium channel family</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x"> (</span><span class="NLM_issue">5220</span><span class="NLM_x">) </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1995&pages=92-95&issue=5220&author=M.+C.+Trudeauauthor=J.+W.+Warmkeauthor=B.+Ganetzkyauthor=G.+A.+Robertson&title=HERG%2C+a+human+inward+rectifier+in+the+voltage-gated+potassium+channel+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrudeau%26aufirst%3DM.%2BC.%26aulast%3DWarmke%26aufirst%3DJ.%2BW.%26aulast%3DGanetzky%26aufirst%3DB.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26atitle%3DHERG%252C%2520a%2520human%2520inward%2520rectifier%2520in%2520the%2520voltage-gated%2520potassium%2520channel%2520family%26jtitle%3DScience%26date%3D1995%26volume%3D269%26issue%3D5220%26spage%3D92%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Wysowski, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Torres, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talarico, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, E. M.</span><span> </span><span class="NLM_article-title">Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1111%2Fj.1572-0241.2001.03927.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=11419817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A280%3ADC%252BD3MzlvFSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2001&pages=1698-1703&author=D.+K.+Wysowskiauthor=A.+Corkenauthor=H.+Gallo-Torresauthor=L.+Talaricoauthor=E.+M.+Rodriguez&title=Postmarketing+reports+of+QT+prolongation+and+ventricular+arrhythmia+in+association+with+cisapride+and+Food+and+Drug+Administration+regulatory+actions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions</span></div><div class="casAuthors">Wysowski D K; Corken A; Gallo-Torres H; Talarico L; Rodriguez E M</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1698-703</span>
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    </div><div class="casAbstract">OBJECTIVE:  To describe the postmarketing safety data used in the risk assessment of cisapride and to summarize the regulatory actions of the Food and Drug Administration (FDA).  METHODS:  The FDA analyzed reports of patients who developed QT prolongation, torsades de pointes, and ventricular arrhythmia in association with the use of cisapride to assess probable etiology and risk factors.  RESULTS:  While cisapride was being marketed from 1993-1999, the FDA received reports of the following patients: 117 who developed QT prolongation; 107, torsades de pointes; 16, polymorphic ventricular tachycardia; 18, ventricular fibrillation; 27, ventricular tachycardia; 25, cardiac arrest; 16, serious (unspecified) arrhythmia; and 15, sudden death; for a total of 341 individual patients affected, following use of cisapride.  Eighty (23%) of the 341 patients died.  Deaths were directly or indirectly associated with an arrhythmic event.  Factors that suggested an association with cisapride included a temporal relationship between use of cisapride and arrhythmia, the absence of identified risk factors and other explanations for arrhythmia in some patients, and cases of positive dechallenge and rechallenge.  In most individuals, the arrhythmia occurred in the presence of risk factors (other drugs and/or medical conditions).  CONCLUSIONS:  Postmarketing reports and pharmacokinetic and electrophysiological data provided evidence that cisapride is associated with the occurrence of QT prolongation and torsades de pointes.  The risk of fatal arrhythmia with cisapride was believed to outweigh the benefit for the approved indication, treatment of nocturnal heartburn due to gastroesophageal reflux disease, leading to the drug's discontinuation in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa_s532o1yAZPq5LRczm8ffW6udTcc2ea_zZeuaSUiC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzlvFSktw%253D%253D&md5=fe88c8545fdcf2a603d75b5e73a33db5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1572-0241.2001.03927.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1572-0241.2001.03927.x%26sid%3Dliteratum%253Aachs%26aulast%3DWysowski%26aufirst%3DD.%2BK.%26aulast%3DCorken%26aufirst%3DA.%26aulast%3DGallo-Torres%26aufirst%3DH.%26aulast%3DTalarico%26aufirst%3DL.%26aulast%3DRodriguez%26aufirst%3DE.%2BM.%26atitle%3DPostmarketing%2520reports%2520of%2520QT%2520prolongation%2520and%2520ventricular%2520arrhythmia%2520in%2520association%2520with%2520cisapride%2520and%2520Food%2520and%2520Drug%2520Administration%2520regulatory%2520actions%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2001%26volume%3D96%26spage%3D1698%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fermini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossa, A. A.</span><span> </span><span class="NLM_article-title">The impact of drug-induced QT interval prolongation on drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=439-447&issue=6&author=B.+Ferminiauthor=A.+A.+Fossa&title=The+impact+of+drug-induced+QT+interval+prolongation+on+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFermini%26aufirst%3DB.%26aulast%3DFossa%26aufirst%3DA.%2BA.%26atitle%3DThe%2520impact%2520of%2520drug-induced%2520QT%2520interval%2520prolongation%2520on%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D6%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Schaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomquist, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susemichel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. L.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970857f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1943-1955&author=J.+M.+Schausauthor=D.+C.+Thompsonauthor=W.+E.+Bloomquistauthor=A.+D.+Susemichelauthor=D.+O.+Calligaroauthor=M.+L.+Cohen&title=Synthesis+and+structure-activity+relationships+of+potent+and+orally+active+5-HT4+receptor+antagonists%3A+indazole+and+benzimidazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm970857f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970857f%26sid%3Dliteratum%253Aachs%26aulast%3DSchaus%26aufirst%3DJ.%2BM.%26aulast%3DThompson%26aufirst%3DD.%2BC.%26aulast%3DBloomquist%26aufirst%3DW.%2BE.%26aulast%3DSusemichel%26aufirst%3DA.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520potent%2520and%2520orally%2520active%25205-HT4%2520receptor%2520antagonists%253A%2520indazole%2520and%2520benzimidazolone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1943%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardle, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2<i>H</i>-[1,3]oxazino[3,2-<i>a</i>]indole-10-carboxamide hydrochloride: the first potent and selective 5-HT<sub>4</sub> receptor antagonist amide with oral activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4760</span><span class="NLM_x">–</span> <span class="NLM_lpage">4763</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00024a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4760-4763&author=L.+M.+Gasterauthor=G.+F.+Joinerauthor=F.+D.+Kingauthor=P.+A.+Wymanauthor=J.+M.+Suttonauthor=S.+Binghamauthor=E.+S.+Ellisauthor=G.+J.+Sangerauthor=K.+A.+Wardle&title=N-%5B%281-Butyl-4-piperidinyl%29methyl%5D-3%2C4-dihydro-2H-%5B1%2C3%5Doxazino%5B3%2C2-a%5Dindole-10-carboxamide+hydrochloride%3A+the+first+potent+and+selective+5-HT4+receptor+antagonist+amide+with+oral+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00024a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00024a002%26sid%3Dliteratum%253Aachs%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26aulast%3DSutton%26aufirst%3DJ.%2BM.%26aulast%3DBingham%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DE.%2BS.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26aulast%3DWardle%26aufirst%3DK.%2BA.%26atitle%3DN-%255B%25281-Butyl-4-piperidinyl%2529methyl%255D-3%252C4-dihydro-2H-%255B1%252C3%255Doxazino%255B3%252C2-a%255Dindole-10-carboxamide%2520hydrochloride%253A%2520the%2520first%2520potent%2520and%2520selective%25205-HT4%2520receptor%2520antagonist%2520amide%2520with%2520oral%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4760%26epage%3D4763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Alisi, A.; Brufani, M.; Cazzolla, N.; Giannangeli, M.; Pinza, M.</span><span> </span><span class="NLM_article-title">Preparation of indazoleamide compounds as serotoninergic agents</span>. PCT Int. Appl. WO 9846589,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=A.+Alisi&author=M.+Brufani&author=N.+Cazzolla&author=M.+Giannangeli&author=M.+Pinza&title=Preparation+of+indazoleamide+compounds+as+serotoninergic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlisi%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520indazoleamide%2520compounds%2520as%2520serotoninergic%2520agents%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Xie, W.; Herbert, B.; Schumacher, R.; Nguyen, T. M.; Ma, J.; Gauss, C. M.; Tehim, A.</span><span> </span><span class="NLM_article-title">Preparation of quinuclidine indazole, benzothiazole, benzisothiazole and benzisoxazoles as ligands for the α7 nicotinic acetylcholine receptor</span>. PCT Int. Appl. WO 2005092890,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Xie&author=B.+Herbert&author=R.+Schumacher&author=T.+M.+Nguyen&author=J.+Ma&author=C.+M.+Gauss&author=A.+Tehim&title=Preparation+of+quinuclidine+indazole%2C+benzothiazole%2C+benzisothiazole+and+benzisoxazoles+as+ligands+for+the+%CE%B17+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26atitle%3DPreparation%2520of%2520quinuclidine%2520indazole%252C%2520benzothiazole%252C%2520benzisothiazole%2520and%2520benzisoxazoles%2520as%2520ligands%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Inoue, T.; Watanabe, S.; Yamagishi, T.; Arano, Y.; Morita, M.; Shimada, K.</span><span> </span><span class="NLM_article-title">Preparation of pyridinylcarboxamide derivatives and analogs for use as calcium or sodium channel blockers</span>. PCT Int. Appl. WO 2010137351,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Inoue&author=S.+Watanabe&author=T.+Yamagishi&author=Y.+Arano&author=M.+Morita&author=K.+Shimada&title=Preparation+of+pyridinylcarboxamide+derivatives+and+analogs+for+use+as+calcium+or+sodium+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520pyridinylcarboxamide%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520calcium%2520or%2520sodium%2520channel%2520blockers%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Foreman, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvain, S. M.</span><span> </span><span class="NLM_article-title">Reaction of organic halides with piperidine. V. Negatively substituted ethyl bromides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1940</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1435</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01863a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1940&pages=1435-1438&author=E.+L.+Foremanauthor=S.+M.+McElvain&title=Reaction+of+organic+halides+with+piperidine.+V.+Negatively+substituted+ethyl+bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja01863a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01863a029%26sid%3Dliteratum%253Aachs%26aulast%3DForeman%26aufirst%3DE.%2BL.%26aulast%3DMcElvain%26aufirst%3DS.%2BM.%26atitle%3DReaction%2520of%2520organic%2520halides%2520with%2520piperidine.%2520V.%2520Negatively%2520substituted%2520ethyl%2520bromides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1940%26volume%3D62%26spage%3D1435%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Di Santo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeffi, C.</span><span> </span><span class="NLM_article-title">A general, versatile synthesis of 2<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolines via tosylmethylisocyanide reaction</span> <span class="citation_source-journal">ARKIVOC</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span><span class="NLM_issue">v</span><span class="NLM_x">) </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=181-195&issue=v&author=R.+Di+Santoauthor=R.+Costiauthor=M.+Forteauthor=C.+Galeffi&title=A+general%2C+versatile+synthesis+of+2H-pyrrolo%5B3%2C4-c%5Dquinolines+via+tosylmethylisocyanide+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DForte%26aufirst%3DM.%26aulast%3DGaleffi%26aufirst%3DC.%26atitle%3DA%2520general%252C%2520versatile%2520synthesis%2520of%25202H-pyrrolo%255B3%252C4-c%255Dquinolines%2520via%2520tosylmethylisocyanide%2520reaction%26jtitle%3DARKIVOC%26date%3D2004%26issue%3Dv%26spage%3D181%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Diaz, P.; Millois Barbuis, C.</span><span> </span><span class="NLM_article-title">Preparation of bi-aromatic compounds, particularly 4-[(3-aminocarbonylhydrazono-2-oxo-2,3-dihydro-1<i>H</i>-indol-5-yl)sulfanylalkyl]benzoic acid derivatives, as PPAR modulators, and their use in cosmetic and pharmaceutical compositions</span>. PCT Int. Appl. WO 2006063863,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+Diaz&author=C.+Millois+Barbuis&title=Preparation+of+bi-aromatic+compounds%2C+particularly+4-%5B%283-aminocarbonylhydrazono-2-oxo-2%2C3-dihydro-1H-indol-5-yl%29sulfanylalkyl%5Dbenzoic+acid+derivatives%2C+as+PPAR+modulators%2C+and+their+use+in+cosmetic+and+pharmaceutical+compositions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520bi-aromatic%2520compounds%252C%2520particularly%25204-%255B%25283-aminocarbonylhydrazono-2-oxo-2%252C3-dihydro-1H-indol-5-yl%2529sulfanylalkyl%255Dbenzoic%2520acid%2520derivatives%252C%2520as%2520PPAR%2520modulators%252C%2520and%2520their%2520use%2520in%2520cosmetic%2520and%2520pharmaceutical%2520compositions%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moormann, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullikson, G. W.</span><span> </span><span class="NLM_article-title">SC-53606, a potent and selective antagonist of 5-hydroxytryptamine 4 receptors in isolated rat esophageal tunica muscularis mucosae</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">1339</span><span class="NLM_x">–</span> <span class="NLM_lpage">1347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=8396633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaK2cXitlektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1993&pages=1339-1347&author=D.+Yangauthor=B.+Goldstinauthor=A.+E.+Moormannauthor=D.+L.+Flynnauthor=G.+W.+Gullikson&title=SC-53606%2C+a+potent+and+selective+antagonist+of+5-hydroxytryptamine+4+receptors+in+isolated+rat+esophageal+tunica+muscularis+mucosae"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae</span></div><div class="casAuthors">Yang, Dai Chang; Goldstin, Bela; Moormann, Alan E.; Flynn, Daniel L.; Gullikson, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1339-47</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">SC-53606 (I) acts as an antagonist of 5-hydroxytryptamine4 (5-HT4) receptor-mediated relaxation of carbachol-induced contractions in rat esophageal tunica muscular mucosae, but does not possess 5-HT4 agonist activity.  I demonstrated a pA2 value against 5-HT in this tissue of 7.91 ± 0.08 (Ki = 12.3 ± 1.17 nM).  Similar pA2 values of 7.68 ± 0.06, 7.67 ± 0.06 and 7.63 ± 0.05 were detd. for the synthetic 5-HT4 receptor agonists SC-53116, 5-methoxytryptamine and renzapride, resp.  In addn., slopes of Schild plots for antagonism of these four agonists by I were 1.07 ± 0.02, 0.98 ± 0.03, 1.04 ± 0.02 and 0.96 ± 0.06, resp., and did not deviate from unity.  The pA2 values for 5-HT4 antagonism against 5-HT were detd. to be 6.80 ± 0.09 for tropisetron and 7.36 ± 0.08 for 2-methoxy-4-amino-S-chlorobenzoic acid-2-(diethylamino)ethyl ester SDZ 205-557), indicating that I is more a potent 5-HT4 antagonist than either of the ref. antagonists.  Radioligand binding studies also demonstrated that I is a selective antagonist with more affinity for 5-HT4 than for other 5-HT receptors.  Displacement of radioligand binding from 5-HT1 and 5-HT2 receptors by I was less than 50% at a 10 μM concn.  Similarly, I displayed little binding affinity at alpha1, alpha2 and beta adrenergic, dopamine1, dopamine2 and muscarinic cholinergic receptors.  The Ki for binding to rat cortical 5-HT3 receptors was 259 ± 28 nM, which was 21 times less than the pA2 concn. in the rat esophageal tunica muscular mucosae assay.  I was also a weaker antagonist at 5-HT3 receptors in guinea pig ileum than either tropisetron or SDZ 205-557 (IC50 values of 40 μM, 0.05 μM and 10 μM, resp., against 10 μM of 2-methyl-5-HT).  These results demonstrate that I is a potent antagonist at the 5-HT4 receptor and possesses selectivity that makes it a useful pharmacol. tool for studying 5-HT4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQrw_JeQx7XrVg90H21EOLACvtfcHk0lhzwDcbeF9Q-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlektg%253D%253D&md5=f62e05ddd4f19c66b7bcea4feb55bfbe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DGoldstin%26aufirst%3DB.%26aulast%3DMoormann%26aufirst%3DA.%2BE.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26aulast%3DGullikson%26aufirst%3DG.%2BW.%26atitle%3DSC-53606%252C%2520a%2520potent%2520and%2520selective%2520antagonist%2520of%25205-hydroxytryptamine%25204%2520receptors%2520in%2520isolated%2520rat%2520esophageal%2520tunica%2520muscularis%2520mucosae%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D266%26spage%3D1339%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The functional hERG/Kv11.1 potassium ion channel assay was performed at Ricerca Biosciences (Bothell, WA).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mialet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmoune, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lezoualc’h, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berque-Bestel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eftekhari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebeke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicsic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishmeister, R.</span><span> </span><span class="NLM_article-title">Exploration of the ligand binding site of the human 5-HT4 receptor by site-directed mutagenesis and molecular modeling</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1038%2Fsj.bjp.0703356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=10821780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVGjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=527-538&author=J.+Mialetauthor=Y.+Dahmouneauthor=F.+Lezoualc%E2%80%99hauthor=I.+Berque-Bestelauthor=P.+Eftekhariauthor=J.+Hoebekeauthor=S.+Sicsicauthor=M.+Langloisauthor=R.+Fishmeister&title=Exploration+of+the+ligand+binding+site+of+the+human+5-HT4+receptor+by+site-directed+mutagenesis+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the ligand binding site of the human 5-HT4 receptor by site-directed mutagenesis and molecular modeling</span></div><div class="casAuthors">Mialet, Jeanne; Dahmoune, Yamina; Lezoualc'h, Frank; Berque-Bestel, Isabelle; Eftekhari, Pierre; Hoebeke, Johan; Sicsic, Sames; Langlois, Michel; Fischmeister, Rodolphe</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-538</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Among the five human 5-HT4 (h5-HT4) receptor isoforms, the h5-HT4(a) receptor was studied with a particular emphasis on the mol. interactions involved in ligand binding.  For this purpose, we used site-directed mutagenesis of the transmembrane domain.  Twelve mutants were constructed with a special focus on the residue P4.53 of helix IV which substitutes in h5-HT4 receptors the highly conserved S residue among the rhodopsin family receptors.  The mutated receptors were transiently expressed in COS-7 cells.  2 Ligand binding or competition studies with two h5-HT4 receptor agonists, serotonin and ML10302 and two h5-HT4 receptor antagonists, [3H]-GR113808 and ML10375 were performed on wild type and mutant receptors.  Functional activity of the receptors was evaluated by measuring the ability of serotonin to stimulate adenylyl cyclase.  3 Ligand binding expts. revealed that [3H]-GR113808 did not bind to mutants P4.53A, S5.43A, F6.51A, Y7.43A and to double mutant F6.52V/N6.55L.  On the other hand mutations D3.32N, S5.43A and Y7.43A appeared to promote a dramatic decrease of h5-HT4(a) receptor functional activity.  From these studies, S5.43 and Y7.43 clearly emerged as common anchoring sites to antagonist [3H]-GR113808 and to serotonin.  4 According to these results, we propose ligand-receptor complex models with serotonin and [3H]-GR113808.  For serotonin, three interaction points were selected including ionic interaction with D3.32, a stabilizing interaction of this ion pair by Y7.43 and a hydrogen bond with S5.43.  [3H]-GR113808 was also docked, based on the same type of interactions with S5.43 and D3.32: the proposed model suggested a possible role of P4.53 in helix IV structure allowing the involvement of a close hydrophobic residue, W4.50, in a hydrophobic pocket for hydrophobic interactions with the indole ring of [3H]-GR113808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEm6BTPYUgX7Vg90H21EOLACvtfcHk0lj-cJNSfJwOkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVGjs78%253D&md5=a188fb16d4d316c476b1093aaa526ca9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703356%26sid%3Dliteratum%253Aachs%26aulast%3DMialet%26aufirst%3DJ.%26aulast%3DDahmoune%26aufirst%3DY.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DBerque-Bestel%26aufirst%3DI.%26aulast%3DEftekhari%26aufirst%3DP.%26aulast%3DHoebeke%26aufirst%3DJ.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DFishmeister%26aufirst%3DR.%26atitle%3DExploration%2520of%2520the%2520ligand%2520binding%2520site%2520of%2520the%2520human%25205-HT4%2520receptor%2520by%2520site-directed%2520mutagenesis%2520and%2520molecular%2520modeling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D527%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rivail, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastineau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthouze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishmeister, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lezoualc’h, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicsic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berque-Bestel, I.</span><span> </span><span class="NLM_article-title">New insights into the human 5-HT<sub>4</sub> receptor binding site: exploration of a hydrophobic pocket</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1038%2Fsj.bjp.0705950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=15351779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVyis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=361-370&author=L.+Rivailauthor=M.+Ginerauthor=M.+Gastineauauthor=M.+Berthouzeauthor=J.+L.+Soulierauthor=R.+Fishmeisterauthor=F.+Lezoualc%E2%80%99hauthor=B.+Maigretauthor=S.+Sicsicauthor=I.+Berque-Bestel&title=New+insights+into+the+human+5-HT4+receptor+binding+site%3A+exploration+of+a+hydrophobic+pocket"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the human 5-HT4 receptor binding site: Exploration of a hydrophobic pocket</span></div><div class="casAuthors">Rivail, Lucie; Giner, Mireille; Gastineau, Monique; Berthouze, Magali; Soulier, Jean-Louis; Fischmeister, Rodolphe; Lezoualc'h, Frank; Maigret, Bernard; Sicsic, Sames; Berque-Bestel, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A body of evidences suggests that a hydrophobic pocket of the human 5-HT4 receptor contributes to the high affinity of some bulky 5-HT4 ligands.  A thorough study of this pocket was performed using mutagenesis and mol. modeling.  Ligand binding or competition studies with selected bulky ligands (RS 39604, RS 100235, [3H]GR 113808 and ML 11411) and small ligands (5-HT and ML 10375) were carried out on wild-type and mutant receptors (W7.40A/F, Y7.43F, R3.28L) transiently transfected in COS-7 cells.  The functional activity of the mutated receptors was evaluated by measuring the ability of 5-HT to stimulate adenylyl cyclase.  For W7.40F mutation, no changes in the affinity of studied ligands and in the functional activity of the mutant receptor were obsd., in contrary to W7.40A mutation, which abolished both binding of ligands and 5-HT-induced cAMP prodn.  Mutation R3.28L revealed a totally silent receptor with a basal level of cAMP prodn. similar to the mock control despite its ability to product cAMP in the presence of 5-HT.  Moreover, a one order loss of affinity of RS 39604 and a 45-fold increase of ML 11411 affinity were obsd.  Mutation Y7.43F modified the affinity of GR 113808, which displays a 13-fold lower affinity for the mutant than for the wild-type receptor.  In conclusion, in the hydrophobic pocket, two polar amino acids are able to interact through hydrogen bonds with bulky ligands depending on their chem. properties.  Moreover, these exptl. data may validate the proposed new three-dimensional model of the human 5-HT4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkPqbDWez4MLVg90H21EOLACvtfcHk0lj-cJNSfJwOkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVyis7c%253D&md5=de43001334ea4d88f90d4dfb8dacdac1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705950%26sid%3Dliteratum%253Aachs%26aulast%3DRivail%26aufirst%3DL.%26aulast%3DGiner%26aufirst%3DM.%26aulast%3DGastineau%26aufirst%3DM.%26aulast%3DBerthouze%26aufirst%3DM.%26aulast%3DSoulier%26aufirst%3DJ.%2BL.%26aulast%3DFishmeister%26aufirst%3DR.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DBerque-Bestel%26aufirst%3DI.%26atitle%3DNew%2520insights%2520into%2520the%2520human%25205-HT4%2520receptor%2520binding%2520site%253A%2520exploration%2520of%2520a%2520hydrophobic%2520pocket%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bojarski, A. J.</span><span> </span><span class="NLM_article-title">Pharmacophore models for metabotropic 5-HT receptor ligands</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2005</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.2174%2F156802606778522186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=17017971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFens7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=2005-2026&author=A.+J.+Bojarski&title=Pharmacophore+models+for+metabotropic+5-HT+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore models for metabotropic 5-HT receptor ligands</span></div><div class="casAuthors">Bojarski, Andrzej J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2005-2026</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  An overview of pharmacophore models, developed for different subtypes of serotonin receptors belonging to the GPCR family, is presented.  Starting with early models for 5-HT1A and 5-HT2 receptor ligands, and ending with the latest ones for 5-HT6- and 5-HT7 receptors, as many as fifty others are briefly summarized.  No models have been developed for 5-HT1F-, 5-HT2B- and 5-HT5B receptor ligands, and in the case of 5-HT1E- and 5-HT5ARs only single pilot studies with non-selective tryptamine derivs. are reported.  For all the other subtypes of 5-HTRs, various pharmacophore hypotheses - either qual. and/or quant. - are characterized by sets of ligands used for their generation, a templates for alignment, the computational methods applied and, eventually, interfeature distances and/or statistical results - if available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaQnt4eol1NrVg90H21EOLACvtfcHk0lj-cJNSfJwOkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFens7fE&md5=c70400be602bf0be330047f128f2615e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F156802606778522186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778522186%26sid%3Dliteratum%253Aachs%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26atitle%3DPharmacophore%2520models%2520for%2520metabotropic%25205-HT%2520receptor%2520ligands%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D2005%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lgx4Pg0-jK4Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zhu, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadambi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Inhibitory effect of carboxylic acid group on hERG binding</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5507</span><span class="NLM_x">–</span> <span class="NLM_lpage">5512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5507-5512&author=B.+Y.+Zhuauthor=Z.+J.+Jiaauthor=P.+Zhangauthor=T.+Suauthor=W.+Huangauthor=E.+Goldmanauthor=D.+Tumasauthor=V.+Kadambiauthor=P.+Eddyauthor=U.+Sinhaauthor=R.+M.+Scarboroughauthor=Y.+Song&title=Inhibitory+effect+of+carboxylic+acid+group+on+hERG+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BY.%26aulast%3DJia%26aufirst%3DZ.%2BJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DGoldman%26aufirst%3DE.%26aulast%3DTumas%26aufirst%3DD.%26aulast%3DKadambi%26aufirst%3DV.%26aulast%3DEddy%26aufirst%3DP.%26aulast%3DSinha%26aufirst%3DU.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibitory%2520effect%2520of%2520carboxylic%2520acid%2520group%2520on%2520hERG%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5507%26epage%3D5512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brudeli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltzau, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andressen, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krobert, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaveness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, F. O.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">8600</span><span class="NLM_x">–</span> <span class="NLM_lpage">8613</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=8600-8613&author=B.+Brudeliauthor=L.+R.+Moltzauauthor=K.+W.+Andressenauthor=K.+A.+Krobertauthor=J.+Klavenessauthor=F.+O.+Levy&title=Synthesis+and+pharmacological+properties+of+novel+hydrophilic+5-HT4+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrudeli%26aufirst%3DB.%26aulast%3DMoltzau%26aufirst%3DL.%2BR.%26aulast%3DAndressen%26aufirst%3DK.%2BW.%26aulast%3DKrobert%26aufirst%3DK.%2BA.%26aulast%3DKlaveness%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DF.%2BO.%26atitle%3DSynthesis%2520and%2520pharmacological%2520properties%2520of%2520novel%2520hydrophilic%25205-HT4%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D18%26spage%3D8600%26epage%3D8613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="note"><p class="first last">The large in vitro pharmacologic profile was performed at Ricerca Biosciences (Bothell, WA) on the following assays: (receptor binding) adrenergic α1 (nonselective) (rat), adrenergic α1A (rat), adrenergic α1B (rat), adrenergic α1D (human), chemokine CCR2B (human), cholecystokinin CK1 (CCKA) (human), cholecystokinin CCK2 (CCKB) (human), muscarinic nonselective (rat), muscarinic oxotremorine M (rat), serotonin 5-HT1A (human), serotonin 5-HT1B (rat), serotonin 5-HT2A (human), serotonin 5-HT2B (human), serotonin 5-HT2C (human), serotonin 5-HT3 (human), serotonin 5-HT4 (guinea pig), serotonin 5-HT5A (human), serotonin 5-HT6 (human), serotonin 5-HT7 (human), σ1 (human), σ2 (rat), sodium channel, site 2 (rat), serotonin transporter (SERT) (human); (enzymatic assays) catechol-<i>O</i>-methyltransferase (COMT) (pig), monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) (human); (cell-based assay) serotonin uptake (human).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Uno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamataki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, R.</span><span> </span><span class="NLM_article-title">CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=477-486&author=Y.+Unoauthor=H.+Fujinoauthor=G.+Kitoauthor=T.+Kamatakiauthor=R.+Nagata&title=CYP2C76%2C+a+novel+cytochrome+P450+in+cynomolgus+monkey%2C+is+a+major+CYP2C+in+liver%2C+metabolizing+tolbutamide+and+testosterone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUno%26aufirst%3DY.%26aulast%3DFujino%26aufirst%3DH.%26aulast%3DKito%26aufirst%3DG.%26aulast%3DKamataki%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DR.%26atitle%3DCYP2C76%252C%2520a%2520novel%2520cytochrome%2520P450%2520in%2520cynomolgus%2520monkey%252C%2520is%2520a%2520major%2520CYP2C%2520in%2520liver%252C%2520metabolizing%2520tolbutamide%2520and%2520testosterone%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D79%26spage%3D477%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and non specific binding to microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&issue=11&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+non+specific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520non%2520specific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26issue%3D11%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Eddy, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimbach, D.</span><span> </span><span class="NLM_article-title">Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=13035677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaG3sXjvVCgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1953&pages=385-393&author=N.+B.+Eddyauthor=D.+Leimbach&title=Synthetic+analgesics.+II.+Dithienylbutenyl-+and+dithienylbutylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic analgesics. II. Dithienylbutenylamines and dithienylbutylamines</span></div><div class="casAuthors">Eddy, Nathan B.; Leimbach, Dorothy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-93</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">cf. C.A. 44, 4579h.  Compds. studied were the 3-(diethylamino), 3-(ethylmethylamino), 3-(dimethylamino), and 3-(1-pyrryl) derivs. of 1,1-bis(2-thienyl)-1-butene and the corresponding derivs. of butane.  All were highly analgesic when administered subcutaneously to mice.  The toxicity was also detd.  The butane derivs. were less toxic and less analgesic than their butene analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobVb8xQBXx2bVg90H21EOLACvtfcHk0lgs61rs2a9JWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXjvVCgsg%253D%253D&md5=f10e46ab856034f792285afac0e448f3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEddy%26aufirst%3DN.%2BB.%26aulast%3DLeimbach%26aufirst%3DD.%26atitle%3DSynthetic%2520analgesics.%2520II.%2520Dithienylbutenyl-%2520and%2520dithienylbutylamines%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1953%26volume%3D107%26spage%3D385%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Dubuisson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, S. G.</span><span> </span><span class="NLM_article-title">The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+formalin+test%3A+a+quantitative+study+of+the+analgesic+effects+of+morphine%2C+meperidine+and+brain+stem+stimulation+in+rats+and+cats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520formalin%2520test%253A%2520a%2520quantitative%2520study%2520of%2520the%2520analgesic%2520effects%2520of%2520morphine%252C%2520meperidine%2520and%2520brain%2520stem%2520stimulation%2520in%2520rats%2520and%2520cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Irwin, S.</span><span> </span><span class="NLM_article-title">Comprehensive observational assessment: a systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse</span> <span class="citation_source-journal">Pychopharmacologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1007%2FBF00401402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=5679627" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1968&pages=222-257&author=S.+Irwin&title=Comprehensive+observational+assessment%3A+a+systematic%2C+quantitative+procedure+for+assessing+the+behavioral+and+physiologic+state+of+the+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2FBF00401402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00401402%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DS.%26atitle%3DComprehensive%2520observational%2520assessment%253A%2520a%2520systematic%252C%2520quantitative%2520procedure%2520for%2520assessing%2520the%2520behavioral%2520and%2520physiologic%2520state%2520of%2520the%2520mouse%26jtitle%3DPychopharmacologica%26date%3D1968%26volume%3D13%26spage%3D222%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Roux, S.; Sable, E.; Porsolt, R. D.</span><span> </span><span class="NLM_article-title">Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effect on behaviour and physiological function</span>. In  <span class="citation_source-book">Current Protocols in Pharmacology</span>; <span class="NLM_contrib-group">Enna, S. J.; Williams, M.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>Suppl. 27, Unit 10.10, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1-23&author=S.+Roux&author=E.+Sable&author=R.+D.+Porsoltauthor=S.+J.+Enna&author=M.+Williams&title=Current+Protocols+in+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DS.%26atitle%3DPrimary%2520observation%2520%2528Irwin%2529%2520test%2520in%2520rodents%2520for%2520assessing%2520acute%2520toxicity%2520of%2520a%2520test%2520agent%2520and%2520its%2520effect%2520on%2520behaviour%2520and%2520physiological%2520function%26btitle%3DCurrent%2520Protocols%2520in%2520Pharmacology%26aulast%3DEnna%26aufirst%3DS.%2BJ.%26pub%3DWiley%26date%3D2004%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Dixon, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smondyrev, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">10–11</span><span class="NLM_x">) </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=647-671&issue=10%E2%80%9311&author=S.+L.+Dixonauthor=A.+M.+Smondyrevauthor=E.+H.+Knollauthor=S.+N.+Raoauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=PHASE%3A+a+new+engine+for+pharmacophore+perception%2C+3D+QSAR+model+development%2C+and+3D+database+screening%3A+1.+Methodology+and+preliminary+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BL.%26aulast%3DSmondyrev%26aufirst%3DA.%2BM.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DPHASE%253A%2520a%2520new%2520engine%2520for%2520pharmacophore%2520perception%252C%25203D%2520QSAR%2520model%2520development%252C%2520and%25203D%2520database%2520screening%253A%25201.%2520Methodology%2520and%2520preliminary%2520results%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2006%26volume%3D20%26issue%3D10%25E2%2580%259311%26spage%3D647%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glide, J. L.</span><span> </span><span class="NLM_article-title">A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&issue=7&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=+Banksauthor=J.+L.+Glide&title=A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0liOWP6dkLbxNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aulast%3DGlide%26aufirst%3DJ.%2BL.%26atitle%3DA%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D7%26spage%3D1750%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Woolfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Donald, A. D.</span><span> </span><span class="NLM_article-title">The evaluation of the analgesic action of pethidine hydrochloride (DEMEROL)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1944</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADyaH2cXhs1KjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1944&pages=300-307&author=G.+Woolfeauthor=A.+D.+Mac+Donald&title=The+evaluation+of+the+analgesic+action+of+pethidine+hydrochloride+%28DEMEROL%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the analgesic action of pethidine hydrochloride (demerol)</span></div><div class="casAuthors">Woolfe, G.; Macdonald, A. A.</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1944</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">300-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A new method for evaluation of analgesics is described, based on the behavior of mice when placed on a metal plate heated to various temps. above 50°.  By this method subcutaneously injected demerol is found to have 17-20% of the analgesic activity of morphine against mild pain stimuli, but to be ineffective against severe pain.  Aminopyrine and antipyrine are effective only in very large doses, and phenobarbital-Na and acetylsalicylic acid have no analgesic action that can be detected by this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDG8L_V7hxwbVg90H21EOLACvtfcHk0liOWP6dkLbxNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH2cXhs1KjsQ%253D%253D&md5=88adc110a721335ba2f1d20aecf4534b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoolfe%26aufirst%3DG.%26aulast%3DMac%2BDonald%26aufirst%3DA.%2BD.%26atitle%3DThe%2520evaluation%2520of%2520the%2520analgesic%2520action%2520of%2520pethidine%2520hydrochloride%2520%2528DEMEROL%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1944%26volume%3D80%26spage%3D300%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Colucci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonito, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscopo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giannuario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span> </span><span class="NLM_article-title">New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm300573d&amp;key=10.1016%2Fj.phrs.2008.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm300573d&amp;key=18508278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300573d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=419-425&author=M.+Colucciauthor=F.+Maioneauthor=M.+C.+Bonitoauthor=A.+Piscopoauthor=A.+Di+Giannuarioauthor=S.+Pieretti&title=New+insights+of+dimethyl+sulphoxide+effects+%28DMSO%29+on+experimental+in+vivo+models+of+nociception+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation</span></div><div class="casAuthors">Colucci, Mariantonella; Maione, Francesco; Bonito, Maria Carmela; Piscopo, Alessandro; Di Giannuario, Amalia; Pieretti, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-425</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">DMSO is one of the most common solvents used exptl. to dissolve hydrophobic substances for in vivo and in vitro purposes.  A wide range of pharmacol. effects exerted by DMSO has been documented in both animal and human exptl. models.  However, only a few and sometimes contrasting data about the effects of DMSO in animal models of nociception and inflammation are presently available.  In this study, we evaluated the effects induced by DMSO and a DMSO-contg. saline on thermal and chem. nociception, inflammation and locomotor activity in CD1 mice.  We demonstrated that centrally or orally administered DMSO displayed anti-nociceptive effects to thermal (hot plate and tail-flick test) and chem. (formalin test) stimuli.  Conversely, DMSO was able to increase both nociceptive phases in the formalin test when applied s.c. in the dorsal surface of the mouse hind paws 10 min before formalin administration.  Oral administration of DMSO produced anti-inflammatory effects on zymosan-induced edema in the mouse paw, whereas local administration potentiated the inflammatory action exerted by zymosan.  Oral and central, but not local, administration of DMSO improved the mouse locomotor activity.  These results suggest that DMSO displayed opposite effects on nociception and inflammation, depending on the route of administration.  New and helpful evidence about DMSO lab. applications need to be considered in the in vivo studies to assess correctly the pharmacol. properties of investigated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIPra2SUYh27Vg90H21EOLACvtfcHk0liOWP6dkLbxNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWmsLk%253D&md5=b82b7797f9069c122e70284a276518ae</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DColucci%26aufirst%3DM.%26aulast%3DMaione%26aufirst%3DF.%26aulast%3DBonito%26aufirst%3DM.%2BC.%26aulast%3DPiscopo%26aufirst%3DA.%26aulast%3DDi%2BGiannuario%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26atitle%3DNew%2520insights%2520of%2520dimethyl%2520sulphoxide%2520effects%2520%2528DMSO%2529%2520on%2520experimental%2520in%2520vivo%2520models%2520of%2520nociception%2520and%2520inflammation%26jtitle%3DPharmacol.%2520Res.%26date%3D2008%26volume%3D57%26spage%3D419%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i94"><a href="/doi/suppl/10.1021/jm300573d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77355"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures regarding the pharmacophore approach, synthetic methods for compounds <b>29</b> and <b>33</b>–<b>35</b>, analyses, 5-HT<sub>4</sub>R functional assay, and in vitro pharmacology profiles. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300573d/suppl_file/jm300573d_si_001.pdf">jm300573d_si_001.pdf (261.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300573d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm300573d" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300573d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67c749216a6a2374","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
